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Abstract: The process by which the totipotent zygote undergoes development into an
adult organism using a single genome is the foundation for epigenetics and cellular dif-
ferentiation. Somatic cell nuclear transfer experiments (SCNT) provided unequivocal
proof of nuclear equivalency between adult somatic cells. However the molecular
mechanisms of somatic cell reprogramming have remained largely a mystery. Recent
advancements in epigenetic reprogramming by defined factors provide new opportuni-
ties to explore factors that regulate induction of pluripotency in somatic cells. Nuclear
reprogramming by SCNT occurs in an 'indirect' manner by unidentified components
within oocyte cytoplasm and requires the destruction of embryos. The introduction of
induced pluripotent stem cells (iPS cells) and 'direct' reprogramming methods created a
tractable system to both study of the process in vitro and potentially derive personal-
ized pluripotent stem cells free of the practical and ethical concerns surrounding em-
bryonic stem (ES) cells and SCNT. Herein we study mouse somatic cell reprogramming
by defined factors and develop novel tools to compare the induced pluripotent state to
the gold standard of pluripotency, ES cells. First, we designed reprogramming vectors
that minimize the number of viruses required to generate iPS cells, yielding pluripotent
cells with minimal genomic alterations from reprogramming factors. This allowed the
creation of transgenic "reprogrammable mouse" strains after gene targeting in ES cells,
providing a renewable source of somatic cells that can be induced to pluripotency by
addition of a drug. In addition we can easily introduce or mate these strains to study
unique genetic variants during reprogramming. Third, we study factors that influence
the induced pluripotent state, specifically how to generate pluripotent cells with all
properties of embryonic stem cells including derivation of "all iPS cell mice" by
tetraploid complementation assays. In contrast to previous reports, we find the majority
(- 80%) of iPS cell lines derived from adult somatic cells of varying organs contain the
developmental potential of ES cells. This outcome correlated with high expression of
Oct4 and Klf4 and low expression of Sox2 and c-Myc during reprogramming. In addi-
tion we report that adult mice derived from iPS cells are healthy and do not develop
tumors. Together these results suggest in vitro reprogramming to pluripotency by de-
fined factors holds great promise for regenerative medicine.
Thesis supervisor: Dr. Rudolf Jaenisch
Title: Professor of Biology
Dedication: I would like to dedicate this to my father James R. Carey for his endless en-
couragement and support of my pursuits towards a life conducting scientific research.
He endures as a model for me both personally and academically as someone who lives
with great integrity, absolute honesty and strength of character.
Acknowledgements:
I would like to first thank Rudolf for taking me into his lab. It has been a remarkable
experience I will never forget. He and all lab members were extremely welcoming upon
arrival and provided me with a fantastic, highly supportive environment to conduct my
thesis research. Although conducted in a super charged, internationally competitive
time surrounding the discovery of induced pluripotent stem cells, Rudolf always main-
tained his patience, support, and encouragement no matter what was going on around
us. His steadfast leadership and long-term commitment ensured the success of all of my
projects.
I also have had the privilege of working alongside a good friend and colleague Jacob
Hanna, who I would like to thank. His keen insights and vision on many projects kept
me from veering off course numerous times. His focus and determination to do the
right experiment were an inspiration throughout my time in the Jaenisch lab. These ex-
periments would also not have been possible without several other close colleagues
who have also become good friends. I would not have got off the ground without the
help of Marius Wernig. His efforts to establish reprogramming technologies in the
Jaenisch lab propelled many careers forward including my own, teaching me my first
reprogramming experiment and helping me design my first reprogramming vectors. I
would like to thank Stella Markoulaki who I worked with on every project to generate
mice. She remains a strong supporter and someone who I can always rely on. Caroline
Beard provided invaluable help in the beginning stages of my projects; her keen advice
and unparalled knowledge of molecular biology will always be remembered as an in-
valuable asset to the Jaenisch lab. Kibibi Gantz is also someone who helped me in the
mouse-generating department. I appreciate her dedication and feel she is a great new
addition to the Jaenisch Lab. I would also like to thank Maya Mitalipova who intro-
duced me to human stem cell work. She provided crucial support in the early years of
my project. In addition I held close collaborations with Menno Creyghton and Albert
Cheng who taught me genome-wide mapping technologies, always showing patience
and dedication to our questions. Along the way I was supported experimentally or
stimulated intellectually from many post-docs and grad students such as Frank Soldner,
Chris Lengner, Kris Saha, JP Kim, Mike Lodato, Leah Medieros, John Cassady, Dina
Faddah, Grant Welstead and always received support in some form or another by any-
one who I asked for help. This is something that is often taken for granted in the
Jaenisch lab!!
Most importantly I want to thank the person who kept me sane throughout this proc-
ess, my fianc Leah Cohen. She has been my most steadfast supporter at all times and
continually helped me stay balanced outside of lab. I feel so very lucky to have her in
my life.
Finally I want to thank my thesis committee members Tyler Jacks, Peter Reddien and
Laurie Boyer. They always encouraged me to keep at it and to be patient so I can do the
right experiment. Their skepticism also helped me stay on course at critical junctures. In
addition I want to thank Alex Meissner for returning to the Whitehead to generously
serve as my outside committee member.
Table of Contents
A b stract ........................................................................................................ 3
D ed ication ..................................................................................................... 4
Acknowledgements.........................................................................................5
Table of Contents........................................................................................ 6
List of Figures............................................................................................. 8
Chapter 1. Introduction....................................................................................9
1.1 Reprogramming by nuclear transfer..........................................9
1.2 Signaling pathways to stabilize pluripotency in vitro...................15
1.3 Core transcriptional circuitry of the pluripotent state...................18
1.4 Epigenetic regulation of pluripotency and differentiation ............... 26
1.5 In vitro reprogramming of somatic cells to pluripotency..................30
1.6 Direct reprogramming to pluripotency with defined factors.............33
1.7 Molecular mechanisms governing in vitro reprogramming..............39
1.8 Does the induced pluripotent state represent
ESC-like pluripotency?......................................................... 46
Chapter 2. Reprogramming of murine and human somatic cells
using a single polycistronic vector...................................................66
A b stract.....................................................................................67
Introduction............................................................................68
R esu lts................................................................................... 69
Discussion...............................................................................74
Materials and Methods..................................................................77
Chapter 3. Single-gene transgenic mouse strains for reprogramming
adult somatic cells......................................................................97
A bstract.................................................................................. 98
R esu lts................................................................................... 98
Materials and Methods................................................................105
Chapter 4. Reprogramming factor expression and stoichiometry influence
the epigenetic and biological properties of iPS cells................ 128
A b stract....................................................................................129
Introdu ction .............................................................................. 130
R esu lts.....................................................................................131
D iscu ssion ................................................................................ 138
Materials and Methods...............................................................140
Chapter 5. Conclusion..................................................................................162
Su m m ary .................................................................................. 163
Future applications of iPSC technology...........................................166
APPENDIX I. Genome-wide maps of chromatin modifications in
tissue-specific iPS cells...................................................................169
LIST OF FIGURES
CHAPTER 1
FIGURE 1:
FIGURE 2:
FIGURE 3:
FIGURE 4:
FIGURE 5:
FIGURE 6:
FIGURE 7:
Two-step derivation of NT-ESCs from terminally differentiated cells.........14
Signaling principles of the "ground state" of pluripotency......................17
Model of Core ES Cell Regulatory Circutry......................................22
Parallel circuitry of the LIF signal pathways......................................24
Four strategies to induce reprogramming of somatic cells....................31
Direct reprogramming involves stochastic epigenetic events.................42
Reprogrammable mouse strain.......................................................44
CHAPTER 2
FIGURE 1:
FIGURE 2:
FIGURE 3:
FIGURE 4:
Generation of murine iPS cells using a single 4F2A polycistronic virus......86
4F2A iPS cells express pluripotency markers........................................87
4F2A iPS cells are pluripotent and contain between 1-3
proviral integrations................................................................ 88
Generation of human iPS lines using a single 4F2A polycistronic virus......89
CHAPTER 3
FIGURE 1: Reprogramming somatic cells from transgenic Collal 4F2A mice......108
FIGURE 2: iPSCs derived from Collal 3F2Atransgenic MEFs expressing.................109
a subset of reprogramming factors
FIGURE 3: Cre-excisable Collal 4F2A transgenic ES cells.....................................110
CHAPTER 4
FIGURE 1:
FIGURE 2:
FIGURE 3:
FIGURE 4:
FIGURE 5:
Generation of Collal 21ox iPSCs ...................................................... 149
Generation of Collal-factor-free 4n-competent iPSCs...........................150
Silencing of Dlkl-Dio3 locus is not a strict marker
of reduced pluripotency..............................................................151
Stoichiometry during reprogramming influences the
epigenetic state of the Dlk1-Dio3 locus...........................................152
iPSC mice do not show elevated mortality from tumors........................153
Chapter 1: Introduction
In vitro somatic cell reprogramming has taken on new meaning in the last few
years with the introduction of induced pluripotent stem cells (iPSCs). Remarkably, the
human genome contains over 22,000 protein-coding genes and yet just three or four are
sufficient to reprogram adult somatic cells into an embyronic-like state. These findings
raised considerable interest in the nature and stability of cellular differentiation, as had
been highlighted by the pioneers of reprogramming research using somatic cell nuclear
transfer (SCNT). The reprogramming of cell identity can now be observed and studied
in a petri dish, providing a model system to test the rules required for rewiring of both
gene expression and chromatin in order for cells to take on new functions. In this chap-
ter I will describe two main areas of scientific research that provide the conceptual and
biological foundation of my thesis research. I will summarize what is understood to
date about nuclear reprogramming and the establishment, propagation and mainte-
nance of pluripotency in vitro. Towards this goal I will end by discussing similarities
and differences between pluripotent cells created by current reprogramming technolo-
gies and speculate as to whether there is sufficient evidence to suggest defined factors
re-establish cell identities with molecular and developmental potential similar to what
has been described by isolation of pluripotent cells from the embryo.
1.1 Reprogramming by nuclear transfer
Upon fertilization the single cell zygote proceeds through a defined set of cellular
divisions using one genome to guide and instruct the development of an adult organ-
ism containing over 200 diverse cell types. The process of cellular differentiation is uni-
directional and fundamentally epigenetic in nature. As differentiation ensues there is a
concomitant reduction in cellular potency, defined herein as the sum of developmental
options accessible to the cell. Totipotency, is the ability to form all lineages of an organ-
ism, and in mammals only the zygote and the first cleavage blastomeres contain this po-
tential. Cleavage divisions allow the zygotic genome to become activated, and as this
period ceases, compaction begins leading to formation of the blastocyst. It is at this
stage that the first segregation of developmental lineages is accomplished. The outer
layer of cells form an epithelium, the trophectoderm, responsible for generating the ex-
traembryonic tissue, and the interior epiblast cells of the inner cell mass (ICM), devel-
ops into the embryo proper. Pluripotency, or the ability to give rise to all somatic cells
including the germ lineage of an adult animal, exists only transiently during develop-
ment but has been experimentally demonstrated to exist within the epiblast cells of the
ICM ". This relatively unspecified cell state can be immortalized in vitro in the form of
embryonic stem cells (ESCs) derived from explantation of the inner cell mass (ICM) of
preimplantation blastocyst embryos, a pluripotent cell type that will be discussed in
later sections 3. Emerging from a brief period of pluripotency the postimplantation
embryo begins gastrulation generating tissues and organs with highly specialized func-
tions. Some tissues, such as the hematopoetic, contain adult stem cells that are consid-
ered multipotent, giving rise to differentiated cells only within their lineage but not oth-
ers. The vast majorities of cells however, become terminally differentiated, rendered
unipotent, and only give rise to identical daughter cells throughout their lifetime.
Beginning more than a half-century ago, scientists tested whether a reduction in
developmental potential during differentiation is an irreversible process, and applied
the technique of somatic cell nuclear transfer (SCNT) to test whether the capacity for
embryonic development still existed within a somatic cell nucleus following differentia-
tion. These experiments were some of the first attempts at nuclear reprogramming,
which for the purposes of this thesis will be defined as a gain in developmental potency.
Somatic cell nuclear transfer (SCNT) describes the technique by which a somatic nu-
cleus is transferred to an enucleated oocyte to generate cloned embryos or animals
achieved by reactivation of developmental gene expression programs without altering
the underlying DNA sequence. The successful derivation of cloned amphibians from
Xenopus intestinal epithelial cell nuclei argued somatic cells contain all basic genetic in-
formation required for development and revealed that epigenetic marks acquired dur-
ing differentiation are fully reversible, providing compelling evidence against the hy-
pothesis that differentiation permanently inactivated or discarded much of the nuclear
genome 6,7. The concept of nuclear equivalency between somatic and embryonic cells
emerged. The genomic nucleotide content between these cells is virtually identical with
embryonic gene expression programs silenced in somatic cells being capable of
reactivation simply by exposure to egg cytoplasm. Only decades later were the pioneer-
ing nuclear transfer efforts of Briggs and King along with the foundational cloning ex-
periments of John Gurdon, successfully translated to mammalian systems by McGrath
and Solter. Using Sendai-virus-mediated cell fusion, they demonstrated murine zygotic
pronuclei could reconstitute an enucleated zygote to generate blastocysts and following
embryo transfer, live mice 8. However following a similar protocol, unsuccessful ex-
periments using nuclei from more developed embryonic cells, such as cleavage stage
blastomeres or inner cell mass (ICM), raised concerns as to the ability of mammalian
systems to successfully generate cloned adult animals from adult somatic cells 9.
These conclusions were soon proved premature, and rested largely upon the ac-
tivation status of the egg, as cytoplasm of unactivated oocytes (Metaphase II arrested)
supported reprogramming after nuclear transfer. By electrical-mediated membrane fu-
sion, embryonic or adult ovine cells introduced into unactivated oocytes generated
adult sheep "'". One hypothesis for the failure of previous efforts was that reprogram-
ming factors remained in the cytoplasm in unactivated oocytes, but were sequested
upon entry into the cell cycle in the fertilized egg. Data by Wakayama and colleagues
support this hypothesis and show in vitro development is markedly reduced in cloned
embryos using oocyte cytoplasm transitioning from meiosis to G1 1. Interestingly, re-
searchers recently addressed whether entry into the cell cycle sequesters reprogram-
ming activities that would otherwise be present within the egg cytoplasm of unacti-
vated oocytes. Eggan and colleagues reversibly arrested activated mouse zygotes using
a microtubule depolymerizing agent nicodozole in combination with a proteasome in-
hibitor MG-132 to delay the metaphase-to-anaphase transition allowing chromosome
capture and replacement 1. Using either embryonic or somatic cell chromosomes, also
arrested in mitosis, - 60% of embryos that received new chromosomes entered the cell
cycle and initiated further cleavage to blastocyst stage embryos with - 30% transferred
to pseudo pregnant females producing adult mice 1. Shortly thereafter this protocol
was applied to mouse blastomeres ". These data argue that reprogramming factors are
removed following zygotic activation, most likely by nuclear condensation, but remain
and accessible even after the initiation of cleavage divisions.
Although many animals have now been produced following transfer of somatic
nuclei into enucleated oocytes: sheep ", cows ", pigs 16,17, goats ". and mice 2, there was
much debate over the identity of donor cells, and whether successes were largely due to
rare stem cells present within the culture. Intriguing evidence also came from studies
comparing nuclear transfer of unique donor cells in mouse. Donor cells with more em-
bryonic origins, such as blastomeres or embryonic stem cells, show a marked increase in
12
generating cloned mice (5-25% of blastocysts transfered) when compared to cumulus
cell or tail-tip fibroblast nuclear donor embryos (1-3% and 0.5% respectively) 12,19-23
These data suggest the embryonic genome may be inherently more amenable to epige-
netic reprogramming than somatic cells. One hypothesis is that embryonic genes essen-
tial for development, such as Oct4 2 are already expressed in embryonic cells. Therefore
faulty or incomplete reactivation was less likely to occur compared to somatic cells,
whose embryonic genes are epigenetically silenced and must be reactivated to an em-
bryonic-like epigenetic state. Evidence in support of this hypothesis has been observed
when comparing gene expression profiles between ESC- or somatic cell derived cloned
embryos 2.
To definitively address the hypothesis that only rare populations of somatic cells
were amenable to cloning, and that highly specialized somatic cells may actually prove
intractable to cloning, much effort was put forth to generate cloned animals from termi-
nally differentiated cells that could be retrospectively identified by permanent alterna-
tions to the genome. B and T lymphocytes proved suitable for this type of analysis as
heavy and or light chain rearrangements to the B- or T-cell receptors yielded cells with
permanent genetic identification reflecting their stage of differentiation reached 26. Simi-
lar approaches using the genetic marking of terminally differentiated olfactory neurons
demonstrated even cells that have exited the cell cycle can re-enter development 27. The
success of these studies required modifications to existing protocols of murine SCNT,
using a two-step procedure that began first by generating ES cells from cloned blasto-
cysts, and then was followed by the generation of adult monoclonal mice using the
tetraploid embryo complementation method.
Tetraploid
Derive blastocyst
MN NT , ES cells injection
FIGURE 1: Two-step derivation of adult mice from terminally differentiated cell nuclei
(Eggan et al., 2004)
The NT-ES cell lines and the derived monoclonal mice carried rearrangements of
the IgH and IgL immunoglobulin loci or TCRa and TCRP chain rearrangements, dem-
onstrating their origin from a mature B or T cell, respectively 26. Later experiments used
different adult, genetically modified, lymphocytes and achieved cloned mice using a
one-step protocol 28
The reprogramming activities of the oocyte or early embryonic cells capable of
reprogramming such a diverse set of somatic cells sparked intense interest in the mo-
lecular identity of reprogramming factors. Following the discoveries and technological
advances described previously, and along with the isolation of human embryonic stem
cells in 1998, cloning captured the imagination of many who believed that "personal-
ized" genetically identical pluripotent cells could be generated to usher in an unprece-
dented era of regenerative medicine ,29. Alternative reprogramming strategies other
than nuclear transfer will be discussed in detail after a review of pluripotency and em-
bryonic stem cells.
1.2: Signaling pathways to stabilize pluripotency in vitro
Embryonic stem cells (ESCs) self-renew indefinitely and with each division, cre-
ate two daughter cells with identical potential, all while retaining the ability to generate
somatic cells of all three germ layers both in vitro and in vivo. ESCs colonize the ICM
following microinjection of blastocysts, and after embryo transfer to pseudo pregnant
mothers produce functional soma and germ cells 30. The initial derivation of ESCs from
normal blastocyst stage embryos was performed using the "129" mouse strain 3. Isola-
tion and maintenance of pluripotent ESCs was first performed using media containing
fetal bovine serum and a layer of mouse embryonic fibroblast (MEFs) feeders. Feeders
were later found to secrete an essential cytokine, LIF, whose signaling through the Jak-
Stat3 pathway is necessary for normal ESC self-renewal ". LIF binding to the LIF recep-
tor causes heterodimerization with gp130, which results in the activation of the recep-
tor-associated tyrosine kinase Jak 32. Activated Jak phosphorylates several tyrosines of
gp130, which serve as docking sites for Stat family transcription factors. In the absence
of LIF, Stat3 activation is sufficient for maintenance of undifferentiated ESCs 3. Interest-
ingly, mutant embryos deficient in the LIF gene form normal ICM ', supporting the ob-
servations that although some requirements for pluripotency in vitro are similar, some
aspects remain distinct from what is necessary for growth and expansion of the epiblast
in vivo.
Serum factors necessary for ESC growth have been identified as bone morpho-
genic factor 4 (BMP4), whose downstream signaling through Smad family of transcrip-
tion factors induces inhibitor of differentiation (Id) genes3 . This pathway was found to
maintain ESC self-renewal by inhibiting lineage-specific transcription factors, which in
turn, enable the self-renewal response to LIF/ Stat3 ". Importantly, without LIF, BMP
acts as a differentiation promoter and generates non-neural epithelial-like cells 36,37,
suggesting the integration of these pathways reinforce self-renewal of ESCs. Austin
Smith and colleagues hypothesized a "ground state" of pluripotency could be isolated
by suppression or neutralization of differentiation signals generally, which would insu-
late the ESC transcriptional network to allow self-renewal. To this end, investigation
into the signaling pathways sufficient for ESC maintenance turned to previously charac-
terized pathways that had been reported to induce differentiation of ESCs 3 6' 3.
A key observation was that autoinductive signaling by fibroblast growth factor-4
(FGF4) and the mitogen-activated protein kinase pathway (via ERK1 /2) induces differ-
entiation of ESCs, which precluded long-term growth of undifferentiated ESCs in de-
fined (serum-free) media. Neither BMB4 nor LIF signaling inhibits activation of ERK1 /2
in ESCs, and importantly, inhibition of ERK1 /2 had previously been reported to en-
hance the maintenance of ESCs 38. Moreover, genetic impairment or selective chemical
blockade of this pathway can sustain self-renewal of mouse ESCs in the absence of LIF
signaling 31. In a landmark study by Smith and colleagues they described the require-
ments for maintenance of what was termed the "ground state" of pluripotency using
defined media with small molecule inhibitors (termed "2i") of both protein kinases
ERK1 / 2 and GSK3P, which when combined with LIF, supported maintenance of fully
pluripotent ESCs without serum or feeders " (Figure 2). The inhibition of GSK3P was
proposed as a means to increase the biosynthetic capacity of ESCs as GSK3p has been
identified as a central inhibitor of various anabolic processes in the cell. Moreover inhi-
bition of GSK3p mimics activation of Wnt signaling, which has also been shown to
promote pluripotency 41-. An alternative to "2i + LIE" conditions was also described,
termed "3i,"which also includes an inhibitor of the FGF receptor, and does not require
addition of LIF for propagation of pluripotent ESCs * . Suppression of these pathways
during development of mouse blastocysts indicate development of the ICM is not im-
peded and that derivation of ESCs from single epiblast cells is greatly enhanced 4
FGF4 FGF4 SU6402
PD184352
BMP
p-ERK p-ERK
LIP
CH1R99021
FIGURE 2: Signaling principles of the "ground state" of pluripotency Self-replication of the pluripotent
state can occur when inductive phospho-ERK signaling is counteracted downstream by LIF and BMP. In
chemically defined conditions, antagonists of this pathway augment self-renewal when phospho-ERK (p-
ERK) is suppressed by maintaining cellular growth capacity and additionally suppressing differentiation
(Ying et al., Nature 2008).
The signaling principles of ground state of pluripotency have broader applications
beyond permissive murine strains. Application of the empirically established ESC deri-
vation protocol to inbred mouse strains other than 129 or C57BL /6, for example the
non-obese diabetic (NOD) strain or even other rodents such as rat, do not yield pluripo-
tent cells similar to ICM-derived ESCs. However under "3i" or "2i+LIF" conditions rat
or NOD mouse E3.5-E4.5 blastocysts give rise to ESCs with molecular and developmen-
tal character reflecting authentic 129 mouse ICM-derived ESCs, such as signaling de-
pendence on LIF /Stat3 and formation of adult chimeras with contribution to the germ-
line "-''. Because ESCs could be isolated from previously refractory strains and species
in vitro, these data argue instability of the pluripotent state in vitro can be overcome
and stabilized with appropriate signaling stimulation 5". These data also highlight the
importance of endogenous genetic determinants, which can be lacking in certain genetic
backgrounds.
1.3: Core transcriptional circuitry of the pluripotent state
The previous section concentrated on the signaling pathways that enable the es-
tablishment and maintenance of the pluripotent state of ESCs in vitro. These pathways
collectively act to stabilize the global transcriptional program of ESCs, which is begin-
ning to be understood. The identification of key transcription factors critical to estab-
lishing pluripotency in vitro and in vivo is the focus of this section. Classical genetic
analysis has been utilized to provide the most compelling evidence to date for a role in
pluripotency, therefore I chose to focus on several genes that were identified or whose
function was validated in vivo as a critical determinant of establishment or specification
of pluripotent cells of the embryo. Following a brief introduction of each factor, I will
summarize more recent work characterizing their role in integrating and maintaining
the ES cell transcriptional network.
Oct4: Expression of this POU-domain transcription factor is restricted to oocytes,
blastomeres, pluripotent early embryo cells, and the germ cell lineage 51-4. Null Oct4
embryos die in utero during the peri-implantation stages and in vitro cultures of the
ICM demonstrate it is responsible for the establishment of pluripotent cells 24, 55. Loss of
Oct4 generates only cells of trophoblast origin in vitro, suggesting it may actively in-
hibit differentiation towards this lineage. Importantly, as a transcription factor, it can
act to either repress or to activate target gene transcription along with partner factors 56
60
Sox2: Sox (SRY-related HMG-box) family proteins are transcriptional regulators
that typically rely on association with partner factors to affect target genes. The expres-
sion pattern of Sox2 is similar to Oct4, marking the ICM, epiblast, and germ cells, how-
ever, Sox2 is also expressed in non-pluripotent tissues such as the multipotential cells of
the extraembryonic ectoderm and uncommitted dividing stem and precursor cells of the
developing central nervous system (CNS) 61 . Sox2 null embryos die at the time of im-
plantation due to a failure of epiblast (primitive ectoderm) development 62. ESCs de-
leted for Sox2 results in trophectoderm and primitive endoderm-like cells suggesting
that like Oct4, it is essential for pluripotency. Sox2 is frequently found at gene promot-
ers as a heterodimer with Oct4 and co-binding has been shown to be necessary for syn-
ergistic gene activation at targets such as Fgf4 63. Co-binding was also reported at the
Sox2 and Oct4 genes themselves 4-66 in addition to another canonical pluripotency
marker, Nanog.
Nanog: A highly divergent homeodomain-containing protein that is activated
upon compaction with expression specifically demarcating the nascent epiblast 6769.
Two groups initially characterized the function of Nanog in ESCs. Yamanaka and col-
leagues used in silico differential display of expressed sequence tag (EST) libraries from
mouse ES cells and various somatic cells to isolate a set of pluripotency-associated
genes. Functional validation demonstrated Nanog-null embryos can develop blasto-
cysts but cannot form a functional epiblast, with explantation of null (-/-) ICM failing to
generate ESCs 70. In a second study Chambers et al. analyzed 10' independent cDNA
plasmids for factors capable of rescuing LIF receptor -/- ESCs. These genetically modi-
fied ESCs used IL6/ sIL6R to activate gpl30 and Stat3, and were screened by episomal
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transfection for self-renewal in media lacking cytokines 68. Ectopic expression of Nanog
endowed transgenic ESCs with the ability to grow in the absence of LIF-receptor, and in
addition, these cells became refractory towards differentiation signals such as exposure
to all-trans retinoic acid. Interestingly, Nanog expression is maintained through the
blastocyst stage in Oct4 null embryos indicating that transcriptional activation of Nanog
during this period does not require Oct4 68.
Nanog has a unique role in maintaining ESCs in vitro. It has been described as a
"licensing" factor of pluripotency because, surprisingly, established ESCs can be main-
tained upon conditional deletion of Nanog 71. Nanog expression fluctuates in ESCs,
which allows partitioning into two populations of Nanog o or Nanoghigh, with Nanogow
cells showing a higher propensity for differentiation. In general, Nanog null ESCs have
a lower threshold for differentiation suggesting it buffers against signals to exit pluripo-
tency 71. Injection into blastocyst embryos demonstrates Nanog null ESCs are capable of
multi-lineage differentiation however fail to contribute to the germ lineage ".
Klf4: Kruppel-like transcription factors (Klfs) are zinc finger proteins that share
homology with the Drosophila embryonic pattern regulatory gene Kruppel ". Although
expression of Klf family of transcription factors is not exclusive to pluripotent cells,
three Klfs are expressed in ESCs: Klf2, Klf4, and Klf5. In ESCs they most likely harbor
redundant functions because loss of pluripotency is only apparent after RNAi-mediated
knockdown of all three 73. Klf5, but not Klf4 or Klf2, knockout embryos show early em-
bryonic leathlity, with null ICM failing to give rise to stable ESCs in vitro ". These fac-
tors may play a role in helping enforce gene expression upon Oct4 and Sox2 targets. For
example Klf4 was reported as an essential factor in the activation of Lefty, a direct Oct4
target, which was unable to be activated with Oct4 and Sox2 alone 75 .
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Given the importance of these factors in the maintenance of pluripotency a key
question is how they act on their transcriptional targets globally. Pioneering studies us-
ing genome-wide location analysis (ChIP-ChIP or ChIP-Seq) in human ESCs, initially
investigating Oct4, Sox2 and Nanog, has demonstrated pluripotency factors form a core
transcriptional regulatory network that governs both pluripotency and the control of
differentiation 76,77. The results revealed three main observations: First, each factor
(Oct4, Sox2, and Nanog) bind the promoters of the other two factors in addition to their
own, forming an interconnected, autoregulatory feed-forward loop. Second, all three
factors often co-occupy the same sites in the promoters of their target genes. Finally, the
list of bound targets can be separated into active or inactive, with the latter being
"poised" for activation upon ESC differentiation (Figure 3) 76. Active genes are typically
involved in maintenance of ESCs, such as Stat3, Nodal, and a Wnt target Tcf3, however
a surprising number of genes bound by Oct4, Sox2 and Nanog are transcriptionally si-
lent. Many of these inactive genes are important transcription factors associated with
lineage specification, for example Pax6 (Ectoderm), Sox6 (Mesoderm), and Onecut1
(Endoderm). This suggests that Oct4, Sox2, and Nanog maintain pluripotency not only
by activating genes responsible for self-renewal, but also by directly repressing genes
associated with differentiation. This hypothesis is supported by genome-wide location
analysis of lysine 27 tri-methylation of histone H3 (H3K27me3), catalyzed by the Ezh2
subunit of Polycomb Repressive complex 2 (PRC2), which shows co-enrichment at
many silenced developmental regulators co-bound by Oct4, Sox2, and Nanog in ESCs 78'
7. The genome-wide binding patterns of Oct4, Sox2, or Nanog have been extended to
additional pluripotency-associated factors as well as global transcriptional regulators
such as p300 and architectural proteins such as CTCF "' 81. Both studies suggested there
are regions extensively occupied by ESC-specific transcription factors and that actively
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expressed genes, as compared to silent or repressed genes, correlated with binding of
multiple factors, whereas the unexpressed targets typically have a single pluripotency
factor bound in ESCs ". Remarkably, the densest binding locus was a previously identi-
fied distal enhancer of Oct4 with 11 bound transcription factors 80. These binding pat-
terns suggest multiple factors reinforce transcriptional activation of the pluripotency
network by simultaneously acting on common targets.
Figure 3: Model of Core ES Cell Regulatory Circutry The Oct4, Sox2, and Nanog transcription
factors (blue) occupy actively transcribed genes, including transcription factors and signaling compo-
nents necessary to maintain the ES cell state. The three regulators also occupy silent genes encoding tran-
scription factors, that, if expressed, would promote other more differentiated states. At this latter set of
genes, RNA pol II (POL2) initiates transcription but does not produce complete transcripts due to the re-
pressive action of PcG proteins * Figure below adapted from Boyer et al., Cell. 2005.
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More precise genetic analysis revealed multiple feedback mechanisms exist be-
tween different pluripotency factors. Sox2 conditional deletion in ESCs causes immedi-
ate differentiation however this phenotype is rescued by ectopic expression of Oct4,
suggesting the role of Sox2 in ESCs may be to maintain expression of Oct4 12. Ectopic
expression of Nanog is also capable of rescuing RNAi depletion of pluripotency factors
such as Esrrb, Tbx3, Dppa4 and Tcll, whose loss would otherwise induce differentia-
tion, by maintaining expression of Oct4 and Sox2 83
Recent studies analyzing the downstream targets of LIF / Stat3 signaling demon-
strated the pluripotency transcription factor Tbx3 is capable of maintaining ESCs in the
absence of LIF 8". Interestingly, ectopic expression of Tbx3 induces Nanog but not Sox2
expression, and is sufficient to stabilize Oct4 and maintain undifferentiated ESCs. This
work uncovered an apparent bifurcation of the LIF-LIFR-gp13O activation signal with
one branch utilizing phosphatidylinositol-3-OH kinase-Akt signaling, instead of Jak
kinases, to maintain expression of Thx3 in ESCs. The other branch of LIF-LIFR-gpl3O
activation occurs through Jak-Stat3 and primarily leads to induction of Klf4, whose
primary downstream target is Sox2 " (Figure 3).
Using Oct4-inducible null ESCs a close connection to Oct4 and the kruppel-
family of transcription factors was uncovered following analysis of acute gene expres-
sion changes upon downregulation of Oct4. Two distinct pathways appear to act on
each of the three Klfs expressed in ESCs. All (Klf2, -4, -5) are capable, by transgenic ex-
pression, of generating LIF-independent ESCs with resistance to differentiation cues
such as by BMPs 4- 86. However only Klf2 is a direct downstream target of Oct4 harbor-
ing a consensus octamer binding site proximal to the promoter that is bound by Oct4 in
ESCs 86.
Moreover Klf2, but not Klf4 or Klf5, does not require Stat3 for propagation and
maintenance of ESCs in the presence of serum, which normally induces differentiation
in Stat3 null ESCs. Expression of Klf2 does not change by addition of LIF under "2i"
(ERK1 /2 & GSK3) conditions, in contrast to Klf4 and Klf5, which are upregulated after
just 1 or 4 hr LIF stimulation. These data describe a hierarchy of Oct4 regulated targets
with Klf2 being a primary target regulated independent of the LIF /Stat3 pathway,
whereas Klf4 and Klf5 are directly downstream of the LIF/ Stat3 signal and most likely
reinforce the transcriptional output of this key pluripotency pathway ".
Figure 4: Parallel circuitry of the LIF signal pathways Niwa et al. (2009) show the Jak-
Stat3 pathway activates Klf4, whereas the PI(3)K-Akt pathway stimulates the transcrip-
tion of Tbx3 (black). Klf4 and Tbx3 mainly activate Sox2 and Nanog, respectively, and
maintain expression of Oct3/4 (red). Transcription of all these transcription factors is
positively regulated by Oct3/4, Sox2, and Nanog (yellow).
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An additional layer of transcriptional regulation in ESCs is by noncoding RNAs,
such as mircoRNAs (miRNA) or large intervening noncoding RNAs (lincRNA). Recent
work has incorporated these molecules in the molecular circuitry maintaining pluripo-
tency gene expression programs. An essential role for miRNAs in development was
shown by Dicer-deficient mice, which fail to develop 87. During embryonic development
and in established ESCs, subsets of miRNAs are preferentially expressed ""-91. ES cells
genetically deficient in miRNA processing enzymes have defects in differentiation and
self-renewal 9 2 ,93. Investigation into the Dicer null (Dgcr8 -/ -) phenotype in ESCs, which
is a cell cycle defect leading to an inability to silence self-renewal genes preventing dif-
ferentation, uncovered a role for let-7 family of miRNAs in silencing self-renewal pro-
gram upon differentiation 4. To further integrate miRNAs into the transcriptional cir-
cuitry of ES cells Marson et al. used ChIP-Seq of core pluripotency factors combined
with quantitative sequencing of short transcripts in ES cells, as well as somatic cells 9'.
In agreement with previous studies , a pattern of binding and regulation similar to
protein coding genes was identified whereby core pluripotency factors occupy the
promoters of most miRNAs preferentially or uniquely expressed in ES cells, and
miRNA genes are silenced in ES cells by PcG proteins only to be expressed later in de-
velopment in specific lineages ".
These studies and others have begun to illustrate the pathways acting down-
stream of LIF /Stat3 and the genetic hierarchy between different pluripotency factors.
Mechanisms ensuring the stability of the transcriptional network of ESCs have afforded
them the ability to continue self-renewal in the absence of certain signaling inputs, rely-
ing on just a few essential factors for propagation.
1.4: Epigenetic regulation of pluripotency and differentiation
The epigenome of ESCs must generate heritable gene expression programs con-
cordant with self-renewal while also retaining the potential to reactivate all develop-
mental programs upon differentiation. This section provides an overview of the various
epigenetic hallmarks associated with pluripotency as well as key epigenetic mecha-
nisms that maintain the epigenome of ESCs.
One hallmark of the ES cell epigenome is the X chromosome state that is fre-
quently utilized as a marker for "ground state" pluripotency. In female mouse embryos
the paternal X chromosome is silenced (Xi) during early cleavage but the inactive X (Xi)
is then reactivated in the ICM, specifically demarcating the nascent epiblast 69-96-97
Shortly thereafter, during uterine implantation, the epiblast transforms into the egg cyl-
inder and in female embryos, one of the X chromosomes undergoes random X inactiva-
tion 98. Female ESCs are characterized by two activated X chromosomes (XaXa) and it is
believed this reflects their preimplantation origins, in which female epiblast cells have
not yet undergone X inactivation. Murine ESCs that are responsive to LIF /Stat3 and ex-
press canonical pluripotency markers such as Oct4, Sox2, Nanog, and Klf4, maintain an
X-chromosome state of XaXa and show random X-inactivation following differentiation
towards somatic lineages, an epigenetic hallmark that is recapitulated even in ESCs de-
rived from cloned embryos 99. Recent work has uncovered Nanog as a key marker, and
potentially mediator of the domain of X chromosome reactivation within the develop-
ing ICM of blastocyst embryos 69. In addition, Oct4 has been proposed to regulate X
chromosome pairing and counting in ESCs ". These data reinforce the close association
between pluripotency factors and epigenetic regulation of X chromosomes.
Higher order chromatin in ESCs has several features that distinguish it from that
of somatic or differentiated cells. Morphologically, ESC chromatin appears as a few dis-
26
tinct domains of heterochromatin that remain large in size but become smaller, more
abundant, and hypercondensed upon differentiation 11-14. In addition, chromatin-
associated proteins, such as the architectural heterochromatin protein HP1 and the
linker histone H1, display hyperdynamic or looser binding profiles not found in differ-
entiated cells "'. Analysis of histone tail modifications associated with euchromatin re-
vealed ESCs have high levels of acetylation at lysine 9 of histone H3 (H3K9ac) as well as
methylation of H3K4 at lineage specific genes when compared to embryonic carcinoma
cells, hematopoietic stem cells (HSCs), and lymphocytes. These authors suggest lineage-
specific genes are primed for expression in ES cells but avoid activation due to opposing
chromatin modifications 106.
Indeed, global histone tail modification profiles show unique patterns in ESCs
and reveal how epigenetic mechanisms control the undifferentiated state in vitro. In
addition to developmental genes necessary for somatic lineages, pluripotency-
associated transcription factors also contribute to the repression of genes necessary for
non-epiblast lineages of the early embryo, such as the trophoblast or primitive endo-
derm 24,5,62 , suggesting global repression of differentiation-inducing factors is a key
mechanism in maintaining undifferentiated ESCs in vitro. Many of the repressed targets
of Oct4, Sox2, and Nanog show a close association with developmental regulators also
bound by Polycomb group (PcG) proteins, which contribute repressive chromatin
modifications and gene silencing 107. PcG proteins comprise at least two distinct re-
pressor complexes (PRC1 and PRC2-PRC3) with core components that are conserved
from fly to human 108. The aforementioned genome-wide studies in human ES cells re-
vealed many of the promoters occupied by PcG proteins also contained the repressive
histone modification H3K27me3, often in expansive regions not only occupying gene
promoters, but extending from 2 to 35 kb away ". The H3K27me3 modification plays a
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role in maintaining silencing and undifferentiated state of ESCs as many target genes
become de-repressed in the absence of the PCRC2 components Eed or Suz12, leading to
precocious differentiation 79 109. In fact, PcG-bound genes appear "poised" for activation
upon differentiation, as these genes are preferentially activated upon ES cell differentia-
tion 79'109. A concept emerging from genome-wide studies of chromatin modifications
was specific histone modifications with opposing effects ("silencing" vs. "activating")
were frequently found to co-exist at developmental gene loci in ESCs. Large H3K27me3
regions frequently overlap smaller H3K4me3 enriched regions at developmental gene
promoters, termed "bivalent domains" l9. Although largely silent in ES cells, these re-
gions adopt some properties associated with an open chromatin structure, one of which
is early replication timing 106. These observations provide insight into organization of
chromatin in pluripotent cells and suggested a model by which silenced developmental
genes harboring bivalent promoters remain "poised" for activation upon differentia-
tion.
Whether the bivalent chromatin configuration can be equated with pluripotent
chromatin remains to be determined. Recent work using nonmammalian vertebrate
embryos has revealed that during the matemal-zygotic transition in Zebrafish more
than 80% of genes acquire H3K4me3, with many also marked by H3K27me3, suggesting
bivalent chromatin structure is not a tissue culture artifact 1". However, Xenopus em-
bryos undergoing gastrulation show more spatially regulated expression of genes that
correlates with subsequent deposition of H3K27me3, whereas H3K4me3 correlates with
earlier, zygotic gene activation 1". Therefore the in vivo function of opposing histone
modifications remains under investigation. It is worth noting several alternative models
have been proposed as well. First, based on findings that H3K4me3 is found at most
protein coding genes in human embryonic stem cells with a stalled RNA PolI, Young
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and colleagues proposed that regulation of many developmental genes might be at the
level of elongation 2. Moreover, there is increasing evidence dynamic gene expression
changes, as well as alternations to the epigenome, occur upon isolation of ESCs that
may not necessarily reflect the epiblast in vivo. Recent work using single-cell RNA pro-
filing of ICM-outgrowths has revealed over half of the known epigenetic modifiers
change their expression during ICM outgrowth with repressive regulators being most
highly expressed 113,114 . The extent to which modifications of chromatin in ESCs reflects
an in vitro adaptation also continues to be an area of intense investigation.
DNA methylation is an essential epigenetic modification required for develop-
ment 115118. Although it is unnecessary for the propagation of ESCs in vitro these cells
cannot differentiate118 . Reduced representation bisulphite sequencing 119,120 has been
applied to both embryonic and somatic cells to analyze genome-wide patterns of DNA
methylation in the context of CpG dinucleotides. CpG islands, found at about 60% of
human gene promoters, revealed a unique pattern in ESCs depending on the density of
CpGs within the particular regions 12. High-CpG-density promoters (HCPs) are mostly
unmethylated and are associated with 'housekeeping' genes and highly regulated de-
velopmental genes. Virtually all HCPs are marked by H3K4me3 in ESCs, regulated by
trithorax-group (trxG) proteins, while others exhibit regulation by trxG and PcG pro-
teins reflected in a bivalent chromatin state (H3K4me3 and H3K27me3). HCPs marked
only by H3K4me3 tend to retain this mark even following differentiation, whereas biva-
lent chromatin states tend to lose one or both marks with a small fraction remaining bi-
valent 121,.122. Hypermethylation of CpG-dense regions lead to exclusion of trxG/PcG ac-
tivity and long-term irreversible gene silencing. A second class, termed low-CpG-
density promoters (LCPs), is largely methylated with only a subset (between 3-7%) con-
taining euchromatin-associated histone modifications such as H3K4me1 /2 and reduced
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methylation levels in ESCs. In contrast to CpG-rich regions, periods of methylation and
de-methylation can occur during differentiation, which may reflect the subset of cis-
regulatory elements that exist within this pool of regulated DNA, among other non-
coding elements such as transposons or interspersed repeat elements "'. This data sug-
gests DNA methylation at distinct regions (CpG-rich and -poor) is regulated differently
in ESCs and during differentiation. Interestingly, analysis of ESC-derived multipotent
neural progenitors and primary cells demonstrated aberrant hypermethylation during
extended proliferation in vitro at some 'weak' CpG islands at particular developmen-
tally regulated genes, again reinforcing that caution should be taken in correlating ob-
servations with cells grown in vitro to their in vivo counterparts 12 .
In vitro reprogramming of somatic cells to pluripotency
As described in the previous sections the molecular and epigenetic factors influ-
encing pluripotency are beginning to be understood. Not only do ESCs hold great
promise for understanding cellular differentiation but also for medical purposes such as
patient-specific regenerative medicine. The isolation and derivation of embryonic stem
cell lines however, either from fertilized or cloned embryos, requires destruction of the
embryo raising ethical as well as practical questions that have hindered progress to-
wards this goal. Alternative sources of pluripotent cells such as reprogramming from
adult somatic cells, avoids such constraints and has remained a major focus for the stem
cell community. This section will describe strategies that have been employed to gener-
ate pluripotent cells in vitro while emphasizing their impact in addressing questions
surrounding reprogramming mechanisms generally (Figure 5). However, to date many
of these approaches still have limitations that preclude use in broader applications of
regenerative medicine.
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Figure 5: Four strategies to induce reprogramming of somatic cells (Jaenisch and Young 2008)
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One such strategy tested whether epigenetic reprogramming of somatic nuclei
can be achieved following fusion of somatic cells with pluripotent embryonic cells. The
general conclusion to date has been that fusion products exhibit the phenotype of the
less-differentiated fusion partner. Fusion of pluripotent teratocarcinoma cells with pri-
mary thymocytes resulted in the formation of pluripotent hybrids that gave rise to tu-
mors "'. Following similar protocols using murine, and later human ESCs, cell hybrids
exhibit many characteristics of ESCs confirming that reprogramming factors exist
within these cells in addition to the egg and early cleavage blastomeres. Functional as
well as molecular tests were performed in order to determine the extent of reprogram-
ming of the somatic cell chromosomes, as one formal possibility is they are simply pas-
Four strategies to induce reprogramming of somatic cells
tionirus
sengers in hybrid cells. However several observations support the conclusion that ex-
tensive reprogramming of somatic chromosomes occurs following cell fusion. At the
molecular level hybrids show demethylation of CpG-containing promoters of pluripo-
tency genes with re-activation of Oct4, as well as reactivation of the inactive somatic X
chromosome in female lymphocyte-ES-cell hybrids 125,126. At the functional level, tera-
tomas could be generated following subcutaneous injection into SCID mice, and genes
of all three germ layers were expressed "'. From a mechanistic viewpoint reactivation of
pluripotency genes has been proposed to require cell division with the first detectable
marker appearing after 2 days 128, while Nanog transgenic ESCs induce pluripotency in
somatic cell hybrids at a much greater efficiency than non-transgenic ESCs upon fusion
with neural stem cells129, suggesting core pluripotency factors can enhance the repro-
gramming process. Yet there is limited evidence that fusion induces extensive genome-
wide reprogramming in somatic cells and careful genome-wide analysis of epigenetic
marks on somatic chromosomes has not been performed to date. In addition the genera-
tion of tetraploid cells without the ability to eliminate chromosomes generating diploid
pluripotent cells, precludes the application of this technology in regenerative medicine.
A second method to isolate pluripotent cells in vitro is by culture-induced repro-
gramming and seems to be confined to a few donor cell types originating from the germ
lineage. Primordial germ cells (PGCs) emerge at gastrulation and, in male embryos,
give rise to spermatogonial stem cells. Both of these cell types have been shown to be
capable of generating pluripotent cells by explanting the cells from embryos at different
stages of development. Growth conditions are essential for the reprogramming of these
cells. From embryonic day 8.5 embryos, primordial germ cells grown in vitro give rise
to embryonic germ (EG) cells "'. EG cells require LIF/Stat3 for growth, express all ca-
nonical pluripotency markers, give rise to teratomas with cells of all three germ layers,
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and can generate adult mouse chimeras ". Spermatogonial stem cells from newborn
and adult male gonads also generate ES-like cells, although at very low efficiency and
after an extended time in culture. Termed male germ stem cells (maGSCs), these ESC-
like cells can be propagated in serum and LIF and uniquely carry a male-specific im-
printing pattern, also capable of inducing teratomas and contributing to chimeras with
germline transmission 13, 1'. While these studies reveal a source of potential adult so-
matic cells capable of generating pluripotent cells in vitro, evidence that similar cell
types exist in human capable of undergoing reprogramming as described for murine
cells is still lacking.
Direct reprogramming to pluripotency with defined factors
The aforementioned techniques applied towards the isolation of pluripotent cells
from adult somatic cell donors all suffer from some form of technical, ethical, or practi-
cal constraints that preclude their broad use in generating patient-specific pluripotent
stem cells. Yet another alternative was the use of individual transcription factors to per-
form direct conversion from one cell type into another. Weintraub and colleagues at-
tempted "transdifferentiation," or conversion of one somatic cell to that of another so-
matic cell without transiting through an embryonic intermediate, turned fibroblasts into
muscle-like cells by over-expression of the master regulator of muscle differentiation,
MyoD 13, ". While some muscle-specific gene activation occurred, re-activation of the
endogenous MyoD gene was not detected in the converted muscle cells, suggesting that
epigenetic reprogramming was incomplete and that maintenance of the myogenic phe-
notype depended on the transgene. Indeed, the MyoD promoter continued to be methy-
lated even after the conversion, suggesting incomplete epigenetic reprogramming.
These studies however, emphasized the power of individual transcription factors to ac-
tivate target genes epigenetically silenced in cells from which they are not normally ex-
pressed.
In 2006 Takahashi and Yamanaka altered the protocol described above only
slightly but achieved dramatically different results by reprogramming somatic cells
back to a pluripotent ES-like state with four transcription factors "1. Starting with a pool
of 24 candidates, some of which were regulators of pluripotency (e.g. Nanog, Oct4,
Sox2, Stat3, Rex1, Klf4), others that were factors thought to facilitate opening of chroma-
tin (e.g. c-Myc), a screen was performed by retroviral transduction using genetically
modified embryonic or adult murine fibroblasts carrying a drug-selectable reporter at
the endogenous promoter of an Oct4 target, Fbxl5. Neomycin was added to culture me-
dium between 3-9 days after transduction of the factors to select for cells that had reac-
tivated the Fbxl5 locus. Indeed colonies appeared within about 9-12 days and could be
mechanically passaged at around two weeks and grown into stable cell lines thereafter.
With initial success using a pool of all 24 factors, single factors were eliminated one-by-
one, ultimately revealing that four factors (Oct4, Sox2, Klf4, and c-Myc) were sufficient
to induce ESC-like cells from adult somatic cells, coined induced pluripotent stem cells
(iPSCs) ". Cells that had reactivated Fbxl5 were shown to be pluripotent by their ability
to form teratomas and contribute to somatic tissues in embryonic chimeras, however
live chimeras were not obtained. These cells had reactivated many pluripotency genes
but importantly the endogenous Oct4 and Nanog genes were not expressed or were ex-
pressed at a lower level than in ES cells, with their respective promoters largely methy-
lated. Therefore although these cells had many properties of ES cells, they most likely
reflected an "incompletely" reprogrammed state.
Building on these studies Yamanaka and two other groups utilized more strin-
gent criteria to isolate fully pluripotent iPS cells by selecting for reactivation of the en-
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dogenous Nanog or Oct4 genes 136-3. Although extremely inefficient, -0.001-0.1% of in-
fected cells give rise to iPSCs, by genetic, epigenetic, and developmental criteria the
cells reflected an authentic pluripotent state: (i) global gene expression of iPS cells
showed highly similar profiles to ES cells; (ii) the chromatin configuration of Oct4 or
Nanog genes was indistinguishable from ES cells (H3K4me3) and the endogenous Oct4
and Nanog promoters were hypomethylated; (iii) X-chromosome status had been re-
programmed to an ESC-like state of XaXa in female iPS cells; (iv) many developmental
and lineage-specific genes had acquired 'bivalent' epigenetic chromatin marks at their
promoters; (v) iPS cells generated post-natal chimeras and contributed to the germ line
with some lines capable of giving rise to late gestation embryos through tetraploid
complementation 13 6 the most stringent test for developmental potency.
An important question was whether genetic modification of the donor cells was
necessary to identify and isolate fully reprogramming iPS cells, which would prove dif-
ficult in human somatic cells as the protocol involved drug-selectable or green floures-
cent protein (GFP) reporters knocked-in to the endogenous loci of Oct4 or Nanog. The
successful isolation of genetically unmodified murine iPSCs by morphology alone ar-
gued these concerns could be overcome 139. Another outstanding question pertained to
the inability of most iPS cell lines to give rise to liveborn adult "all iPSC" mice in
tetraploid complementation assays, with most studies describing only derivation of late
gestation "all iPSC" embryos (-E12-14.5). This protocol is the most stringent test of
pluripotency and forces iPSCs to give rise to all tissues of the adult animal. Although
still not completely settled, a few recent reports have confirmed the derivation of iPSCs
capable of generating liveborn "all iPSC" pups and adult mice 14-112, arguing that repro-
gramming can, in some cases, give rise to fully pluripotent stem cells with all properties
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of ICM-derived embryonic stem cells. Whether technical or biological constraints are
behind the limited isolation of 4n-competent iPSCs remains under investigation.
Reprogramming by defined factors is a slow and inefficient process compared to
SCNT or cell fusion, where reactivation of Oct4 or Nanog occurs within 1-2 cell divi-
sions. During in vitro reprogramming to generate iPSCs reactivation of core pluripo-
tency genes appears to take weeks. Retroviral delivery of reprogramming factors al-
lowed endogenous pluripotency genes to take over control of the pluripotent gene ex-
pression program as retroviruses become silenced by DNA methylation in embryonic
cells, as was observed in Nanog- or Oct4-selected iPSCs 136-138. Drug-inducible viruses of
Oct4, Sox2, Klf4, and c-Myc, showed a minimum time of 9 days ectopic expression is
required for generation of stable iPSCs in mouse 13,14
Shortly after the derivation of germline-competent murine iPSCs, success with
human somatic cells gave rise to human induced pluripotent stem cells (hiPSCs) "4-4.
One group used the previously described set of transcription factors but alternatives to
the reprogramming factor cocktail being were reported as well (Oct4, Sox2, Nanog, and
Lin28) 4. Yet the demonstration that defined factors could reprogram cell types other
than fibroblasts as well as terminally differentiated cells remained unknown. Yamanaka
and colleagues reported the generation of iPSCs from adult mouse liver and gastric
epithelial cells 148 and the successful reprogramming of terminally differentiated B-cells
provided definitive evidence that this protocol can be applied to a wide range of cell
types other than fibroblasts 149. Importantly, the ability to induce pluripotency with the
combination of Oct4, Sox2, Klf4, and c-Myc appears to be evolutionarily conserved
among mammals as iPSCs from somatic cells of species other than mouse and human
have now been derived including rat, pig, sheep, rabbit, bovine, and monkey.
36
Previously SCNT and gene therapy had been had been combined to repair dis-
eased lineages in mice using cloned ESCs to derive genetically repaired hematopoetic
cells ". In a similar effort, iPSCs proved capable of repairing diseased tissues in several
studies using mouse models of sickle cell anemia and Parkinson's 151, 12. Moreover with
the derivation of hiPSCs efforts turned towards the generation of disease-specific hu-
man iPSCs 1 3 -1.. with the ability to employ differentiation protocols to examine the mo-
lecular profile of the diseased cell type in vitro.
Derivation of pluripotent cells using direct reprogramming with defined factors
represented a breakthrough towards generating personalized pluripotent stem cells
without the ethical or practical constraints associated with embryonic stem cells. How-
ever technical limitations remained in that the reprogramming process involved inte-
gration of proviruses carrying oncogenes such as Klf4 and c-Myc, with some iPSCs har-
boring between 15-20 total proviral integrations. Indeed tumors have been reported
from chimeric mice generated from iPSCs due to reactivation of the c-Myc proviruses
156. Extensive efforts to eliminate the use of viruses or integrating DNA elements have
been underway for several years with successes being reported in both mouse and hu-
man reprogramming.
First, the recipe(s) for reprogramming revealed several factors were not genes ex-
clusive to ESCs, and suggested that potentially somatic cell types that expressed Sox2,
Klf4 or c-Myc, could be used to eliminate the need for additional delivery of transgenes
carrying these factors. To this end, multipotent neural progenitor cells (NSCs) proved
successful in both mouse and human. Elimination of all factors except Oct4 has been re-
ported, generating either 2-factor (Oct4+Klf4 or Oct4+c-Myc in mouse), or 1-factor
iPSCs (Oct4 only in both mouse and human) 157-159. Interestingly however, similar ex-
periments reported by others suggested in NSCs reprogramming efficiencies were
lower when Sox2 was delivered ectopically in addition to three other factors suggesting
the relative protein stochiometry of reprogramming factors could influence the genera-
tion of iPSCs 160. Although successful in eliminating some factors, use of somatic cells
expressing endogenous levels of reprogramming factors has not yet overcome the need
for ectopic delivery of Oct4.
Second, success has been reported in generating integration-free iPSCs mostly in
human and mouse fibroblasts with many different delivery mechanisms: 1) repeated in-
fectionltransfection: adenoviruses carrying Oct4, Sox2, Klf4, and cMyc or by repeated
transfection of two plasmids carrying the same factors, or in human, repeated transfec-
tion of multiple episomal vectors carrying seven reprogramming factors 161-163; 2) excis-
able viruses: including a single polycistronic vector carrying reprogramming factors
leading to one proviral integration that is excised upon isolation of iPSCs 154'164-165; 3) pro-
tein delivery: purified Oct4, Sox2, Klf4 and cMyc 166; and 4) modified RNA delivery: Oct4,
Sox2, Klf4, and cMyc, to human fibroblasts to generate hiPSCs 167. Although technically
iPSCs can be generated using all of the aforementioned protocols, with the recently re-
ported RNA-delivery being most promising, most remain highly inefficient and require
weeks if not months to isolate genetically unmodified pluripotent cells.
Third, chemically defined protocols for reprogramming have successfully re-
placed some factors individually but no such single, or combination of compounds is
capable of generating iPSCs without requiring transgenes of at least two reprogram-
ming factors 168-171 . Importantly, the action of some of these compounds has been re-
ported to act by inducing Nanog expression, or by inhibiting chromatin-associated pro-
teins that maintain repressive epigenetic marks at the promoter of Oct4 168-171
Molecular mechanisms governing in vitro reprogramming by defined factors
Direct reprogramming to pluripotency has opened up a major biomedical re-
search field with goals of generating patient-specific hiPSCs for regenerative medicine.
Yet this technology also generated an alternative approach in studying the underlying
mechanisms of epigenetic reprogramming that could not be analyzed by the labor-
intensive methods such as SCNT. This section will focus on what is known about the
mechanisms of reprogramming by defined factors and will also describe novel tools
that have been generated to examine the biological principles of epigenetic reprogram-
ming to pluripotency. Five general observations described herein can be summarized as
follows: 1) the action of individual reprogramming factors (Oct4, Sox2, Klf4, c-Myc)
during iPSC generation can be replaced by related or unrelated transcription factors,
with the former being well documented; 2) when controlling technical parameters asso-
ciated with in vitro growth and entry into the cell cycle, virtually all somatic cells have
the potential to give rise to iPS cells given enough cell divisions; 3) reprogramming fol-
lows a stochastic course to pluripotency with some cells reprogramming earlier than
others but the outcome of any given cell cannot be identified a priori; 4) reprogramming
is amenable to acceleration with some factors influencing iPSC formation in a cell-cycle-
dependent or cell-cycle-independent fashion; 5) genetic or environmental perturbations
that negatively or positively influence the stability of ESCs, also affect reprogramming
efficiencies and the ability to isolate stable iPSCs.
The four reprogramming factors described by Takahashi and Yamanaka (Oct4,
Sox2, Klf4 and cMyc) are members of a family of homologous transcription factors. Oct4
for example, belongs to the octamer-binding (Oct) family of transcription factors, which
contain the POU domain 172, and has two closely related homologs Oct1 and Oct6. Simi-
larly, Sox2, part of the SRY-related HMG-box (Sox) transcription factors, characterized
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by the presence of the high-mobility group (HMG) domain has many homologs (Sox1,
Sox3, Sox7, Sox15, Sox17, Sox18). To test the stringency of reprogramming and whether
closely related family members could substitute for reprogramming factors, Nakagawa
et al. (2008) performed reprogramming with 13 related transcription factors and found
no other substitute for Oct4, however related factors to Sox2, Klf4, and cMyc were capa-
ble of generating iPSCs 156. In addition these authors and others uncovered the dispen-
sability of c-Myc during reprogramming, which seems only to increase efficiencies but
not be strictly required 156,.173 Mice generated from iPSCs show tumors that reflect
reactivation of the previously silenced c-Myc provirus, and elimination of this factor
from the reprogramming cocktails reduced the rate of tumor formation in some studies
156,174. Alternate combinations of known pluripotency factors have now been applied to
iPSC generation such as Esrrb, Nr5a21 75 -17 6 which are capable of replacing Klf4 and
Oct4 in four-factor reprogramming cocktails respectively. The conserved DNA-binding
properties of the pluripotency factors and their related family members capable of re-
programming to pluripotency, most likely arises from the ability bind consensus motifs
that reactivate the autoregulatory and feed-forward loops by activating endogenous
pluripotency genes 76.
When considering reprogramming efficiencies an important issue that still re-
mains today is whether different groups use the same "marker" to indicate a success-
fully reprogrammed cell. Some markers are less stringent than others. Alkaline phos-
phatase (AP) and SSEA1 are not as exclusive to ESCs as are Nanog or Oct4. The use of
reactivation of endogenous Oct4 or Nanog by GFP knock-in reporters appears to most
faithfully reflect a fully reprogrammed state. Using reactivation of Oct4 or Nanog as de-
tected by GFP, reprogramming efficiency in various studies on mouse cells have indi-
cated that approximately 0.001-0.5% of cells infected with all four factors are repro-
grammed into iPS cells after approximately 2-3 weeks 136,138,139
A system of doxycycline-inducible lentiviruses was created that allowed tempo-
ral control of reprogramming factor expression, which also had advantages to retrovi-
ruses that become irreversibly silenced upon entry into the pluripotent state 143,144 Dur-
ing reprogramming, non-specific, pluripotency-associated markers such as alkaline
phosphatase (AP) and SSEA1 appear in a significant fraction of cells only a few days af-
ter induction of reprogramming factors while a small fraction express the core pluripo-
tency factors such as Sox2, Nanog, or Oct4 late in the initial formation of iPSCs (- d14-
16). Experiments utilizing the temporal control of virus expression, by withdrawl of
doxycycline (DOX) from the culture media at various times during reprogramming,
demonstrated the minimum time required to generate mouse iPSCs with Oct4, Sox2,
Klf4, and c-Myc is about 9 days and efficiencies increasing with prolonged exposure to
reprogramming factors 13,1. Other markers of the pluripotent state were examined
such as the ability to silence retroviruses as well as X-reactivation. Using somatic cells
with a Sox2 GFP knock-in reporter to observe reactivation of endogenous loci combined
with infection with a retroviral Tomato reporter, the pattern of expression between
fluorescent reporter and GFP was mutually exclusive, suggesting the ability to silence
closely correlated with the reactivation of core pluripotency factors ". Similar observa-
tions were made using X-linked GFP reporters suggesting reactivation of X-
chromosomes occurs simultaneously with reactivation of pluripotency markers such as
Nanog and Sox2 ".
A hypothesis for such low reprogramming efficiencies was that upon initial
transduction with reprogramming factors only a small fraction of infected cells received
the appropriate proviral integration patterns that led to a specific expression level and
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protein stochiometry that was optimal for iPSC generation. This was potentially re-
flected in the variation in the kinetics of reactivation of pluripotency markers such as
Nanog or Oct4 during reprogramming upon primary infections and could not be ruled
out because of the genetically heterogenous population of cells undergoing repro-
gramming. This lead to a prediction that if somatic cells had a similar integration pat-
tern and presumably similar expression of reprogramming factors they should repro-
gram with similar efficiencies and kinetics.
A key insight made by Meissner et al. (2007) was that even when controlling for
integration patterns, reprogramming depends on stochastic epigenetic events. Clonal
analyses demonstrated that the activation of pluripotency markers can occur at different
times in individual mitotic daughter cells of the same infected fibroblast 139, suggest-
ing cell divisions give rise to subclones with different biological properties (Figure 4).
This most likely reflects epigenetic changes in chromatin modifications or DNA methy-
lation that occur differently between clones.
B GFP
Oct4-GFP or - . .
Nanog-GFP fibroblasts Reprogram
Virus(factors) Day 6 Day 12 Day 20 Day 25 Day 31
Figure 4: Direct reprogramming involves stochastic epigenetic events
Indeed both DNA methylation and histone modifications have been reported to
influence reprogramming efficiencies. Use of the DNA methyltransferase inhibitor 5-
azacytidine during reprogramming increased reprogramming efficiencies most likely
by inhibiting the maintenance of repressive DNA methylation at key pluripotency
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genes ". In addition, histone deacetylase (HDAC) inhibitors such as valproic acid
(VPA) improved reprogramming efficiencies and enabled derivation of 2-factor human
iPSCs only requiring infection with Oct4 and Sox2 178, 179. Klf4 and c-Myc may solely be
responsible for "priming" chromatin during reprogramming, enabling more direct ac-
cess to Oct4 and Sox2 targets as pre-infection with the former reprogramming factors
followed by infection with the latter, increased the kinetics of iPSC formation 180 .
Given that growth and propagation of ESCs is positively or negatively regulated
by cytokines or small molecules added to the medium, increased reprogramming effi-
ciencies have been reported by enhancing Wnt signaling or use of "2i / LIF" conditions
181,182, suggesting similar pathways regulate the establishment of iPSCs. Importantly, in-
hibitors of pluripotency in ESCs are similarly observed to affect iPSCs generation. In
agreement with previous studies using Nanog null ESCs, iPSCs cannot be established
from somatic cells in which Nanog is disrupted underscoring the essential role Nanog
plays in entry into the pluripotent state 69.
The drug-inducible lentivirus systems gave way to the "reprogrammable mouse
model" for studying induction of pluripotency in homogeneous transgenic somatic cells
(Figure 6). In this "secondary system" strategy, primary iPS cells are generated from fi-
broblasts infected with Dox-inducible lentiviral vectors carrying the reprogramming
factors Oct4, Sox2, Klf4, and c-Myc. Single iPS clones are injected into mouse blastocysts
to generate chimeras and contribute to a variety of genetically homogeneous "secon-
dary" somatic cells that carry the same Dox-inducible factors in their genome as their
primary iPS cells. Cells from chimeric mice created using genetically reprogrammed
cells can be triggered via drug administration to enter an ES-cell-like state without the
need for additional direct genetic manipulation. This technical advancement enables
creation of large numbers of genetically identical somatic cells that can be repro-
grammed to an ES-cell-like state simply by exposure to a drug. Because the injected
iPSC lines carried a constitutively expressed antibiotic resistance gene, homogenous
iPSC-derived somatic cell populations such as embryonic fibroblasts, mesenchymal
stem cells, neural precursors, and lymphocytes could be isolated that carried provirus
integration patterns identical to those in the primary iPS cell lines
FIGURE 6: Reprogramable mouse strain
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Predictions of increased efficiencies once genetically identical somatic cells were
tested did bear out as secondary systems could now generate iPSCs between 1-10% af-
ter 2-3 weeks " 14. These data argued that appropriate factor expression levels influ-
ence reprogramming however major epigenetic barriers must be overcome because the
majority of cells still do not generate iPSCs after 2-3 weeks. In addition not all secon-
dary systems proved equivalent, each had unique induction levels of the reprogram-
ming factors in somatic tissues of reprogrammable mice. In some lines certain provi-
ruses could not be reactivated in all somatic tissues tested because they had becoming
epigentically silenced during differentiation towards particular somatic lineages. For
example, in one reported secondary line Sox2 was readily activated in several somatic
tissues such as neural precursors or keratinocytes but was unable to be reactivated in
intestinal epithelium cells precluding the generation of iPSCs until Sox2 was reintro-
duced ".
A second advantage of the secondary systems was that germline transmission of
iPSC genomes carrying dox-inducible proviruses allowed screening for segregation of
some reprogramming factors to generate mice carrying different combinations of provi-
ruses to use as a drug-screening platform for the missing factors 180. However because
this system was based on infection with individual viruses, up to 7 proviral integrations
had to be tracked with each generation therefore it proved extremely difficult and labo-
rious to maintain a mouse colony containing all four factors.
A landmark study using secondary systems was performed by long-term analy-
ses of clonal cell populations derived from pro/ pre-B cells of the hematopoetic lineage
to determine the dynamics of reprogramming and to assess the fraction of donor cells
that are susceptible to reprogramming 185. These populations have a higher cloning effi-
ciency for single cells and better tolerance of reprogramming factors. In addition, these
cells represent a well-defined lineage-committed population with the rearrangement of
the IgH locus allowing for the unambiguous retrospective identification of the donor
cells. In this study reprogramming efficiency was defined as the potential of a donor cell
to generate an iPSC daughter at some point. Plating single secondary pro/pro-B cells
into single wells and subsequently passaging until the apprearance of iPSCs as indi-
cated by a Nanog-GFP reporter, nearly every cell was able to generate iPSCs (>90%) 185
The kinetics of reprogramming displayed a broad distribution for isolation of iPSCs,
spanning 2-18 weeks, consistent with the observation that the process involves stochas-
tic and rate-limiting epigenetic event(s). Additional inhibition of the p53/p2l pathway
or ectopic expression of Lin28, while controlling for the same growth conditions, accel-
erated conversion into iPSCs and was directly proportional to the increase in cell divi-
sion rate. Thus, p53 inhibition did not increase the fraction of cells that could be repro-
grammed but rather accelerated the formation of iPSCs in time, which appeared after a
similar number of cell divisions. In contrast to these findings, ectopic expression of
Nanog accelerated reprogramming in a manner that was independent of the rate of cell
divsions 185-186
Does the induced pluripotent state represent ESC-like pluripotency?
An unresolved question in the reprogramming field is whether iPSCs are equiva-
lent to ESCs. If there are differences such as extensive genetic or epigenetic abnormali-
ties capable of influencing iPSCs during differentiation and/or transplantation this
could preclude the application of this promising technology in regenerative medicine.
Yamanka's group first reported that iPSCs derived from different adult tissues showed
variation in function compared to ESCs both in vitro and in vivo. First, some iPS cell
lines were unable to form primary neurospheres in standard in vitro assays, and after
generating secondary neurospheres (SNS) from additional iPS cell lines, these SNSs
showed different behaviors in vivo, either incorporating into brain tissue or developing
large teratomas after injection into NOD/ SCID mice 1. Of the 31 mice injected with
ESC-derived SNSs (28/31 or 90%) lived for up to 45 weeks with only one revealing a
small tumor after autopsy. In contrast a significant fraction of the mice injected with
iPSC-derived SNS either died prematurely with some having observable tumors, while
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others that survived through the experimental period, had tumors of varying sizes
upon dissection. Strikingly, some lines exhibited mortality rates higher than 80%. These
issues raised valid concerns about the safety of differentiated tissues from iPSCs. Addi-
tional reports suggest the cellular physiology of iPSC-derived somatic cells is limited
and that reprogramming causes potentially harmful genomic alternations that may con-
sequently lead to tumors or other cellular defects upon differentiation and transplanta-
tion in vivo. Careful analysis of mouse and human iPSCs and ESCs has identified recur-
rent chromosomal aberrations including a high incidence of chromosome 8 (mouse), or
12 and 17 duplications (human), while some hiPSC-derived somatic cells such as he-
mangioblastic derivatives, undergo early senescence and show limited expansion in vi-
tro 187.
Compared to functional tests for pluripotency, molecular analyses allow for
more quantitative comparisons of iPSCs and ESCs. Some initial investigation into iPSCs
derived from multiple adult tissues suggested that at least for some clones, iPSCs are
similar if not indistinguishable from ESCs derived from embryo of nuclear transfer ex-
periments. These included profiling of global gene expression, modifications of histone
tails, the state of X chromosome inactivation, and profiles of DNA methylation. How-
ever, some studies using global expression analyses concluded that iPSCs are a unique
subtype of pluripotent cells that retain a consistent gene expression signature distin-
guishable from ESCs, even after extended passaging 188. These results have been reana-
lyzed and new datasets generated by other groups who have reported that most likely
small variations between human iPSCs and ESCs in chromatin structure and global
gene expression may constitute experimental "noise" and do not reflect a consistent
signature that distinguishes iPSCs from ESCs189 190.
Assays for developmental potency in mice, such as chimera formation and
germline contribution are routinely passed in many of the iPSCs derived to date. How-
ever the production of "all-iPSC mice" by tetraploid complementation (4n) has proven
more difficult for the vast majority of iPSCs. However as stated previously some suc-
cess in generating tetraploid-competent iPSCs has been reported. Two recent studies
concluded that the only distinguishable difference between ESCs and the vast majority
of iPSCs was the abnormal reduction in the expression of the maternally imprinted
Dkll-Dio3 locus and that this expression difference was the underlying cause for the
inability to generate all-iPSC mice by tetraploid complementation. Another study com-
pared the patterns of global DNA methylation and in vitro differentiation of early pas-
sage iPSCs derived from B lymphocytes or fibroblasts with those of ESCs from fertilized
embryos or by nuclear transfer. Analysis of the methylation profiles suggested that re-
programming with transcription factors frequently creates iPSC lines that have retained
epigenetic marks reminiscent of their cell-of-origin. Others report similar results but ob-
serve these phenotypes reside with extended passaging 191. These data argue differences
in gene expression, chromatin marks and DNA methylation endow iPSC lines with, de-
pending on your perspective, functional limitations represented by a unique ability to
give rise to somatic cells of their tissue-of-origin more efficiently than other lineages, a
phenomenon termed epigenetic memory 192. However some lines showed only partial
demethylation of the endogenous promoter of Nanog, a key "licensing" factor required
for entry into pluripotency, therefore it could be argued these cells were incompletely
reprogrammed and comparisons to ESCs or other iPSCs that are completely repro-
grammed would not yield reliable results.
Many parameters unfortunately have not been controlled for in these studies.
These include the presence and incomplete silencing of transgenes, different combina-
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tions of reprogramming factors used to induce iPSCs, natural heterogeneity that exists
between different pluripotent ESC lines, incomplete reprogramming in early passage
cell lines, and the genetic background of cells. In addition many of the reported pheno-
types of iPSCs can also be found in ESCs, such as subtle but detectable levels of ge-
nomic abberations 193. Therefore the key question is whether any of the described pheno-
types lie outside the variation that exists between ESCs. Careful control for many pa-
rameters described above will allow for more definitive tests of the similarities between
ESCs and iPSCs in developmental assays.
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ABSTRACT:
Directed reprogramming of somatic cells by defined factors provides a novel
method for the generation of patient-specific stem cells with the potential to bypass
both the practical and ethical concerns associated with somatic cell nuclear transfer
(SCNT) and human embryonic stem cells (hES). Although the generation of induced
pluripotent stem cells (iPS) has proven a robust technology in mouse and human, a
major impediment to the use of iPS cells for therapeutic purposes has been the viral-
based delivery of the reprogramming factors because multiple proviral integrations
pose the danger of insertional mutagenesis. Here we report a novel approach to re-
duce the number of viruses necessary to reprogram somatic cells by delivering re-
programming factors in a single virus utilizing 2A "self-cleaving" peptides, which
support efficient polycistronic expression from a single promoter. We find that up to
four reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) can be expressed from a
single virus to generate iPS cells in both embryonic and adult somatic mouse cells
and we show that a single proviral copy is sufficient to generate iPS cells from
mouse embryonic fibroblasts. In addition we have generated hiPS lines from human
keratinocytes demonstrating that a single polycistronic virus can reprogram human
somatic cells.
INTRODUCTION
Viral vector mediated transduction of defined factors has been used to generate in-
duced pluripotent stem (iPS) cells from embryonic or adult somatic cells in both
mouse and human. By gene expression and developmental potential iPS cells are
equivalent to embryonic stem (ES) cells maintaining a full capacity for differentia-
tion with the ability to form teratomas, generate chimeras, and contribute to the
germline (1-8). This technology can be readily applied to many cell types in addition
to fibroblasts as numerous cell types have been shown to be amenable to direct re-
programming including pancreatic P cells, neural precursors and terminally differ-
entiated B cells (9-11). Without the ethical or practical concerns associated with hu-
man embryonic stem cells (hESC), iPS cell technology has emerged as the most
promising method for cell-based therapies of regenerative medicine (12, 13). Yet the
current protocols involve viral based delivery of reprogramming factors leading to
multiple proviral copies throughout the genome in addition to potentially harmful
oncogenes, warranting serious concerns regarding insertional mutagenesis or poten-
tial re-activation of silenced viral transcripts in cells derived from iPS cell lines.
One improvement to the current strategy would be the delivery of repro-
gramming factors within the context of a single polycistronic vector. The use of in-
ternal ribosomal entry sites (IRES) in polycistronic vectors has been shown to ex-
press multiple genes from one promoter but this frequently leads to non-
stoichiometric expression and significantly lower levels of the downstream cis-
tron(s). One alternative to this method is autonomous "self-cleaving" 2A peptides
originally identified and characterized in apthovirus FMDV (foot-and-mouth dis-
ease virus) (14, 15). 2A oligopeptides are generally ~ 18-22 amino acids long and
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contain a highly conserved c-terminal D(V/I)EXNPGP motif that mediates 'ribo-
somal skipping' at the terminal 2A proline and subsequent amino acid "2B" glycine
(16). The most well characterized 2A peptides are derived from foot-and-mouth dis-
ease virus (FMDV - subsequently referred to as "F2A"), equine rhinitis A virus
(ERAV - "E2A"), porcine teschovirus-1 (PTV-1 - "P2A"), and insect Thosea asigna vi-
rus (TaV - "T2A"). Importantly the ability to express four proteins in vivo has been
achieved using 2A peptides (17).
In this work we examined whether polycistronic vectors utilizing 2A peptides
can be applied to in vitro reprogramming with the goal of delivering the repro-
gramming factors in a single polycistronic virus. To test this we developed a four-
factor 2A (4F2A) doxycycline (DOX)-inducible lentivirus encoding mouse cDNAs
for Oct4, Sox2, Klf4, and c-Myc separated by three different 2A peptides (P2A, T2A,
and E2A respectively). Our findings are three-fold: First, we demonstrate that up to
three 2A peptides allow expression of the four reprogramming factors in a single
vector being sufficient to reprogram both embryonic and adult murine somatic cells.
Second, we find that a single proviral copy of the 4F2A is sufficient to reprogram
mouse embryonic fibroblasts (MEFs), suggesting a single transgene could poten-
tially reprogram somatic cells. Finally, we show that the 4F2A can be utilized in re-
programming human cells by generating several iPS lines from neonatal foreskin
keratinocytes.
RESULTS:
GENERATION OF MOUSE iPS CELLS USING A SINGLE POLYCISTRONIC
VIRUS
Our goal was to generate polycistronic viral vectors that would express mul-
tiple reprogramming genes from a single promoter using 2A peptides. For this one,
two, or three 2A oligopeptides containing unique restriction sites were ligated into
FUW lentivirus (18) backbones to allow efficient cloning of Oct4, Sox2, c-Myc and
Klf4 each separated by a different 2A sequence. Vectors carrying four, three or two
factors consecutively with different combinations of F2A, T2A, E2A or P2A se-
quences (Fig. 1 A) were tested for their ability to express individual factors by tran-
sient transfection in human 293 cells. Western blot analysis demonstrated that 2A
peptides support efficient expression of two, three or all four cistrons from a single
polycistronic vector (Fig. 1 B).
A tetracycline inducible lentivirus vector was constructed where expression
of the genes was controlled from the tetracycline operator minimal promoter (tetOP;
Fig. 1 C). To test whether all four genes of a single four-factor (Oct4/Sox2/Klf4/c-
Myc) virus could be expressed upon DOX addition MEFs were infected with the
polycistronic vector (referred below to as "4F2A") as well as a constitutive FUW len-
tivirus carrying the tetracycline controllable trans-activator (M2rtTA; abbreviated as
rtTA). Two independent experiments were performed and drug inducible expres-
sion of the virus was tested 3 days post-infection by qRT-PCR. Using primers for vi-
ral specific transcripts (E2A-cMyc), robust induction was observed (7-10 fold) in cells
cultured with DOX as compared to control medium (Fig. 1 D). To test the relative
induction compared to ES cells, Oct4 and Sox2 primers that cannot discriminate be-
tween viral or endogenous transcripts were utilized and in both experiments in-
fected DOX induced MEFs were significantly higher than in ES cells (- 3.5- and -17-
fold over ES levels respectively). Western blot analysis of cells isolated at 3 days af-
ter infection demonstrated that little or no protein was expressed when the cells
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were cultured without DOX whereas robust induction was seen in the presence of
DOX with levels of Oct4 and Sox2 protein being similar to that in ES cells (Fig. 1 E).
To test whether the 4F2A vector was able to reprogram somatic cells to a
pluripotent state MEFs containing a GFP reporter driven by the endogenous Nanog
promoter were infected with virus (4F2A+rtTA). 85-90% of the cells stained for Oct4
at 48 hours after transduction indicating high titre infection (Fig. 2 A). Morphologi-
cal changes were observed a few days after addition of DOX (data not shown) with
distinct colonies appearing after about 8 days and Nanog-GFP+ cells at approxi-
mately 25 days after DOX induction (Fig. 2 B). After mechanical isolation and sub-
sequent passage the cells had the typical morphology of ES cells and grew inde-
pendently of DOX. Four independent 4F2A iPS cell lines were established that were
positive for the pluripotency markers AP, SSEA1 and Nanog-GFP (Fig. 2 C).
To investigate whether adult somatic cells could be reprogrammed using the
4F2A vector, we infected tail-tip fibroblasts (TTFs) from 14 week-old mice with the
4F2A + rtTA vectors. Similar to MEFs, typical morphological changes were observed
a few days after addition of DOX media. Colonies appeared around 8 days and con-
tinued to expand until they were picked (day 16) based on morphology. After sev-
eral passages four stable iPS cell lines were established that stained positive for all
pluripotency markers (Nanog, Oct4, SSEA1, AP) (Fig. 2 C). MEF iPS cell lines were
injected subcutaneously into SCID mice and were shown to induce teratomas that
contained differentiated cells of all three germ layers (Fig. 3 A). Finally, injection of
MEF iPS cells (#4) into blastocysts generated postnatal chimeras (Fig. 3 B) demon-
strating that a single 4F2A polycistronic virus can reprogram MEFs to a pluripotent
state.
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To determine the number of proviruses carried in the 4F2A iPS cell lines,
DNA was extracted and subjected to Southern blot analysis using an enzyme that
does not cut in the vector sequences. Using Oct4, Sox2, c-Myc and Klf4 probes for
hybridization, we detected bands of identical molecular weight confirming that the
factor sequences were carried in one provirus. The total number of proviruses was
between one and three with iPS cell line #4 carrying a single viral insert (Fig. 3 C).
One of two integrations from iPS cell line #1 failed to produce a band after c-Myc
hybridization, suggesting a 3' deletion of the c-Myc sequences may have occurred. A
second digest confirmed the proviral copy numbers (supporting information (SI)
Fig. IA).
To estimate reprogramming efficiency MEFs were infected with the 4F2A and
rtTA vectors and plated at 0.25x10A6 per 10cm plate culture dish. About 70% of the
MEFs were infected as estimated by immunostaining of Oct4 at 48 hours after infec-
tion (SI Fig. 2 A). Cells were cultured in ES media containing DOX for 20 days and
subsequently transferred to ES cell medium until GFP+ colonies were counted on
day 25. An average of -14.7±4 colonies were detected in three independent dishes
(10+10+17) indicating a relative efficiency of 0.0001%. This is four-orders of magni-
tude lower than that of "secondary" fibroblasts or B cells carrying preselected DOX-
inducible proviruses (19).
To test the kinetics of reprogramming using the 4F2A virus we performed
dox-withdrawl experiments where at specified days (i.e. 2, 4, 8, 12 etc) DOX contain-
ing media is replaced with ES media and the number of Nanog-GFP+ colonies are
counted at day 25. Using separate drug-inducible viruses to deliver the four factors
it has been reported that -9-12 days is the minimum time required for the genera-
tion of stable iPS cells (20, 21). Cells are not passaged during this time in order to
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minimize duplication of reprogramming events. Two independent experiments
were performed and in both cases single Nanog-GFP+ colonies were present on
plates cultured in DOX media for 8 days, similar to the minimum time required us-
ing separate viruses (SI Fig. 1 B).
These data demonstrate that a single polycistronic virus containing the four
factors linked by three 2A peptides allows factor expression sufficient to generate
iPS cells from embryonic or adult somatic cells. Importantly, our results also show
that a single polycistronic proviral copy is sufficient to reprogram somatic cells to
pluripotency.
GENERATION OF HUMAN iPS CELLS USING A SINGLE POLYCISTRONIC
VIRUS
To investigate whether human cells could be reprogrammed with the poly-
cistronic vector, neonatal human foreskin keratinocytes (NHFK) were transduced
with both the constitutive rtTA and DOX-inducible 4F2A vectors. The fraction of in-
fected cells was 10% as determined by staining for Oct4 at 48 hours after transduc-
tion (SI Fig. 3 A). Cells were incubated in keratinocyte medium + DOX and allowed
to grow for 6 days until they were passaged and cultured in hESC media + DOX on
gelatinized plates. Colonies were first detected at day 12 and most displayed trans-
formed morphology with a few colonies exhibiting a distinct appearance that re-
sembled hESC-like morphology. Two such colonies generated in independent infec-
tions were picked between 22 and 35 days after infection and found to expand as
distinct colonies with morphology similar to hESC (Fig. 4 A). These cells were ex-
panded in the absence of DOX and gave rise to a homogenous population identical
to hESC (Ker-iPS) after an additional 2-5 passages. The cells stained for the pluripo-
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tency markers AP, Oct4, Nanog, Sox2, SSEA4, Tral-60, Tral-81 (Fig. 4 B, SI Fig. 3 B)
and had a normal karyotype (Fig. 4 C). DNA fingerprinting excluded that such Ker-
iPS cell lines were contamination from previously established human iPS cells or
hES lines from our lab (data not shown). To determine proviral copy number in Ker-
iPS cell lines genomic DNA was extracted and subjected to Southern blot analysis
using an enzyme that does not cut in the vector sequences. Probes for all four repro-
gramming factors show hybridization to similar molecular weight band(s) again in-
dicating they were carried on a single virus. Two different digests (XbaI & BamHI)
show the 4F2A proviral copy number is three (#1.1) and two (#3) respectively (SI
Fig. 4 A-B).
To test for pluripotency, one line, Ker-iPS #1.1, was injected subcutaneously
into SCID mice. These cells induced teratomas and after histological examination
differentiated into cells of all three germ layers (Fig. 4 D). In addition, Ker-iPS #1.1
cells, when subjected to an in vitro neural differentiation protocol produced nestin+
neural progenitor cell populations as well as Tujl+ post-mitotic neurons as detected
by immunostaining. (Fig. 4 E).
DISCUSSION:
The experiments described in this paper show that up to four different repro-
gramming factors inserted into a polycistronic vector separated by 2A sequences can
be expressed at levels sufficient to achieve reprogramming. This is in contrast to
IRES based polycistronic vectors where the down-stream genes are often expressed
at substantially lower levels. Embryonic and adult murine fibroblasts as well as
postnatal human keratinocytes were induced to form pluripotent iPS cells when in-
fected with the FUW rtTA and 2A vector transducing Oct4, Sox2, Klf4 and c-Myc.
Our finding that a single proviral copy of a polycistronic vector suggests that with
sufficient expression it may be possible to reprogram using a stably expressed trans-
gene. This is supported by the reports suggesting insertional mutagenesis is not nec-
essary for reprogramming and that transient expression of reprogramming factors is
sufficient to geneate iPS cells (22, 23). Preliminary work by Okita et al. (2008)
achieved reprogramming of murine embryonic fibroblasts using Moloney viruses
expressing three factors separated by F2A peptides but with a significant reduction
in efficiency. We extend these findings by demonstrating that even at a low effi-
ciency 2A vectors can reprogram adult murine somatic cells as well as human
keratinocytes.
In addition Okita et al. (2008) were able to reprogram murine embryonic fi-
broblasts using multiple transient transfections of two plasmids expressing Oct4-
Klf4-Sox2 and cMyc respectively. Although iPS cells were generated with greatly
reduced efficiency, iPS cell lines with no detectable vector integration were recov-
ered. Interestingly many of the iPS cell lines generated after transient transfection
contained integrated plasmids suggesting that stable integration of exogenous se-
quences can occur.
We observe a reprogramming efficiency significantly lower than previous ex-
periments using single vectors to transduce each of the four factors (SI Fig. 2 B). It is
possible that the lower reprogramming efficiency is due to the stochiometry of factor
expression from the polycistronic vector, which may be suboptimal for inducing re-
programming. Transduction with separate vectors allows integration of different
numbers of proviruses for each factor, therefore reprogramming may select for a
specific set of proviral integrations that result in high expression or an optimal sto-
chiometry between the different factors. This may not be possible using the 2A sys-
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tem, which has been reported to support near equimolar protein expression in vivo
(17). Also, when separate vectors transducing each of the four factors were used for
induction of iPS cells, Nanog-GFP positive cells were detected as early as 16 days af-
ter DOX induction in contrast to GFP positive cells observed 22-25 days after 4F2A
vector transduction, consistent with less optimal reprogramming. Moreover,
whereas iPS cells frequently carry multiple Oct4 or Klf4 proviruses, consistently
fewer Sox2 proviruses were found suggesting that a high level of Sox2 expression
may be unfavorable for reprogramming (24).
Ultimately multiple technologies may converge to allow the generation of
therapeutically acceptable iPS cells without viral integrations or lingering repro-
gramming factors within the genome. In a recent proof-of-principle work non-
integrating adenoviruses were used alone or in tandem with an inducible Oct4
transgene to reprogram mouse hepatocytes and fibroblasts respectively, demonstrat-
ing insertional mutagenesis is not neccessary for reprogramming (23). iPS cells
without detectable viral integrations were recovered, however efficiencies were sig-
nificantly lower than Moloney or lentivirus reprogramming of fibroblasts. It will be
important to determine whether other more accessible cell types are amenable to
adenovirus-mediated reprogramming as hepatocytes are harder to obtain and grow
from human patients in comparison to keratinocytes or fibroblasts. Furthermore
transient technologies such as adenovirus or DNA transfection of reprogramming
factors may not have the ability to express reprogramming factors throughout the
minimum time interval at levels necessary for acquisition of an iPS state, especially
important for human reprogramming. Because the four factors are expressed from a
defined location the polycistronic vector system described in this paper should sim-
plify the study of reprogramming mechanisms and may facilitate the excision of the
vector resulting in iPS cells that carry no exogenous transgenes.
MATERIALS AND METHODS
Viral preparation and infection.
Construction of 4F2A lentiviral vectors containing Oct4, Sox2, Klf4, and c-Myc under
control of the tetracycline operator and a minimal CMV promoter was generated after
EcoRI cloning from a FUW lentivirus backbone. All constructs were generated using
unique restriction sites after amplification by PCR to place an individual factor between
a respective 2A peptide (lt XbaI-NheI; 2nd SphI; 3rd XhoI; 4th AscI). Respective 2A se-
quences: P2A - GCCACGAACTTCTCTCTGTTAAAGCAAGCA GGAGATGTTGAA-
GAAAACCCCGGGCCT; T2A GAGGGCAGAG-
GAAGTCTTCTAACATGCGGTGACGTGGAGGAGA ATCCCGGCCCT; E2A -
CAGTGTACTAATTATGCTCTCTTGAAATTGGCTGG AGATGTTGAGAG-
CAACCCAGGTCCC). Replication-incompetent lentiviral particles (4F2A and M2rtTA)
were packaged in 293T cells with a VSV-G coat and used to infect MEFs containing a
GFP allele targeted to the endogenous Nanog locus (25) (7). 14-week old tail tip fibro-
blasts were derived from mice previously published (12). Human keratinocytes (NHFK)
were obtained from Coriell Institute for Medical Research Camden, NJ. Viral super-
natants from cultures packaging each of the two viruses were pooled, filtered through a
0.45 muM filter and subjected to ultracentrifugation for concentration. Virus pellets
were resuspended in ES cell medium (DMEM supplemented with 10% FBS (Hyclone),
leukemia inhibitory factor, p-mercaptoethanol (Sigma-Aldrich), penicil-
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lin/ streptomycin, L-glutamine and nonessential amino acids (all from Invitrogen) be-
fore being applied to cells for 24 hours.
Western Blot
100 y1 of lysis buffer containing 2% SDS, 10 mM dithiothreitol, 10% glycerol, 12% urea,
10 mM Tris-HCl (pH 7.5), 1 mM phenylmethylsulfonyl fluoride, 1x protease inhibitor
mixture (Roche), 25 yM MG132 proteosome inhibitor, and boiled for 5 min. Proteins
were then quantified using Bradford reagent (Pierce) and taking spectrophotometric
readings at 590 nm. Concentrations were estimated against a standard curve generated
using bovine serum albumin. Total protein (5 pg) was subjected to electrophoreses in a
denaturing 10% polyacrylamide gel containing 10% SDS. Proteins were then transferred
onto Immobilon-P membranes (Millipore) using a semi-dry transfer apparatus. Mem-
branes were blocked in PBS, 0.01% Tween 20 containing 2% nonfat powdered milk (Bio-
Rad). Proteins were detected by incubating with antibodies at a concentration of 50
ng/ml in blocking solution. Antibodies used were Oct4 (h-134 Santa Cruz Biotechnol-
ogy); Sox2 (mouse monoclonal R&D Biosystems); c-Myc (06-340 Upstate); Klf4 (H-180
Santa Cruz Biotechnology); GAPDH (sc-25778 Santa Cruz Biotechnology).
Quantitative RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). Five micrograms of total
RNA was treated with DNase I to remove potential contamination of genomic DNA us-
ing a DNA Free RNA kit (Zymo Research). One microgram of DNase I-treated RNA
was reverse transcribed using a First Strand Synthesis kit (Invitrogen) and ultimately
resuspended in 100 mul of water. Quantitative PCR analysis was performed in triplicate
using 1/50 of the reverse transcription reaction in an ABI Prism 7000 (Applied Biosys-
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tems) with Platinum SYBR green qPCR SuperMix-UDG with ROX (Invitrogen). Equal
loading was achieved by amplifying GAPDH mRNA and all reactions were performed
in triplicate. Primers used for amplification were as follows:
Oct4 F, 5'-ACATCGCCAATCAGCTTGG-3' and
R, 5'-AGAACCATACTCGAACCACATCC-3'
Sox2 F, 5'-ACAGATGCAACCGATGCACC-3' and
R, 5'- TGGAGTTGTACTGCAGGGCG-3'
4F2A (E2A-cMyc) F, 5'-GGCTGGAGATGTTGAGAGCAA-3' and
R, 5'-AAAGGAAATCCAGTGGCGC
GAPDH F, 5'-TTCACCACCATGGAGAAGGC-3' and
R, 5'-CCCTTTTGGCTCCACCCT-3'
Error bars represent s.d. of the mean of triplicate reactions.
Southern blotting
10 Rg of BamHI digested genomic DNA was separated on a 0.7% agarose gel, trans-
ferred to a nylon membrane (Amersham) and hybridized with 2P random primer
(Stratagene) labeled probes for OCT4 (EcoRI-PstI fragment of pFUW-tetO-
OCT4 plasmid), KLF4 (full length KLF4 cDNA), c-MYC (full length c-MYC
cDNA) and SOX2 (full length fragment of pFUW-tetO-SOX2 plasmid).
Immunofluorescent staining
Cells were fixed in 4% paraformaldehyde for 20 minutes at 25 *C, washed 3 times with
PBS and blocked for 15 min with 5% FBS in PBS containing 0.1% Triton-X. After incuba-
tion with primary antibodies against Oct4 (Santa Cruz h-134), Sox2 (R&D Biosystems),
Nanog (anti-ms R&D and anti-h), Tra-1-60, (mouse monoclonal, Chemicon Interna-
tional); hNANOG (goat polyclonal R&D Systems); mNANOG (Bethyl A300-398A),
Tral-81 (mouse monoclonal, Chemicon International), SSEA4 and SSEA1 (monoclonal
mouse, Developmental Studies Hybridoma Bank) for 1 h in 1% FBS in PBS containing
0.1% Triton-X, cells were washed 3 times with PBS and incubated with fluorophore-
labeled appropriate secondary antibodies purchased from Jackson Immunoresearch.
Specimens were analyzed on an Olympus Fluorescence microscope and images were
acquired with a Zeiss Axiocam camera.
Mouse Chimera and Teratoma Formation
Diploid blastocysts (94-98 h after hCG injection) were placed in a drop of Hepes-CZB
medium under mineral oil. A flat tip microinjection pipette with an internal diameter
of 16 pm was used for iPS cell injections. Each blastocyst received 8-10 iPS cells. After
injection, blastocysts were cultured in potassium simplex optimization medium
(KSOM) and placed at 37 *C until transferred to recipient females. About 10 injected
blastocysts were transferred to each uterine horn of 2.5-day-postcoitum pseudo-
pregnant B6D2F1 female. Pups were recovered at day 19.5 and fostered to lactating
B6D2F1 mothers when necessary. Teratoma formation was performed by depositing
2x10A6 cells under the flanks of recipient SCID or Rag2-/- mice. Tumors were isolated
3-6 weeks later for histological analysis.
Human Teratoma formation and analysis
hiPSCs were collected by collagenase treatment (1.5mg /ml) and separated from
feeder cells by subsequent washes with medium and sedimentation of iPSC
colonies. iPSC aggregates were collected by centrifugation and resuspended in a ratio
of 10A6 cells in 250p1 of iPSC culture media. iPSCs were injected subcutaneously by 21
gauge needle in the back of SCID mice (Taconic). A tumor developed within 6 weeks
and the animal was sacrificed before tumor size exceeded 1.5 cm in diameter. Tera-
tomas were isolated after sacrificing the mice and fixed in formalin. After sectioning,
teratomas were diagnosed base on hematoxylin and eosin staining. Karyotype analysis
was done with CLGenetics (Madison, WI).
In Vitro differentiation of human IPS cells into neuronal progenitors:
Human keratinocyte iPS cells were allowed to outgrow in culture without pasaging for
2 weeks with daily medium change. At day 15 after passage distinct neural rossets were
observed and picked mechanically by pooled glass pipett (26). Rosettes were replated
on dishes precoated with 15ptg/ml polyomithin/ 10tg/ml of laminin (Po/Lam) in
N2B27 medium supplemented with FGF2 (20ng/ml) EGF (20ng/ml) (All R&D Sys-
tems). After 5-7 d cells were dissociated by scraping with cell lifter and pippeting to
single cells in N2B27 medium and replated to Po/Lam culture dishes.
Differentiation and immunocytochemistry
Induction of differentiation of neural progenitors was performed by withdrowal of
FGF2 and EGF from culture medium for 5days. Cells were fixed in 4% paraformalde-
hyde for 20 min and stained for human nestin (Chemicon; 1:100) and Tuj-1 (1:100) and
subsequently washed 3 times with PBS and incubated with fluorophore-labeled appro-
priate secondary antibodies purchased from Jackson Immunoresearch. Specimens were
analyzed on an Olympus Fluorescence microscope and images were acquired with a
Zeiss Axiocam camera.
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FIGURE LEGENDS
FIGURE 1: Generation of murine iPS cells using a single 4F2A polycistronic virus.
A.FUW lentivirus constructs tested by transient transfection. In total four 2A peptides
(F2A, T2A, E2A, and P2A) were used.
B.Transient transfection of 293 cells with FUW 2A lentiviruses. Cells were harvested af-
ter 48 hours and analyzed by western blot (WB). Efficient protein expression was ob-
served in all constructs tested, indicating four unique 2A peptides support robust pro-
tein expression. NOTE: Sox2 protein is not detected in ES cells because only a short ex-
posure was used.
C.Schematic of the 4F2A DOX-inducible lentivirus containing three types of 2A pep-
tides (P2A, T2A, and E2A). Murine cDNAs for Oct4, Sox2, Klf4, and c-Myc. This par-
ticular sequence of factors and 2A peptides is subsequently referred to as "4F2A."
D.RT-PCR anaylsis of mRNA induction in cells transduced with OSKM 4F2A+rtTA for
3-days. Total Oct4 or Sox2 induction was used to test levels of 4F2A induction relative
to ES cells. E2A-cMyc primers were used to detect viral-specific transcripts. Error bars
represent s.d. of the mean of triplicate reactions.
E.Western blot analysis of MEFs transduced with 4F2A+rtTA for three days. Cells in-
fected with 4F2A DOX-inducible lentivirus + rtTA produce all four reprogramming fac-
tors upon addition of doxycycline, DOX.
FIGURE 2: 4F2A iPS cells express pluripotency markers.
A.Immunostaining of Oct4 protein indicates high titre infections can be achieved with
the 4F2A. MEFs were cultured in DOX media for 2 days after transduction with 4F2A +
rtTA.
B.Morphology changes in NanogGFP-MEFs transduced with 4F2A + rtTA cultured in
ES media + DOX. Colonies appeared ~ 8 days similar to cells infected with single vi-
ruses. Nanog GFP+ colonies were observed by day 25 after DOX media removal at day
20. Two columns show typical colonies observed on the plate.
C.4F2A iPS lines generated from Nanog-GFP MEFs or 14-week tail-tip fibroblasts
(TTFs) that stain positive for pluripotency markers AP, SSEA1, Oct4 and have reacti-
vated the endogenous Nanog locus (GFP+ for MEFs and by immunostaining for TTF).
FIGURE 3: 4F2A iPS cells are pluripotent and contain between 1-3 proviral integra-
tions.
A.In-vivo differentiation of 4F2A MEF-iPS lines #1,2, and 4. Histological analysis of
teratomas induced after subcutaneous injection into SCID mice indicates iPS lines con-
tribute to all three germ layers.
B.Moderate to high contribution postnatal chimeric mice as detected by agouti coat
color from 4F2A iPS line #4.
Southern blot analysis of 4F2A proviral integrations in MEF-iPS cell lines #1-4. iPS cell
DNA was digested with BamHI. Hybridization of the same molecular weight fragment
using all four probes indicates presence of 4F2A provirus. Red arrow highlights iPS line
#4 which contained one proviral copy of the 4F2A. * indicates endogenous allele.
FIGURE 4: Generation of human iPS lines using a single 4F2A polycistronic virus.
A. Neonatal human foreskin keritinocytes (NHFK) transduced with 4F2A (carrying
mouse cDNAs) + rtTA. On day 22 a single colony was picked and expanded, giving rise
to colonies resembling hES colonies. These colonies were picked and a stable hiPS line
was established.
B.Ker hiPS #1.1 immunostaining for pluripotency markers AP, Oct4, Nanog, SSEA-4,
Tral-60, and Tral-81. DAPI stain is in lower panels.
C.Karyotype of Ker hiPS #1.1 is normal 46 XY.
D.In-vivo differentiation of Ker hiPS #1.1. Hematoxylin and eosin staining of teratoma
sections generated by Ker hiPS #1.1
E.In vitro differentiation of Ker hiPS #1.1. (Left) Ker-iPS #1.1-derived neural precursors
exposed to differentiation conditions for 6 days produce terminally differentiated neu-
rons as detected by anti-Tuj1 immunostaining (green). (Right) Ker-iPS #1.1 neural pre-
cursors (NPs) undergo spontaneous differentiation. NPs were detected by anti-Nestin
immunostaining and differentiated neurons by anti-Tuj1 (red). DAPI stain for DNA in
both pictures is blue.
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SI FIGURE 1: Southern blot of MEF-derived iPS lines and dox-withdrawl indicating
8 days is sufficient to generate iPS lines.
A.Southem blot analysis of 4F2A MEF iPS lines. A second digest was performed (XbaI)
to confirm the proviral copy number. In this digest iPS line #2 and #4 show 1 proviral
copy, however only #4 had 1 proviral copy in both digests.
B.Dox-withdrawl after 8 days post-infection of Nanog GFP MEFs with rtTA+OSKM
generated two iPS lines. Both generated stable iPS lines after 1-2 passages.
SI FIGURE 2: Relative efficiencies reprogramming using 4F2A
A.Relative reprogramming efficiency of 4F2A in MEFs. NanogGFP MEFs were infected
with 4F2A+rtTA and cultured in ES media (+ / - DOX) for 48 hours. Cells were fixed and
stained for Oct4 protein. An estimated infection efficiency was ~ 70%. The same virus
was also used to infect 0.2 5x10A6 Nanog GFP MEFs and cells were cultured on DOX for
20 days. After withdrawl of DOX at day 20, GFP+ colonies were counted at day 25, in
three plates 10, 10, and 17 GFP+ colonies were observed.
SI FIGURE 3: Infection efficiency and pluripotency analysis of Keratinocyte-derived
human iPS lines.
A.Infection efficiency from two experiments as detected by Oct4 immunostaining in
Keratinocytes infected with 4F2A+rtTA and cultured in hES media+DOX for 48 hours.
Efficiency of infection was ~10-20% based on fraction of cells positive for Oct4 protein.
B.Human iPS lines stain positive for pluripotency markers expressed in hES cells (Ker
iPS #3 is shown).
SI FIGURE 4: Proviral copy number of Keratinocyte-derived human iPS lines.
A. Southern blot analysis of Ker-iPS lines. 10mg of genomic DNA was harvested and
digested with XbaI. Hybridization of the same molecular weight fragment indicates
presence of 4F2A provirus. Probes for Sox2, Klf4, and c-Myc suggested 2 (#1.1) and 1
(#3) proviral copies. Common bands observed between the two iPS lines are not viral
integration as these were derived from independent infections.
B. Southern blot analysis of Ker-iPS lines. 10mg of genomic DNA was harvested and
digested with BamHI. Hybridization of the same molecular weight fragment indicates
presence of 4F2A provirus. Probes for Oct4 and c-Myc indicate 3 (#1.1) and 2 (#3) provi-
ral copies.
Table S1: Table summarizing pluripotency tests as well as relative efficiencies for all iPS
lines generated. GFP, GFP reporter gene present; ES, expression of ES cell markers (AP,
SSEA1, Oct4 or Sox2); TF, teratoma formation; PC, postnatal chimeras. Mouse chimer-
ism was estimated by agouti coat color.
Source of cells GFP PS lines Efficiency ES TF PC
(iPS/input, %)
(m) embryonic fib Nanog 5 0.0001% Yes Yes Yes
(m) adult fib No 4 ND Yes No No
(h) Keratinocytes No 2 0.00001% Yes Yes No
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Chapter 3
A single-gene transgenic mouse strain for reprogramming adult
somatic cells
Bryce W. Carey, Styliani Markoulaki, Caroline Beard, Jacob Hanna, and
Rudolf Jaenisch
This thesis chapter has been published: Carey BW, Markoulaki S, Beard C, Hanna J,
Jaenisch R. Nat Methods. 2010 Jan;7(1):56-9.
ABSTRACT: We report a novel transgenic mouse model for direct reprogramming of
somatic cells by expressing four reprogramming factors from a single genomic locus
using a drug-inducible transgene. Multiple somatic cell types explanted from differ-
ent tissues can generate induced pluripotent stem cells (iPSC) by culture in doxycy-
cline (Dox). Because the reprogramming factors are carried on a single polycistronic
construct the transgenic mice can be easily maintained and transferred into another
background.
RESULTS: Generation of induced pluripotent stem cells (iPSCs) by primary infection
using Moloney based gene delivery generates iPSCs with an efficiency between 0.001-
0.1% ". The creation of "secondary" systems that utilize doxycyline (Dox)-inducible
lentiviruses to generate iPSCs from murine somatic cells allows the reprogramming of
genetically homogenous somatic cell populations and avoids the genetic heterogeneity
of primary infections 58. However secondary lines harbor multiple (>7) proviruses, each
with different capacities for reactivation as indicated by the variegated expression of
reprogramming factors after Dox exposure in addition to the inability of factors to reac-
tivate in some somatic tissues 6. Although secondary models have been used to generate
transgenic animals carrying all or a subset of factors by germline segregation of the
proviruses, it remains difficult to maintain all factors in one mouse because the multiple
transgenes segregate in each generation 9.
Here we report a transgenic mouse model that overcomes these limitations and
minimizes the variegation of factor levels by inducing reprogramming factor expression
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from a single genomic site. The collagen type I (Collal) gene has been used as an ex-
pression locus for Oct4 (also called Oct3/4 or Pou5fl) and demonstrated to be capable of
transgene induction in multiple somatic cell types including mouse fibroblasts, kerati-
nocytes, adrenal glands, and neural precursor cells 6,10, 11. We generated "single-gene"
transgenic mouse strain(s) that express three or four reprogramming factors from the
Collal locus.
Using homologous recombination of embryonic stem cells (ESCs) carrying a
drug-inducible reverse tetracycline trans-activator (M2rtTA) in the Rosa26 locus, we in-
serted four reprogramming factors as a single polycistronic transgene in an expression
cassette termed "4F2A," which harbors four murine reprogramming genes (Oct4, Sox2,
Klf4, and c-Myc) separated by three 2A self-cleaving peptides (Fig. la,b). This cassette
has been shown to reprogram embryonic and adult murine fibroblasts as well as human
keratinocytes 12. Transgenic animals carrying one copy of each transgene
rtTA(1):4F2A(1) were generated and intercrossed to derive animals carrying various
combinations of transgene copies rtTA(2): 4F2A(1), rtTA(1):4F2A(2) and
rtTA(2):4F2A(2). Importantly, no tumors or other health problems were detected in any
of the transgenic mice for up to 31 weeks of age (Supplementary Table 1).
We used qRT-PCR analysis to quantify the Dox-induced expression level of the
4F2A transgene (Tg) in mouse embryonic fibroblasts (MEFs) using primers specific to
the 4F2A Tg and observed >100-fold induction in MEFs carrying a single copy of both
the rtTA and 4F2A (Supplementary Figure 2a). Protein expression for three of the four
factors was confirmed by immunoflourescence demonstrating robust Dox-inducible ex-
pression (Supplementary Figure 2b). The relative induction as compared to transcript
levels in ESCs or MEFs was quantified by qRT-PCR analysis using exon specific primers
for each factor demonstrating that the expression of Oct4 and Sox2 was in the same
range whereas Klf4 and c-Myc were expressed at a 3- to 5-fold higher than in ES cells
(Supplementary Fig. 3a). To test whether factor expression was copy number depend-
ent we quantified transcript levels in adult fibroblasts carrying different copies of the
two transgenes. qRT-PCR analysis showed a copy number and Dox-dependent expres-
sion of the 4F2A Tg (1:1 <1:2 < 2:2; Supplementary Fig. 3b).
Mice carrying different copies of each transgene (1:1, 2:1, 1:2, 2:2) were tested for
the ability to generate iPSCs from defined tissues (Supplementary Table 2). MEFs iso-
lated from animals carrying single copy rtTA(1):4F2A(1) and cultured in the presence of
Dox gave rise to colonies within 2 - 4 weeks that could be picked and after 2-3 passages
generated iPS cell lines that expressed the pluripotency markers alkaline phosphatase
(AP), SSEA1, and had reactivated the endogenous Nanog locus as detected by immu-
nostaining (Fig. 1c). However, we failed to obtain iPSCs from any tissue of adult mice
carrying single copies of each Tg respectively.
To assess whether higher transgene expression levels would allow the generation
of iPSCs from other cell types, tail tip fibroblasts (TTF), epidermis-derived keratino-
cytes, liver cells, mesenchymal stem cells (MSCs), pro-B cells, macrophages and intesti-
nal epithelial cells were derived from mice carrying different combinations of Tg copies
and cultured in the presence of Dox. We were able to isolate iPSCs from adult liver cells
as well as keratinocytes from mice carrying 2 copies of rtTA and 1 copy of 4F2A
(rtTA(2): 4F2A(1)). Colonies appeared at d12-16 after addition of Dox (Supplementary
Figure 4a), were manually picked, expanded without Dox after 2-3 passages and shown
to express pluripotency markers AP, SSEA1, and Nanog (Fig. 1c). Other cell types such
as CD11b+ macrophages from spleen, CD19+ pro-B cells from bone marrow, intestinal
epithelium, adult tail-tip fibroblasts, and mesenchymal stem cells (MSCs) generated
iPSCs only in the presence of a second copy of 4F2A transgene. iPSCs from adult fibro-
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blasts, CD11b+ macrophages, and pro-B cells were derived from animals carrying 2
copies of the 4F2A Tg and one copy of the rtTA Tg (rtTA(1):4F2A(2)) whereas intestinal
epithelial cells and mesenchymal stem cells (MSCs) required the presence of a second
rtTA Tg (rtTA(2):4F2A(2)). The iPSCs grew in the absence of Dox and expressed the
pluripotency markers AP, SSEA1, and Nanog (Fig. 1c and Supplementary Figure 4b).
Complete demethylation of the endogenous Oct4 promoter was observed in five iPSC
lines tested after bisulfite treatment and sequencing (Fig. ld and Supplementary Figure
4c).
To assess pluripotency we tested the ability of Collal 4F2A iPSCs to differenti-
ate in vivo. Liver, keratinocyte, and MEF-derived iPSCs were injected sub-cutaneously
into SCID mice, giving rise to teratomas containing cells from all three germ layers
(Figure le and Supplementary Fig. 4d). Two lines were tested for the ability to contrib-
ute to post-natal chimeras. MEF iPSC line #11 contributed to adult chimeras after injec-
tion into blastocysts (Fig. If). In addition we generated high contribution post-natal
chimeras from macrophage-derived iPSC line (#5) that also transmitted the iPSC ge-
nome through the germline (Fig. if and Supplementary Figure 4e).
Our data demonstrate that iPSCs can be derived from multiple somatic tissues of
adult mice carrying the Collal 4F2A polycistronic transgene. The observations that
some donor cell types were able to generate iPSCs only from animals with two copies of
the transgene suggests cell types such as intestinal epithelial cells, MCSs, pro-B cells or
TTFs require higher levels of factor expression for reprogramming than other cell types
such as MEFs or hepatocytes. Alternatively, differences in the induction level of the
Collal locus in certain cell types may require multiple copies of a Collal transgene to
reach a threshold of expression capable of achieving an iPS cell state.
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We characterized reprogramming efficiencies in two distinct mouse transgene ra-
tios (1:2 and 2:2) using pro-B cells. From each strain CD19+ cells were harvested from
bone marrow and plated at similar densities (1x10 6) per well. Colonies appeared in both
genotypes around day 12-14 but with different efficiencies. Alkaline phosphatase (AP)
and Nanog immunostaining showed a 100-fold higher efficiency at a 2:2 than at a 1:2
transgene ratio (Supplementary Fig. 5a,b). To quantify the efficiency more precisely we
tested the kinetics of reprogramming CD19+ pro-B cells (using ratio 2:2). Approxi-
mately 5x105 cells were cultured with Dox and changed to ES media without dox at in-
dicated times. Reprogramming was assessed and quantified as Dox-independent,
Nanog-positive iPS cells by immunostaining on day 25. We found Nanog-positive colo-
nies increased with prolonged culture and directly correlated with the number of input
donor cells (Supplementary Figure 5c,d).
In addition to the Collal 4F2A system we established a transgenic model carry-
ing only a subset of reprogramming factors to demonstrate the potential utility for re-
placement of individual reprogramming factors9 . Using a three-factor 2A expression
cassette lacking Sox2 (Oct4-T2A-Klf4-E2A-cMyc; abbreviated as '3F2A") western blot
analysis demonstrated that cells transduced with the 3F2A lentivirus were capable of
expressing all three reprogramming factors (Fig. 2a). This cDNA was used in a Collal
targeting vector to generate Collal 3F2A transgenic ESCs that also harbored a drug-
inducible M2rtTA at the Rosa 26 locus (Fig. 2b). After injection of 3F2A ESCs into blas-
tocysts we obtained E13.5 chimeric embryos and isolated MEFs. When the cells were
cultured in the presence of Dox induction of the transgene was ~ 120-fold as seen by
qRT-PCR (Supplementary Fig. 6a). Because the 3F2A-MEFs lacked the essential repro-
gramming factor Sox2 they were infected with a Sox2 lentivirus (pFUW-tetO Sox2) (Fig
2c). Colonies appeared after 12-16 days and were picked at day 25. iPSCs were estab-
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lished after 2-3 passages staining positive for pluripotency markers AP, SSEA1 and
Nanog (Fig. 2d). Four independent iPSC lines (MEF 3F2A+S iPSC) carried a single Sox2
provirus as detected by Southern (Fig. 2e) in addition to the single copy of rtTA and
OKM Tg. All MEF 3F2A+S iPSC lines carried the 3F2A Tg as demonstrated by Southern
analysis using probes for Oct4, Klf4, and c-Myc which all hybridized to a -4.8 kb band
as expected for the single 3F2A transgene (Supplementary Fig. 6b,c). iPSC line #34 gave
rise to high contribution chimeras when injected into blastocysts (Fig 2f and Supple-
mentary Table 3) with two of the four chimeras transmitting the iPSC genome through
the germline (Fig. 2f). Somatic cells derived from animals carrying the 3F2A transgene
will be useful to screen for small molecules that replace Sox2 for reprogramming.
Recently, several strategies have been described that allow the generation of vec-
tor-free iPSCs following excision of reprogramming transgenes 13-1. To establish a sys-
tem that would permit the isolation of vector-free iPSCs from a defined transgenic
strain, we created a Collal 4F2A targeting vector harboring loxP sites flanking the Tg
(Collal 2lox 4F2A) (Fig. 3a) leaving a single loxP site in the Collal 3' UTR after Cre-
mediated excision. The construct was targeted to the Collal locus in ESCs carrying the
M2rtTA transgene at the Rosa 26 locus (Fig 3b). To assess whether the transgene could
be excised freshly passaged transgenic ESCs were exposed to a recombinant cell-
permeable Cre protein (HTN-Cre) for 20 hours. Deletion of the Collal 2lox 4F2A was
detected in sibling colonies that were cultured in the presence or absence of G418 giving
rise to 2 out of 16 neo sensitive colonies (Fig. 3c) that had deleted the transgene as veri-
fied by Southern blot analysis using an external Collal 5' probe as well as probes for
Oct4 and c-Myc cDNA (Fig. 3d). Mice derived from this ES cell line will be useful as
donors for generating iPSCs that carry no vector sequences.
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The transgenic models described in this study have several advantages over pre-
vious systems: 1) the previous "secondary" iPSCs were derived from primary iPS cells
generated by lentivirus-mediated gene transfer of the four reprogramming factors 6,.
Because the individual proviruses carrying the four factors segregate independently it
has been difficult to derive mice homozygous for all factors that could be used as a con-
venient source for reprogrammable cells. In the present system all reprogramming fac-
tors are expressed from one cassette (e.g. 4F2A) inserted into a single locus, facilitating
the maintenance of the strain as well as the transfer of the reprogramming factors to
mouse strains carrying other genetic determinants of interest. 2) Unlike proviral trans-
genes that may be silenced by DNA methylation or other epigenetic mechanisms upon
germ line transmission, this transgenic system expresses the four reprogramming fac-
tors from a specific locus (Collal) that is widely expressed in the adult mouse and is ca-
pable of reprogramming cells from seven different tissues of the adult. 3) No tumors or
other adverse effects have been observed in the transgenic mice suggesting that the
Collal 4F2A system is both safe and practical for extended breeding. 4) Reprogram-
ming factor stochiometries are fixed within each somatic cell type. This system creates
iPSCs from multiple somatic tissues and allows comparison among iPSCs not previ-
ously possible. Moreover this system generates iPSCs that can now be compared to ge-
netically identical ESCs. 5) The generation of 3F2A transgenic mice lacking one of the 4
factors will allow screening of somatic cells for small molecules to replace the fourth
factor (such as Sox2, Fig. 2). 6) Finally, the generation of mice carrying the loxP flanked
4F2A construct will allow the excision of the transgene and derivation of adult mice
created from vector-free iPSCs ".
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MATERIALS AND METHODS:
Collal targeting and vectors (1) Collal 4F2A: A ~ 5.8kb EcoRI generated fragment con-
taining Oct4-P2A-Sox2-T2A-Klf4-E2A-c-Myc (also named "4F2A") cDNA was gener-
ated from a previously published plasmid FUW-Ubi-4F2A 1 2 and ligated into
ptet.splicePL3 vector (containing tetO promoter + SV40 intronpA) similarly digested
with EcoRI to obtain ptet.splicePL3-OSKMpA. A 7.3kb NotI generated fragment was
obtained from the ptet.splicePL3-OSKMpA and ligated into a NotI digested
mCol.loxneo targeting vector that contained both 5' and 3' homology arms towards the
3' UTR of the Collal locus as well as a pgk-driven neo resistance cassette for selection
of transgenic cells. The resulting -18 kb targeting construct (Collal 4F2A) was line-
arized with PvuI restriction enzyme digestion (25 [Lg), precipitated and resuspended in
400 l HEPES, then electroporated into V19 ES cells (V6.5 ES cells containing a reverse
tetracycline trans-activator (M2rtTA) driven by the Rosa26 promoter). After 24 hours
G418 (350 gg per ml) was added to ES cell medium (DMEM supplemented with 10%
FBS (Hyclone), leukemia inhibitory factor, p-mercaptoethanol (Sigma-Aldrich), penicil-
lin/streptomycin, L-glutamine and nonessential amino acids (all from Invitrogen). Neo-
resistant colonies were picked 10 days later, expanded and DNA isolated for testing of
correct targeting by Southen analysis. (2) Collal 2lox 4F2A: the 7.3 kb NotI generated
fragment from ptet.splicePL3-OSKMpA was blunt-ended and ligated with a EcoRV di-
gested pBS246 plasmid (containing two loxP sites). The resulting pBS246.tetO-OSKMpA
was digested with NotI generating a fragment of 7.6 kb that was ligated into the previ-
ously mentioned NotI digested mCol.loxneo targeting vector. The resulting vector
Collal 2lox 4F2A was digested for targeting of V19 ES cells as described above. (3)
Collal 3F2A: A three-factor cDNA containing Oct4-T2A-Klf4-c-Myc was generated by
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PCR amplification of Oct4 using 5' XbaI-EcoRI and SphI containing primers whose
product was then TOPO cloned following manufactures instructions (pCR 2.1 TOPO
Invitrogen). The TOPO-Oct4 plasmid was then digested with XbaI and SphI and the 1.1
kb Oct4 cDNA was ligated to a similarly digested FUW-Ubi-4F2A ~ 10 kb fragment.
The resulting FUW-Ubi-3F2A was digested with EcoRI to generate a ~ 4.0 kb fragment
that was cloned into the ptet.splicePL3 vector as described above. A 6.3 kb fragment
from ptet.splicePL3-tetO-3F2ApA was generated by NotI digestion and ligated into the
mCol.loxneo targeting vector. The resulting 17kb plasmid (Collal 3F2A) was linearized
with PvuI restriction enzyme (25 pg), precipitated, resuspended in 400 jl HEPES and
electroporated into V19 cells. Selection was the same as described above.
Mouse chimera and teratoma formation: Diploid blastocysts (94-98 h after hCG injec-
tion) were placed in a drop of Hepes-CZB medium under mineral oil. A flat tip mi-
croinjection pipette with an internal diameter of 16 pm was used for iPS cell injections.
Each blastocyst received 8-10 iPS cells or ES cells. After injection, blastocysts were cul-
tured in potassium simplex optimization medium (KSOM) and placed at 37 *C until
transferred to recipient females. About 10 injected blastocysts were transferred to each
uterine horn of 2.5-day-postcoitum pseudo-pregnant B6D2F1 female. Pups were recov-
ered at day 19.5 and fostered to lactating B6D2F1 mothers when necessary. For sum-
mary see Supplementary Table 4. Teratoma formation was performed by depositing
2x10A6 cells under the flanks of recipient SCID mice. Tumors were isolated 3-6 weeks
later for histological analysis.
Somatic cell isolation and culture: For MEF isolation, chimeric embryos were isolated
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at E13.5, and the head and internal organs were removed. The remaining tissues were
physically dissociated and incubated in trypsin at 37'C for 20 min after which cells were
resuspended in MEF medium. 24 hours later puromycin (2 pg/ml) was added and the
cells were expanded for two passages before freezing or plating in doxycline containing
media (2 tg /ml) for reprogramming experiments. Somatic organs were isolated from 4-
6 week-old transgenic mice. Epidermal keratinocytes and intestinal epithelium were
isolated and cultured as previously described 6. For mesenchymal stem cells (MSCs)
and pro-B cells whole marrow was isolated from the femur and tibia after removal of
the condyles at the growth plate by flushing with a syringe and 30-guague needle con-
taining DMEM+5% FBS (Hyclone, Thermo Fisher Scientific). CD19+ pro-B cells were
isolated by MACS cell separation (Miltenyibiotec Cat# 130-052-201) following manufac-
tures instructions. Purified B cell subsets were resuspended in IMDM with 15% FCS as
well as IL-4, IL-7, SCF (10 ng /ml each, Peprotech), doxycyline (2 [tg/ml) and plated on
OP9 bone marrow stromal cells (ATCC). Three days later the medium was changed to
ESC medium plus Dox. Macrophage cells (CD11b+) from freshly isolated spleen were
isolated by MACS cell separation and plated by a similar protocol described for CD19+
pro-B cells. Mesenchymal stem cells were selected through differential plating on tissue
culture plates (10cm) for 72h in a-MEM supplemented with 15% FBS. Once plates
reached a full monolayer cells were split into 6-well dishes and cultured in the presence
of Dox. For isolation of liver cells mice were first perfused with 50 ml HBSS buffer (w /o
Ca2+ and Mg2+) then 50 ml HBSS (w/o Ca2+ and Mg2+) containing collagenase (type
IV) (Sigma Cat# C5138) (100U/ml). Liver was dissected away from surrounding tissues
and dissociated in 10ml DAG media (phenol-red free EMEM Gibco-11054-020 and Bo-
vine serum albumin (BSA) lg/0.5L) and filtered two times through a sterile 100 pM cell
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strainer. Liver cell preparations were centrifuged at 30 g for 3 minutes at 4 *C and the
cells were washed two times with DAG media and then plated on y-irradiated MEFs in
ES media + Dox.
Antibodies and Immunostaining: Cells were fixed in 4% paraformaldehyde for 20
minutes at 25 *C, washed 3 times with PBS and blocked for 15 min with 5% FBS in PBS
containing 0.1% Triton-X. After incubation with primary antibodies against Oct4 (Santa
Cruz H-134), Sox2 (R&D Biosystems), Klf4 (Santa Cruz H-180), Nanog (Bethyl A300-
398A), SSEA1 (monoclonal mouse, Developmental Studies Hybridoma Bank) for 1 h in
1% FBS in PBS containing 0.1% Triton-X, cells were washed 3 times with PBS and incu-
bated with fluorophore-labeled appropriate secondary antibodies purchased from Jack-
son Immunoresearch. Specimens were analyzed on an Olympus Fluorescence micro-
scope and images were acquired with a Zeiss Axiocam camera. Alkaline phosphatase
(AP) staining was done following manufactures instructions (Vector Labs).
Bisulfite Sequencing DNA was isolated from indicated cell lines and conversion of
unmethylated CpG dinucleotides was performed using EpiTect bisulfite kit (Qiagen)
following manufacturer's instructions. Following PCR amplification (see Supplemen-
tary Table 5) gel purified DNA fragments were subcloned into TOPO TA vector (Invi-
trogen) and transformed into TOP-10 bacterial cells. 10 clones per cell line were sent for
sequencing in both forward and reverse directions (M13F /R).
Southern Blotting 10 gg of restriction enzyme digested genomic DNA was separated
on a 0.7% agarose gel, transferred to a nylon membrane (Amersham) and hybridized
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with "P random primer (Stratagene) labeled probes for Collal 5' genomic (external) se-
quences, Collal 3' (internal) located in 3' arm of Collal targeting vectors (XhoI-PstI
fragment of TOPO2.1 5'mCollal & XbaI-PstI 3'mCollal plasmids), Klf4 (full length Klf4
cDNA from pFUW-tetO-Klf4), c-Myc (full length c-Myc cDNA from pFUW-tetO-c-
Myc), Oct4 (EcoRI-PstI exon1 fragment of cDNA from pFUW-tetO-Oct4), and Sox2 (full
length cDNA from pFUW-tetO-Sox2 plasmid).
Recombinant HTNCre protein delivery to Collal 21ox 4F2A transgenic ES cells:
Transgenic ES cells were passaged one day prior to Cre protein transduction to obtain a
monolayer. ES cell medium containing 10 pM HTNCre protein was prepared after ap-
propriate dilution from 200pM stock and incubated with transgenic ES cells for 20
hours. After this time media was changed to ES cell media and cells were incubated for
1 more day until passaging (1:10,000) for single cell colony formation.
Quantitative RT-PCR: Total RNA was isolated using Trizol reagent (Invitrogen). Five
micrograms of total RNA was treated with DNase I to remove potential contamination
of genomic DNA using a DNA Free RNA kit (Zymo Research). One microgram of
DNase I-treated RNA was reverse transcribed using a First Strand Synthesis kit (Invi-
trogen) and ultimately resuspended in 100 p1 of water. Quantitative PCR analysis was
performed in triplicate using 1/50 of the reverse transcription reaction in an ABI Prism
7000 (Applied Biosystems) with Platinum SYBR green qPCR SuperMix-UDG with ROX
(Invitrogen).
Equal loading was achieved by amplifying GAPDH mRNA and all reactions were per-
formed in triplicate. Primers used for amplification are listed in Supplementary Table
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5. Data were extracted from the linear range of amplification. All graphs of qRT-PCR
data shown represent samples of RNA that were DNase treated, reverse transcribed
and amplified in parallel to avoid variation inherent in these procedures. Error bars
represent s.d. of the mean of triplicate reactions.
Col 4F2A PCR genotyping: PCR performed using three sequencing primers (Collal
frtA F, frtB R, 4F2A R) listed in Supplementary Table 5. PCR reaction: 95C / 1min (1 cy-
cle), 94 C0 /30", 70 C /45" (2 cycles), 94 C /30", 68 C /45"(5 cycles), 94 C /20", 66
C0 ! 1min (29 cycles); 4 Co. Wild-type Collal is ~ 300bp, targeted Collal 4F2A product is
~ 550bp.
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FIGURE LEGENDS
FIGURE 1. Reprogramming somatic cells from transgenic Collal 4F2A mice. (a) A
targeting vector to the 3' UTR was utilized to deliver four murine reprogramming fac-
tors (Oct4, Sox2, Klf4, and c-Myc) as a single dox-inducible polycistronic transgene 11,12
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Red triangles indicate loxP sites. pA indicates poly-adenylation sequence. TetO is
tetracycline operator minimal promoter. (b) Southern analysis of DNA obtained from
Neo-resistant V19 ES cell colonies was digested with XbaI and probed for correct
targeting of the Collal 3' UTR using a 5' external Collal probe to the genomic sequence
outside the targeting vector homology arms ". Lines #2 and #11 were correctly targeted
as indicated by hybridization to 5.3 kb band (untargeted allele ~ 4.7 kb). (c) Collal 4F2A
iPS cells express pluripotency markers. Bright field (BF) images and immunostaining
for pluripotency markers alkaline phosphatase (AP), SSEA1, and Nanog. Scale bar,
1mm. (d) Oct4 promoter using bisulfite sequencing. Open circles indicate unmethylated
and closed circles indicate methylated CpG dinucleotides. Shown are representative se-
quence analyses from Collal 4F2A transgenic MEFs, embryonic stem cells (V6.5), and
two Collal 4F2A iPSC lines: pro-B-derived #1 and liver-derived line #5B. (e) Hematox-
ylin and eosin staining of teratomas induced after subcutaneous injection of Collal
4F2A Liv iPSC #5B and Ker iPSC #2 into SCID mice indicates Collal 4F2A iPSCs con-
tribute to all three germ layers. Scale bar, 100pm (f) Postnatal chimeric mice detected by
agouti coat color from Colla14F2A MEF iPSC #11 and MAC iPSC #5.
FIGURE 2: iPSCs derived from Collal 3F2Atransgenic MEFs expressing a subset of
reprogramming factors. (a) Western blot analysis of 293 cells transiently transfected
with pFUW-Ubi 3F2A lentivirus. (b) Southern analysis of DNA obtained from Neo-
resistant V19 ES cell colonies. DNA was digested with XbaI and probed for correct tar-
geting using a 5' Collal probe. Three lines (# 2, 4, 18) were correctly targeted as indi-
cated by hybridization to the 5.3kb band (untargeted allele - 4.7 kb). (c) 3F2A MEFs
were infected with a Dox-inducible lentivirus carrying a Sox2 cDNA (pFUW-tetO-Sox2)
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and transferred to ES cell medium containing Dox after 48 hours. Typical iPSC colonies
appeared around day 12 and were mechanically passaged at day 25. Scale bar, 1mm. (d)
Immunostaining for AP, SSEA1 and Nanog of iPSC line #34. DAPI staining is shown in
the inset. Scale bar, 1mm. (e) Southern blot analysis of 3F2A+S iPS cell clones. DNA was
isolated from each iPSC line and digested with XbaI. The presence of a single Sox2 pro-
viral copy was detected with a Sox2 cDNA probe for hybridization. A similar sized
band was detected in lines #36 and 30 suggesting these cells are sibling subclones from
the same infected cell. (f) 3F2A+S MEF derived iPS cells give rise to post-natal chime-
ras. High contribution chimera (as detected by agouti coat color) obtained after injection
of 3F2A+S iPSC line #34 into blastocysts. This chimera contained iPSCs that contributed
to the germline as shown by agouti pups present after mating to BDF1 females.
FIGURE 3: Cre-excisable Collal 4F2A transgenic ES cells. (a) Targeting vector con-
taining loxP sites flanking the 4F2A transgene. A similar targeting scheme as described
in Figure la was used. (b) Targeting of 3F2A to the Collal locus in R26 M2rtTA trans-
genic ES cells. Southern analysis of DNA obtained from Neo-resistant ES cell colonies
digested with XbaI and probed for correct targeting using a 5' external Collal probe
(compare Fig. la). Multiple clones were correctly targeted as indicated by hybridization
to the 5.3kb band (untargeted allele ~ 4.7kb). Line #2 was chosen for Cre-induced exci-
sion. (c) Recombinant cell-permeable HTN-Cre transduced into Collal 2lox 4F2AES
cells. Cells were grown in ES cell medium containing HTN-Cre protein for 20 hours. 24
hours later the cells were trypsinized, plated at high dilution (1:10,000) and colonies
were picked and expanded before being split into ES medium or ES medium + G418.
Bright field images depict a subclone that is G418-sensitive. Scale bars, 1mm. (d) South-
ern blot analysis of HTN-Cre-induced excision of Collal 2lox 4F2A transgene in ESCs.
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DNA obtained from sister clones of Neo-sensitive ES cell colonies was digested with
XbaI and probed using a 5' external Collal probe (compare Fig. 1a). Two subclones (#4
and 9) do not show hybridization to the -5.3kb band corresponding to the targeted
Collal 4F2A after exposure to HTN-Cre protein (left). Oct4 and c-Myc cDNA probes
do not hybridize to the expected 5.8kb band (also XbaI digested DNA) corresponding to
the Collal 4F2A Tg (center and right, respectively).
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Supplementary Figure 1
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SUPPLEMENTARY FIGURE 1: Genotyping of Collal 4FZA transgenic ES cells and mice. (a) Southern blot
analysis. 10ug of DNA from Neo-resistant ES cells after Collal 4F2A targeting was digested with EcoRI.
An internal probe (Collal 3) was used to detect copy number and correct targeting to the Collal locus.
Although the resolution between the targeted and wild-type alleles was not possible, no band other than
the genomic was present for clones #2 and #11. These were clones that had the correct band sizes using
an external 5' probe for the Collal locus (see Fig. la). A second digest (Xbal) and probe using c-Myc
confirms a single copy of the 4F2A transgene In clones #2 and #11 (size - 5.kb). (b) PCR genotyping using
primers specific for either the targeted or wt Colla1 locus to detect mice carrying different copy numbers
of the Collal 4F2A transgene. A targeted allele gave rise to a band size - 550bp whereas untargeted allele
was - 300bp. Primer sequences are listed in Supplementary Table 5.
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SUPPLEMENTARY FIGURE 2: Collal do-inducible pression of 4F2A transgne (a) qRT-PCR analysis
of mRNA Induction in single-copy rtTA(1);4F2A(1) transgenic MEFs. Cells were cultured in ES medium
+ Dox, harvested 48 hours later and RNA was isolated. E2A-cMyc primers were used to detect
transgene-specific transcripts. Error bars represent s.d. of the mean of triplicate reactions.
(b) Immunostaining for Oct4, Sox2, and Kf4 proteins. Single-copy rtTA(1);4F2A(1) MEFs were cultured
in ES media + Dox for 48 hours. Inset pictures are DAPI stain to detect cell nuclei.
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SUPPLEMENTARY FIGURE 3: Expression of the 4FZA transgene in Collal 4FZA (1:1) ratio. (a) Relative
induction of 4F2A Tg using exon-specific primers to determine relative transcript levels compared to ES cells
and MEFs. Single copy (1)rtTA;(1)4F2A transgenic MEFs were tested by qRT PCR in the absence or presence
of Dox for 48 hours. For both Oct4 and Sox2 the induction was normalized to ES cell levels. For KIf4 and
c-Myc the induction was normalized to MEFs. Error bars represent s.d. of the mean of triplicate reactions
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SUPPLEMENTARY FIGURE 3: Expression of the 4FZA tramgene in TTFs derived from mice carrying
different numbers of transgene copies. (b) Effect of transgene copy number on
expression. EZA-cMyc primers were used to detect transgene-specific transcripts. Adult tail-tip fibroblasts were
isolated from mice carrying 1 copy of each transgene rtTA(1):4F2A(1), 1 copy of rtTA and 2 copies of
4F2A rtTA(1):4F2A(2). or 2 copies of each rtTA(2):4FZA(2) were grown in Dox containing medium for 48
hours and the expression level was quantified by qRT PCR. Error bars represent s.d. of the mean of triplicate
reactions.
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SUPPLEMENTARY FIGURE 5: Efficiency of reprogramming Collal 4F2A pro-B cells. (a) Alkaline phosphatase
(AP) staining of pro-B-derived colonies on day 25 after transgene induction. Reprogramming was performed in
two distinct mouse transgene ratios (1:2 and 2:2). From each strain CD19+ cells were harvested from bone
marrow and plated at similar densities (1x10) per well. On day 20 Dcx media was exchanged for ES media
without Dox. (b) Quantitative summary of pro-S iPSCcolonies as detected by AP (red) and Nanog
immunostaining (blue). 1x10O bone marrow derived CD19+ cells were plated into 12-well plates (n= # wells
per genotype). Dox containing media was removed on day 20 and three wells were stained and counted
respectively on day 25. Error bars represent standard deviation. (c) Time-dependent increase in pro-B iPSC
colonies using Collal transgenic mice rtTA(2):4F2A(2). 5x10 bone marrow derived CD19+ cells were plated
into 12-well plates (n= N wells per cell density). Wells were stained for Nanog protein and counted on
indicated day after 4F2A transgene induction. Error bars represent standard deviation.
(d) Cell density-dependent increase in pro-B iPSC colonies using CollaI transgenic mice rtTA(2):4F2A(2).
Indicated donor cell numbers were plated into 12-well plates (n = # wells per cell density). Dox containing
media was removed on day 20. Wells were stained for Nanog protein and counted on day 25. Error bars
represent standard deviation.
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SUPPLEMENTARY FIGURE 6: Dox-Induced transgene expression In 3F2A MEFs and characterIzation of
3F2A+S IPSCs (a) qRT-PCR analysis of 3F2A MEFs. Primers specific for the OKM-2A Tg (E2A-My see Methods)
were used to detect transgene expression in MEFs cultured in the presence of Dox. Values are normalized
to GAPOH and relative to non-transgenic MEFs which were set as "l". (b) Southern blot analysis of DNA
from 3F2A+S MEF IPSC. DNA was isolated and digested with Xbal to confirm presence of the targeted
Collal allele in IPS cell lines. An external 5' probe was used and hybridized to the expected 5.3kb band.
(c) Southern blot analysis on 3FZA+S MEF iPSC DNA was isolated and digested with Xbal to confirm the
presence of a single OKM-2A transgene. The expected 4.8kb band was detected with probes for Oct4, KIf4,
or c-Myc.
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Supplementary Table 1. Aging of mice carrying different transgene copies
genotype MICE(n) Age (weeks)
Col1a1 4r2(1); R26rt ^ (1) 9 31
Colla14r2^(1); R26tA (2) 4 29
Colla14r2^(2); R26'^ (1) 4 25
Colla14r2^(2); R264TA (2) 2 6
Colla14r2^(1); R26 cAG-i A (1) 7 25
Supplementary Table 1: Aging of mice carrying different combinations of transgene copies.
Animals were carrying different combinations of transgenes were generated as described in
Supplementary Fig. 1 and aged. So far no tumors or other health issues have been noted.
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Supplementary Table 2. IPSC derivation from different donor cell types
GENOTYPE
1. rtTA (1): 4F2A (1)
2. rtTA (2): 4F2A (1)
3. rtTA (1): 4F2A (2)
4. rtTA (2): 4F2A (2)
S. CAG-rtTA (1): 4F2A (1)
+ -
4. - + - - -
ND + ND
ND + ND
+ 
- NO
Supplementary Table 2: Summary of experiments to derive iPS cells from Collal 4F2A mouse strains
carrying different numbers of transgene copies. Animals with different combinations of rtTA and 4F2A
transgenes were generated by interbreeding of double heterozygous animals (rtTA(1):4F2A(1)). Cells
from different tissues were plated in Dox containing medium on 12-well or 6-well plates and
independent iPSC lines were established by picking single colonies from separate wells explanted.
"+" indicates successful iPSC generation and -" indicates failure to obtain iPSCs from the respective
donor cells. MEFs, mouse embryonic fibroblasts: TTF, tail-tip fibroblasts; MSCs, mesenchymal stem cells.
Between 8-24 colonies were picked for each cell type. ND = not done.
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Supplementary Table 3. Diploid blastocyst injections of transgenic iPSC and ESC lines
Genotype 
-- BlastocystCellColla M2rtTA Injected Chimerism (%) Germline/total
ESC OSKM(4F2A) +/- +/- 40 9/13 75-100 4/5
iPSCF" 4F2A #11 +/- +1- 45 8/16 10-60 ND
iPSCV"~ OKM-2A+S #34 +/- +/- 26 4/5 30-90 2/4
iPSC vac 4F2A #MS +/+ +/+ 36 2/5 50-100 1/2
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Supplementary Table 4. Summary of iPSC pluripotency tests
ESC PosteatmalSource of cells markets Teratorm chinwra Gefne
Etoekric F A) + + + ND
+ ND ND ND
steumn *fM$ ) + ND ND ND
PMB et(19.) + IND NO ND
+ No ND ND
ESC markers: positive for pluripotency markers (AP, SSEA1, Nanog)
Teratoma: gives rise to all three germ layers in teratoma assay of pluripotency
Post-natal chimera: contributes to postnatal chimera as detected by coat color (agouti)
Germllne: indicates contribution of iPSC genome to germline
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Chapter 4
Reprogramming factor expression and stoichiometry influence the
epigenetic and biological properties of iPS cells
Bryce W. Carey, Styliani Markoulaki, Jacob Hanna, Kabibi Ganz, Yossi Bouganim,
Jongpil Kim, Menno Creyghton, Grant Welstead, Qing Gao, and Rudolf Jaenisch
127
ABSTRACT:
We used a genetically defined transgenic system to identify parameters affecting the
epigenetic and pluripotent state of iPS cells. We found that high expression of Oct4
and Klf4 combined with lower expression of c-Myc and Sox2 significantly affect the
epigenetic and pluripotent state of iPS cells, the majority (80%) of which generated
all-iPSC mice by 4n complementation and maintained normal imprinting at the DIk1 -
Dio3 locus. Moreover, LOI at Dlkl-Dio3 did not strictly correlate with reduced pluri-
potency. Our results argue that idiosyncratic conditions during the reprogramming
process profoundly influence the epigenetic state and the pluripotent potential of iPS
cells. Thus, it may be problematic to define a "generic" state of iPS cells in efforts
comparing the pluripotent potential and epigenetic state of iPS and ES cells.
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NOTE: This manuscript is under consideration for publication. We are currently per-
forming additional experiments for resubmission.
INTRODUCTION:
Direct reprogramming generates induced pluripotent stem cells (iPSCs) with the
molecular profile and developmental potential of embryonic stem cells (ESCs), yet several
studies have suggested that subtle differences in gene expression or chromatin modifica-
tions yield iPS cell lines with reduced pluripotency when compared to ESCs. Tissue-specific
iPSCs have been reported to harbor "epigenetic memory," which correlates with the ability
to give rise to somatic cells of their tissue-of-origin more efficiently than other lineages 1-3
arguing the donor cell-of-origin carries a critical influence on the functionality of iPSCs. The
identification of molecular markers associated with higher degrees of pluripotency sug-
gested factor-mediated reprogramming is associated with frequent (>95% of isolated
lines) aberrant silencing of maternally expressed genes at a single imprinted locus (Dlk1 -
Dio3). The expression state of transcripts from within the locus was reported to be a pre-
dictor of the ability to give rise to high contribution chimeras and all iPSC mice in 4n-
complementation assays, the most stringent assay for pluripotency 4 s. These data argue
faulty or incomplete reprogramming is a common outcome of factor-mediated reprogram-
ming.
While the successful generation of "all iPSC mice" suggests at least some iPSC lines
can pass the most stringent test of pluripotency 6-8, it remains unclear whether technical or
biological parameters influence the molecular and biological properties of iPSCs. Compari-
sons between ESCs and iPSCs often lack proper ESC controls and to date it has been diffi-
cult to simultaneously control variables in reprogramming experiments such as complete
reactivation of endogenous pluripotency genes, basal reprogramming vector expression 9,
genetic background of donor cells, unique reprogramming factor cocktails 10, and distinct
proviral integrations 11.
In this study we used a transgenic system that eliminates many if not all of these
variables in the generation of iPSCs. Our results demonstrate that even slight variation in
transgene stochiometry or reprogramming factor protein levels, leave a major impact on
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the epigenetic and biological characteristics of iPS cells and raise the possibility that the
epigenetic state and pluripotency of iPSCs is determined by idiosyncratic events during the
generation of individual iPS cells.
RESULTS
DERIVATION OF TISSUE-SPECIFIC iPSCs:
To generate iPSCs under highly defined conditions from multiple somatic tissues of
origin, we isolated cells from a previously published mouse model of factor mediated re-
programming 12. Briefly, these mice carry a single polycistronic vector carrying Oct4, Sox2,
Klf4, and c-Myc (herein termed "OSKM-Jae") under the control of a doxycycline-inducible
promoter that was inserted into the collagen type la locus (Collal) in gene-targeted ESCs
expressing the reverse tetracycline inducible M2rtTA (rtTA) from the ROSA26 promoter 13.
To test whether basal vector expression has an effect on the reprogrammed cell state iPSCs
were derived from the strain carrying an excisable reprogramming factor cassette (2lox
OSKM-Jae). Cells derived from four different somatic tissues: liver (Liv), CD19+ proB cells
(pB), whole Brain tissue (B) and tail-tip fibroblasts (TTF) were isolated and induced with
DOX under optimized conditions for iPSC derivation described previously (Fig. 1a)13. After
2-3 weeks colonies were mechanically picked from independent wells and DOX-
independent iPSC lines established after several passages. All iPSC lines stained positive for
pluripotency markers alkaline phosphatase (AP), SSEA-1 and Nanog (Fig. 1b). In addition
to Oct4 and Nanog, expression of pluripotency markers such as Rex1 (or Zfp42), Esrrb, and
Tcf3 were comparable among all nine iPSCs and maintained at levels similar to control ES
cell lines as measured by qRT-PCR (Fig. 1c). iPSC lines from each somatic lineage generated
differentiated tissue of all three germ layers in teratoma assays (Fig. 1d, Supplemental
Fig. 1) and were able to generate adult chimeras (Supplemental Table 1).
Since all nine lines had been derived from the Collal 21ox OSKM-Jae mouse excision
of the OSKM-Jae cassette was achieved by infection with an adenovirus carrying Cre re-
combinase and the green fluorescence protein (GFP), and sorting GFP+ cells 24 hours post-
infection then plating at clonal cell concentrations to isolate and analyze independent sub-
clones. Southern blot (Fig. le) and PCR analyses (Fig. 1f, Supplemental Fig. 2a) confirmed
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precise excision of the vector from the Collal genomic locus. In addition Collal factor-free
iPSCs (11ox iPSCs) are distinguishable from factor-containing cell lines as transcript levels
were significantly reduced as detected by qRT-PCR (Supplemental Fig. 2b). These detect-
able differences between the factor-containing iPSCs and the factor-free daughter clones
are known to have quantifiable changes in global gene expression that may have additional
phenotypic consequences during differentiation 9.
"ALL iPSC" MICE FROM FACTOR-FREE iPS CELLS:
In agreement with previous studies all iPSCs derived with the Collal OSKM-Jae
transgene generated teratomas and adult chimeras after blastocysts injection some of
which were shown to contribute to the germline. To determine whether these OSKM-Jae
iPSC lines could generate full-term "iPSC mice" we performed tetraploid (4n) complemen-
tation assays. Two newly derived ESC controls from a similar breeding scheme to the
tested iPSCs were used as a benchmark (Collal OSKM-Jae ES cell lines #1B, #1C). Both ES
cell lines (#1B,C) gave rise to live born mice with efficiencies ranging from ~ 1.67 to 3%
respectively (Fig. 2a) two of which survived to adulthood (#1C). Both were male and had
uniform agouti coat color with genotyping confirming the origin of ESC mice (data not
shown). To test the potential of tissue-specific iPSCs to generate all iPSC mice we injected
all nine independent factor-free iPSCs into 4n-blastocysts and compared their ability to
produce live-born mice to ES cell controls. Upon caesarean section 19.5 d.p.c. we obtained
breathing pups, termed iPSC mice, with normal morphology in seven out of nine (- 78%)
lines from different somatic origins (Fig. 2b, Table 1). Overall efficiencies ranged from 0.5-
7.5% (avg. 2.2%), which is similar to ES and SCNT-ES cells as well as other reports with
embryonic or adult fibroblast derived iPSC mice 6-8,14-16. Most newborns were sacrificed
after breathing was established while some gave rise to healthy pups that survived to
adulthood (BC2 Ad.5), all of which were male and had a uniformly agouti coat color (Fig.
2b).
To exclude minor contributions of tetraploid host cells we utilized a PCR-based ap-
proach to detect DNA from host blastocyst-derived cells. Our PCR protocol showed three
distinct products depending on whether the Collal locus was untargeted, targeted with
OSKM-Jae, or contained a factor-free 11ox allele with a detection limit of ~ 1-5% following a
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DNA titration curve (Fig. 2c). PCR of DNA from different tissues of six "all iPSC" mice
showed only the Colla 111ox product with no detectable contribution from host blastocysts
cells (Fig. 2d). Similar results were observed with tail tissue from BC2 Ad.5 iPSC mice (Fig.
2d). These data support the conclusion that OSKM-Jae-induced factor-free iPSCs are com-
petent to generate all-iPSC mice by tetraploid complementation at an efficiency that was
similar to that of genetically similar ES cells.
To determine whether the presence of the OSKM-Jae vector interfered with the po-
tential to generate all iPSC mice we injected vector-containing parental iPSCs into 4n-
blastocysts. As shown in Table 1, five out of the nine lines were able to produce all iPSC
mice (avg. 2%) (Supplemental Fig. 3a). Most mice appeared normal with a few containing
herniated umbilical cords or noticeably larger size (Supplemental Fig. 3b). DNA obtained
from tissues of sacrificed mice as well as tail tissue from two iPSC adult mice confirmed
their origin by PCR with a detection limit of 5% (Supplemental Fig. 4a). Supplemental
Fig. 4b shows that both adult mice contribute the targeted Collal allele to 100% of the
genotyped F1 pups (57/57) arguing these are healthy and fertile adult mice.
To examine more closely the general health and physiology of mice generated from
pluripotent cells, hematological analyses as well as tests for enzyme secretion indicative of
organs such as liver, pancreas, brain and muscle were performed at three months of age.
All eight mice that had been derived from germline transmission, ESCs or iPSCs had similar
health parameters in 17 categories. (Supplemental Fig. 5).
These data indicate that the majority of vector-free and vector containing iPSCs iso-
lated from different tissues were able to generate all iPSC mice after injection into 4n blas-
tocysts which is the most stringent assay available for pluripotency. The efficiency between
ES cells and iPSCs was very similar (2.5 and 2.1% respectively, p=0.3071) (Fig. 2c). In our
experiments the OSKM-Jae transgene did not appear to greatly influence to ability to gen-
erate all iPSC mice (2.0 vs. 2.2%). In addition, tissue-of-origin influences on the pluripo-
tency of iPSCs appear to be negligible in 4n-complementation assays using the Collal
OSKM-Jae reprogramming system.
SILENCING OF DLK1-D103 LOCUS IS NOT A STRICT MARKER OF REDUCED PLURIPO-
TENCY
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Although residual expression of the four factors did not greatly impair the ability to
generate all iPSC mice we observed that some lines failed in this assay. Two recent reports
found that aberrant epigenetic silencing of a single imprinted locus, a region on chromo-
some 12qF1 flanked at each end by the Dlkl-Dio3 genes respectively, correlated with the
inability of iPS cell lines to generate all iPSC mice by 4n-complementation4, s9. To determine
whether this could faithfully predict the failure of iPSCs from our system to produce all
iPSC mice, we analyzed expression of transcripts from within the Dlkl-Dio3 region. We
tested two maternally expressed imprinted RNAs, the noncoding RNA Gtl2 (also known as
Meg3) and the small nucleolar RNA Rian. Both genes were expressed at levels similar to ES
cell control in a majority of lines (6/9), while a minority (3/9) exhibited reduced expres-
sion (Fig. 3a). Several lines that had repressed the Dlkl-Dio3 locus exhibited high contribu-
tion chimeras with some contributing to the germline (iPSC clone pBL4) (Fig. 3b).
To further analyze the molecular properties of the Dlkl-Dio3 locus in Collal OSKM-
Jae iPSCs we examined the extent of DNA methylation at a key regulatory element, the in-
tergenic germline-derived differentially methylated region (IG-DMR), which is a control
element for the imprinted region 17,18. Using methylation-sensitive Southern blotting we
tested two ES cell clones together with six iPSC lines that either showed reduced or ESC-
like levels of both Gtl2 and Rian. Pluripotent cell lines with ESC-like expression of Gtl2 and
Rian showed both methylated and unmethylated IG-DMR alleles (Fig. 3c) in two independ-
ent methylation-sensitive digests (HpaII or HhaI). However, only methylated IG-DMR al-
leles were detected in two iPSC lines (Livp2E2, pBL4) with reduced levels of Gtl2 and Rian
expression, while the third (BE1) did not show a gain in methylation at the CpGs tested by
Southern. With the exception of iPSC line BE1, we observed that the majority of lines with
repressed transcripts within Dlkl-Dio3 locus showed a gain of DNA methylation at CpGs
within the IG-DMR locus, whereas iPSCs with ESC-like expression did not. Similar analyses
on additional iPS cell lines derived from keratinocytes and MEFs further demonstrated that
the majority of iPSCs derived using the OSKM-Jae transgene preserved normal imprinting
of the Dik1-Dio3 locus (Supplemental Fig. 6).
Two previous papers reported that silencing of the Dlkl-Dio3 imprinted region cor-
related strictly with reduced chimerism, efficiency of contribution to the germline, and an
inability to generate late stage embryos or all iPSC mice in 4-complementation assays 4,.
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To further assess the developmental potential of the Collal OSKM-Jae iPSCs we performed
2n blastocyst injections to generate adult chimeras from all nine lines to analyze chimerism
based on agouti coat color (n=44) dividing the chimeras into two groups based on Gtl2 ex-
pression (Gtl2-ON or Gtl2-LOW). All lines, independent of the status of Dlkl-Dio3 had vari-
able contributions with no significant difference between the two groups (Fig. 3d,e).
Our results differ from the previous study that demonstrated the predictive value of
the imprinting state of the Dlkl-Dio3 locus in determining the potential of iPSC to produce
all iPSC mice (Fig. 3f). Factor-free iPSC line pBL4 Ad.1 gave rise to all iPSC mice (Table 1)
and late stage embryos with southern blot analysis of the IG-DMR locus confirming that
these mice carried only methylated alleles (Fig. 3g, Supplemental Fig. 7a,b). We conclude
that reduced expression of genes within the Dlk3-Dio3 locus does not appear to strictly cor-
relate with reduced pluripotency in iPSCs. Our data do not, however, exclude the possibility
that iPSCs with loss of imprinting at Diki -Dio3, can only generate iPSCs after the vectors
have been excised.
STOCHIOMETRY DURING REPROGRAMMING INFLUENCES THE EPIGENETIC STATE OF
DLK1-DIO3 LOCUS
It is puzzling that two transgenic mouse strains carrying almost identical transgenes
(Supplemental Fig. 8) inserted into the same expression locus generated normal iPSCs at
significantly different frequency and did not show a strict correlation with Dlkl-Dio3 locus
as expected. To investigate the basis for these differences we analyzed the contribution of
transgene expression and reprogramming factor stoichiometry in both strains (referred to
as "OSKM-Jae" 13 vs. "OKSM-KH" 16)
In order to rule out the possibility that genetic background or differences in trans-
gene ratios within our system modifies DIkl-Dio3 imprinting, we analyzed established
blood and liver-derived iPSCs from four genetically distinct mice carrying unique transgene
ratios (e.g. heterozygous or homozygous) at the ROSA26 and Collal genes. Indeed, neither
had an impact on our results since, similar to our earlier observations, we found six (66%)
iPSCs showing ESC-like expression of Gtl2, Mirg, and Rian, and only three (33%) exhibiting
reduced expression of these genes (Supplemental Fig. 9).
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To determine whether measurable differences distinguished these two systems, we
tested transgene induction as well as reprogramming factor protein levels from transgenic
mouse embryonic fibroblasts (MEFs) derived from the same Collal targeted parental ES
cell lines (OSKM-Jae or OKSM-KH). Transgenic MEFs were cultured in DOX and transgene
induction levels analyzed by qRT-PCR using primers for Oct4 and Sox2 cDNA. Neither sys-
tem showed significant differences in transgene RNA levels prior to or upon induction (Fig.
4a). To compare the translation efficiency of the two transgenes, we analyzed the protein
levels of the reprogramming factors. Surprisingly, western blot analysis showed that re-
programming factor protein levels were significantly different in the two strains with
Collal OSKM-Jae induced MEFs exhibiting higher levels of Oct4 and Klf4 and lower levels
of Sox2 and c-Myc than those of similarly induced Collal OKSM-KH MEFs (Fig. 4 b). Quan-
tification of band intensities after normalization to the loading control, indicates that
OSKM-Jae MEFs had - 5- and 15-fold higher protein levels of Oct4 and Klf4 and 0.56- and
0.51-fold lower protein levels of Sox2 and c-Myc as compared to OKSM-KH MEFs (Fig. 4c).
High levels of unprocessed large molecular weight precursor proteins were consistent with
inefficient processing to mature functional Oct4 and Klf4 proteins in OKSM-KH cells. (see *
in Fig. 4 b). These results demonstrate that subtle differences in the vector construction
have an important impact on the resulting protein levels.
To examine whether the differences in reprogramming factor protein levels can di-
rectly impact the epigenetic state of the iPSCs we analyzed IG-DMR methylation in iPSCs
created by induction of OSKM-Jae alone or by additional ectopic expression of Oct4 or Klf4
or of both factors using dox-inducible lentiviruses. For this we derived secondary MEFs
from a single Gtl2-ON iPSC line, BC2, by injection into 2n-blastocysts and initiated repro-
gramming to generate stable DOX-independent iPSCs in all four conditions (OSKM,
OSKM+O, OSKM+K, OSKM+O+K). At day 20, twenty-four colonies were picked from inde-
pendent wells in all conditions and the establishment of DOX-independent iPSCs occurred
at varying rates. Induction of OSKM-Jae with addition of Oct4, or both Oct4 and Klf4, in-
creased the rate of DOX-independent iPSCs dramatically, with >80% of colonies picked
generating iPSCs independent of reprogramming factors by two passages. This was in con-
trast to OSKM-Jae alone or OSKM+K, which showed 30% and 50% of picked colonies giving
rise to DOX-independent iPSCs at passage 3 (Supplemental Fig. 10). Upon isolation of ad-
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ditional DOX-independent iPSCs from all conditions, DNA was harvested and analyzed by
Southern blot to determine the extent of aberrant DNA methylation at the IG-DMR within
the Dlkl-Dio3 locus. Aberrant methylation occurred at a rate of 44% (OSKM), 42%
(OSKM+0), or 42% (OSKM+K) in iPSCs from MEFs. However, additional ectopic expression
of Oct4 and Klf4 significantly reduced aberrant silencing to ~ 15% of recovered lines
(OSKM+O+K) (p=0.0 4 41 Fisher's exact, two-tailed) (Fig. 4e,f) demonstrating that specific
reprogramming factor levels during reprogramming can influence the resulting epigenetic
makeup at the IG-DMR locus in iPSCs. The specificity of the process is exemplified by the
accelerated appearance of stable iPSCs by Oct4 overexpression alone, but was insufficient
to reduce aberrant DNA methylation at the IG-DMR locus.
iPSC MICE DO NOT SHOW ELEVATED MORTALITY FROM TUMORS
The generation of a large number of transgene-free iPSC lines from adult tissues af-
forded us the ability to analyze the susceptibility of somatic cells derived from iPSCs to
generate tumors in vivo. We additionally chose to analyze long-term health outcomes of
mice from the Collal OSKM-Jae strain because, in contrast to other systems, it did not
cause increased mortality rates over a 16-month time period even in the presence of trans-
genes. High contribution chimeric mice (>90%) derived from Collal OSKM-Jae transgenic
ESCs survived for up to 16 months without any detectable weakness or presence of tumors
in contrast to chimeras generated from Collal OKSM-KH transgenic ESCs confirming pre-
vious results 16 (Supplemental Fig. 11).
To this end we analyzed long-term survival trends for iPSC chimeras from two
mouse cohorts, one for mice generated from factor-containing iPSCs (n=38) and the other
for mice derived from factor-free iPSCs (n=36) to observe any elevated rates of tumori-
genesis. Fig. 5a shows that for up to 16 months iPSC chimeras survived without any de-
tectable tumors or weakness causing death with similar results obtained from factor-free
iPSC-derived mice kept so far for up to four months. The origins of iPSC-derived chimeras
were from reprogrammed MEFs, CD11b+ macrophages, CD19+ proB cells, adult fibroblasts,
whole brain and liver tissue. In mice that were sacrificed no tumors were detected upon
post-mortem pathological analysis, and mortality was typically the result of problems
found in non-transgenic strains such as extreme dermatitis and in one case, a hernia. Fig.
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5b indicates that cumulative mortality rates were no different in aged mice of the Collal
OSKM-Jae mouse colony.
Using the Collal-OSKM-Jae reprogramming system we observed normal lifespans
in iPSC-derived mice for up to 16 months with - 90-100% of mice surviving 12 months.
These data suggest that at least during the time of observation of this study, the Collal-
OSKM-Jae system does not produce adult mice with increased predispositions towards tu-
morigenesis following somatic cell differentiation.
DISCUSSION:
In this paper we used a highly defined inducible transgenic system that eliminates
all genetic variables for the generation of iPSCs. We derived multiple iPS cells from several
tissues of an adult mouse and demonstrate that the majority are capable of generating high
contribution iPSC chimeras as well as "all iPSC mice" in 4n-complementation assays at fre-
quencies similar to control ESCs. Our results argue that tissue-of-origin has a limited if any
effect on the ability of iPSCs to differentiate as tested by this most stringent assay for pluri-
potency. Moreover, only a minority of our iPSC lines silenced transcripts within the im-
printed Dlkl-Dio3 locus and contrary to expectations, this did not preclude the generation
of all-iPSC mice. We further characterized differences in factor stoichiometry between re-
programming systems and demonstrate that this can directly influence aberrant DNA
methylation within the Dlkl-Dio3 locus during derivation of iPSCs. Finally, we failed to de-
tect any tumors in mice derived from these iPS cells over the course of 12-16 months.
Our data emphasize the critical importance of factor level and/or stoichiometry as a
key determinant of the pluripotent state of iPSCs. The recovery of a high proportion of
iPSCs with identical pluripotency as ESCs correlated with higher levels of pluripotency fac-
tors such as Oct4 (5-fold) and Klf4 (15-fold) and lower levels of Sox2 (0.5-fold) and c-Myc
(0.5-fold) when compared to a system that yielded iPSCs of which only a small fraction
were competent to generate all-iPS mice by 4n-complementation s,16. Though the two
transgenic systems (OSKM-Jae vs. OKSM-KH) were identical, i.e. polycistronic vector inser-
tion into identical positions in the 3' UTR of the Collal gene under the DOX inducible regu-
lation of the same transactivator carried in the ROSA 26 locus, the biological properties of
the iPCSs such as imprinting of the Dlkl-Dio3 locus, 4n competence and tumor incidence
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were very different. Though both, DOX induced and basal transcription levels of the vec-
tors were very similar in both strains, major differences in the absolute and relative repro-
gramming factor protein levels were observed. The different efficiency of translation and
processing of the factors may be explained by subtle differences in vector design: (i) the
arrangement of the second and third factor differed (SK vs. KS), (ii) two different 2A se-
quences were used (P2A vs. F2A) and (iii) the two COOH terminal factors Sox2 and c-Myc
were preceded by an IRES sequence in the OKSM-KH mice as opposed to a T2A and E2A
sequence preceding Klf4 and c-Myc in the OSKM-Jae mice. Indeed, the high levels of un-
processed large molecular weight precursor proteins in the OKSM-KH strain were consis-
tent with inefficient processing to mature functional Oct4 and Klf4 proteins, potentially due
to the F2A peptide used to mediate translation of these proteins.
The elevated rates of LOI at the Dlkl-Dio3 locus previously reported, suggested that
factor-mediated reprogramming was ineffective at maintaining normal imprinting at this
locus during reprogramming. We demonstrate that these results are highly system de-
pendent and may be due to the specific expression and/or stoichiometry of particular re-
programming factors. Consistent with this hypothesis we found that enhanced expression
of Oct4 and Klf4 in OSKM-Jae MEFs further reduced aberrant methylation at the Dlkl-Dio3
locus during iPSC isolation.
Of critical importance to the iPS field is the question of how similar or different iPS
cells are as compared to ES cells. A number of recent studies have demonstrated epigenetic,
genetic and biological differences between iPS and ES cells though, at least in some cases,
the functional consequences of these differences have not been clarified l,2,19-22. However,
a major complication in these comparisons is whether and how we can define a "generic"
state of ES and iPS cells. The results presented in this study argue that subtle and tempo-
rary differences in the level and stochiometry of the reprogramming factors during early
stages of iPSC formation can have profound and irreversible consequences for the epige-
netic state and the pluripotent potential of iPS cells. This is consistent with the notion that
incomplete or imperfect reprogramming is not a fundamental biological problem of factor
induced iPSC generation but rather due to technical and often not well-controlled variables.
Thus, comparisons between ES and iPS cells may often be influenced by idiosyncratic and
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difficult to control differences that occur during the generation of individual pluripotent
cells qualifying conclusions about generic differences between ES and iPS cells.
MATERIALS AND METHODS:
Somatic cell isolation and culture: Somatic organs were isolated from a 6-week-old
agouti Collal 21ox OSKM-Jae transgenic male mouse heterozygous for the Rosa26 M2rtTA
and homozygous at the Collal locus harboring the 21ox OSKM-Jae cassette. Adult tissues
were isolated with whole brain tissue being plated immediately into ES cell medium with
doxycycline (2 [tg/ml). For blood reprogramming whole marrow was isolated from the fe-
mur and tibia after removal of the condyles at the growth plate by flushing with a syringe
and 30-guague needle containing DMEM+5% FBS (Hyclone, Thermo Fisher Scientific).
CD19+ pro-B cells were isolated by MACS cell separation (Miltenyibiotec Cat# 130-052-
201) following manufactures instructions. Purified B cell subsets were resuspended in
IMDM with 15% FCS as well as IL-4, IL-7, SCF (10 ng/ml each, Peprotech), doxycyline (2
Rg/ml) and plated on OP9 bone marrow stromal cells (ATCC). Three days later the medium
was changed to ESC medium plus Dox. For isolation of liver cells mice were first perfused
with 50 ml HBSS buffer (w/o Ca2+ and Mg2+) then 50 ml HBSS (w/o Ca2+ and Mg2+) con-
taining collagenase (type IV) (Sigma Cat# C5138) (100U/ml). Liver was dissected away
from surrounding tissues and dissociated in 10ml DAG media (phenol-red free EMEM
Gibco-11054-020 and Bovine serum albumin (BSA) 1g/0.5L) and filtered two times
through a sterile 100 [tM cell strainer. Liver cell preparations were centrifuged at 30 g for 3
minutes at 4 *C and the cells were washed two times with DAG media and then plated on y-
irradiated MEFs in ES media + Dox.
Excision of Collal 21ox OSKM-Jae cassette in iPSCs
For Cre-recombinase-mediated vector excision iPSCs were plated into a single well of 12-
well plate at high confluency and infected with adenovirus carrying GFP and Cre-
recombinase purchased from University of Iowa gene core (http://www.uiowa.edu/-gene/) for
24 hours. Cells were harvested with 0.05% trypsin/ethylenediaminetetraacetic acid
(EDTA) solution (Invitrogen), and subjected to FACS sorting (FACS-Arai; BD Biosciences) of
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a single cell suspension for EGFP-expressing cells 24 hours after infection. Cells were re-
plated at a low density containing ES cell medium. Individual colonies were picked 10 to 14
days after electroporation.
Collal 21ox OSKM-Jae ES cell isolation
Following protocols described previously 23 we isolated ES cells from blastocyst embryos
using ESC derivation media: KOSR (knock-out serum replacement, Gibco, Cat# 1028-028),
LIF ESGRO (1x 107 U ESGRO/ml; Chemicon, Cat# ESG1106), Mek1 inhibitor (PD98059; Cell
Signaling Technology, Cat# 9900), non-essential amino acids, glutamine solution,
pen/strep solution. Embryos were obtained after mating C57Bl6/DBA/129 mixed non-
sibling male and female mice heterozygous at ROSA26 and Collal locus (rtTA +/-; OSKM-
Jae +/-). For ESC derivation isolated 3.5 d.p.c. blastocysts were plated in 4-well plates con-
taining MEF feeders. Immediately prior to plating, the zona surrounding the blastocyst was
removed by brief exposure to acid Tyrode's solution (Sigma, Cat# T-1788). After zona re-
moval, a single blastocyst was placed into a well of a 4-well plate, placed in a C02 incubator
and allowed to attach to the feeder layer. Attachment is observed within 24-48 h. After
passaging genotyping was performed on Collal OSKM-Jae ESC lines: #1B is homozygous at
the ROSA26 locus (rtTA +/+) and wildtype at Collal (-/-). #1C is homozygous for both
transgenes (ROSA26 & Collal).
Col OSKM-Jae PCR genotyping: PCR performed using three sequencing primers (Collal
frtA F, frtB R, 4F2A R) published previously13. PCR reaction: 95CO/lmin (1 cycle), 94 Co
/30", 70 C/45" (2 cycles), 94 CO/30", 68 CO/45"(5 cycles), 94 CO/20", 66 Co/1min (29 cy-
cles); 4 Co. Wild-type Collal is ~ 300bp, targeted Collal 4F2A product is ~ 550bp.
Quantitative RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). Five micrograms of total RNA
was treated with DNase I to remove potential contamination of genomic DNA using a DNA
Free RNA kit (Zymo Research). One microgram of DNase I-treated RNA was reverse tran-
scribed using a First Strand Synthesis kit (Invitrogen) and ultimately resuspended in 100 ul
of water. Quantitative PCR analysis was performed in triplicate using 1/50 of the reverse
transcription reaction in an ABI Prism 7000 (Applied Biosystems) with Platinum SYBR
green qPCR SuperMix-UDG with ROX (Invitrogen). Equal loading was achieved by amplify-
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ing GAPDH mRNA and all reactions were performed in triplicate. Primers used for amplifi-
cation were as follows:
Oct4 F, 5'-ACATCGCCAATCAGCTTGG-3' and
R, 5'-AGAACCATACTCGAACCACATCC-3'
Sox2 F, 5'-ACAGATGCAACCGATGCACC-3' and
R, 5'- TGGAGTTGTACTGCAGGGCG-3'
OSKM-Jae (E2A-cMyc) F, 5'-GGCTGGAGATGTTGAGAGCAA-3' and
R, 5'-AAAGGAAATCCAGTGGCGC
GAPDH F, 5'-TTCACCACCATGGAGAAGGC-3' and
R, 5'-CCCTTTTGGCTCCACCCT-3'
HPRT F, 5'-GCAGTACAGCCCCAAAATGG-3'
R, 5'-GGTCCTTTTCACCAGCAAGCT-3'
Southern blotting
For analysis of OSKM-Jae excision in iPSC lines 10 [tg of XbaI digested genomic DNA was
separated on a 0.7% agarose gel, transferred to a nylon membrane (Amersham). The mem-
brane was pre-hybridized with hybridization buffer (1% bovine serum albumin in 7% SDS
and 0.5M sodium phosphate, pH 7.5) at 650C and hybridized with 32P random primer
(Stratagene) labeled probes for 5' Collal probe (external) 13 and mouse Klf4 (full length
Klf4 cDNA). For analysis of IG-DMR, DNA was digested with StuI plus methylation-
insensitive MspI or methylation-sensitive HpaII or HhaI. The blot was hybridized with
probe M4 (IG-DMR) as previously described 24.
Western Blotting
Cell pellets were lysed on ice in Laemmli buffer (62.5 mM Tris-HCl pH 6.8, 2% sodium do-
decyl sulphate, 5% fl-mercaptoethanol, 10% glycerol and 0.01% bromophenol blue) for 30
min in presence of protease inhibitors (Roche Diagnostics), boiled for 5-7 min at 100*C and
subjected to western blot analysis. Primary antibodies: rabbit anti-Oct4 (1:1000, scH-134,
Santa Cruz), rabbit anti-Sox2 (1:1000, #2748, Cell Signaling), goat anti-Klf4 (1:1000,
AF3158, R&D Biosystems), rabbit anti-c-Myc (1:1000, #9402, Cell Signaling), and rabbit
anti-actin (1:2000, A2066, Sigma). Blots were probed with anti-mouse, anti-goat, or anti-
rabbit IgG-HRP secondary antibody (1:10,000) and visualised using ECL detection kit (GE
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Healthcare).
Immunofluorescent staining
Cells were fixed in 4% paraformaldehyde for 20 minutes at 25 *C, washed 3 times with PBS
and blocked for 15 min with 5% FBS in PBS containing 0.1% Triton-X. After incubation
with primary antibodies against Oct4 (Santa Cruz h-134), Sox2 (R&D Biosystems),
mNANOG (Bethyl A300-398A), SSEA1 (monoclonal mouse, Developmental Studies Hybri-
doma Bank) for 1 h in 1% FBS in PBS containing 0.1% Triton-X, cells were washed 3 times
with PBS and incubated with fluorophore-labeled appropriate secondary antibodies pur-
chased from Jackson Immunoresearch. Specimens were analyzed on an Olympus Fluores-
cence microscope and images were acquired with a Zeiss Axiocam camera.
Mouse Chimera and Teratoma Formation
All 4n-injections were performed using B6D2F2 embryos as the iPSC lines and ESCs. Collal
21ox OSKM-Jae iPSCs were derived from an agouti mouse and could be identified by coat-
color as adults. Diploid or tetraploid blastocysts (94-98 h after hCG injection) were placed
in a drop of Hepes-CZB medium under mineral oil. A flat tip microinjection pipette with an
internal diameter of 16 pim was used for iPS cell injections. Each blastocyst received 8-10
iPS cells. After injection, blastocysts were cultured in potassium simplex optimization me-
dium (KSOM) and placed at 37 *C until transferred to recipient females. About 10 injected
blastocysts were transferred to each uterine horn of 2.5-day-postcoitum pseudo-pregnant
B6D2F1 female. Pups were recovered at day 19.5 and fostered to lactating B6D2F1 moth-
ers when necessary. Teratoma formation was performed by depositing 2x10^6 cells under
the flanks of recipient SCID or Rag2-/- mice. Tumors were isolated 3-6 weeks later for his-
tological analysis.
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FIGURE LEGENDS
FIGURE 1: Generation of Collal 21ox iPSCs. (a) Experimental scheme describing the
Collal 21ox OSKM-Jae mouse strain for deriving iPSCs. (b) Immunostaining for alkaline
phosphatase (Alk. Phos.), SSEA1 and Nanog on iPSC lines derived from four adult tissues
(designation of donor tissue and cell line on top). (c) qRT-PCR of pluripotency genes in
Collal 21ox OSKM-Jae iPSCs and control ES cell lines. Relative expression levels normalized
to the housekeeping gene HPRT. (d) Hematoxylin and eosin (H&E) staining of teratomas
induced after subcutaneous injection of Collal 21ox OSKM-Jae iPSCs into SCID mice indi-
cates contribution to all three germ layers.
(e) Southern analysis of iPSCs obtained from sorted (GFP+) single iPSCs after transduction
with adenovirus carrying Cre-recombinase. DNA was digested with XbaI and probed for
correct targeting using a 5' Collal probe. All lines showed band size (- 4.7kb) expected for
an untargeted Collal locus 13 and lack of signal with an internal probe using Klf4. Same in-
dicated iPSC lines are loaded in +Cre OSKM excision (right). (f) PCR genotyping of Collal
21ox OSKM-Jae iPSCs pre- and post-excision of reprogramming factor cassette. Homozygous
targeted Collal allele give rise to a band size ~ 550bp whereas untargeted allele is ~
300bp. 1lox-Collal after excision shows a slight higher band - 350-400bp. Ad, adenovirus.
FIGURE 2: Generation of iPSC mice from Collal-factor-free iPSCs. (a) Results summa-
rizing the tetraploid (4n) complementation assay using two ES cell lines (Collal 21ox
OSKM-Jae #1B,C ) and 9 Collal-factor-free iPSC lines. All data was generated 19.5 d.p.c.
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Grey indicates visible re-absorptions (negative values), green indicates stillborn embryos
with estimated development from E8-20, blue indicates live born pups that began breath-
ing. Names of each cell line, total number of blastocysts transferred, and % found breathing
(relative to blastocysts transferred) at birth are indicated below the graph. AVG column
(far right) displays averages for all categories: "ESC" is from lines #1B and 1C and "iPSC"
from OSKM-Jae derived iPSCs (both factor-free and factor-containing). P-value, student's t-
test = 0.3071 for live born category (b) Representative brightfield images of nine pups
from BC2 Ad.5 factor-free iPSC line (left panel). All are male with agouti fur. Two panels be-
low show 4n mice from three other Collal-factor-free iPSC lines. (c) DNA titration curve
for PCR genotyping assay demonstrate ~ 1-5% detection limit. (d) PCR assay for tetraploid
cells and iPSC contribution to iPSC mice. Band size distinguishes 1lox-iPSCs from tetraploid
host cells (BDF1 lane) and Collal factor-containing cells (#660) indicating 4n-mice were
derived from 11ox iPSC lines only. DNA was isolated from live born pups HD (head) and TL
(tail & limbs) and from adult mice DNA used was from tail tissue.
FIGURE 3: Silencing of Dlkl-Dio3 locus is not a strict marker of reduced pluripotency.
(a) qRT-PCR of nine Collal 21ox OSKM-Jae iPSCs and one ES cell control (V6.5) of Gtl2 and
Rian. Expression levels are relative to GAPDH. "Gtl2-LOW" is represented in iPS lines with
<50% expression of both genes (right). Error bars indicated standard error of the mean of
three biological replicates (SEM). (b) Brightfield pictures of Collal 21ox OSKM-Jae chime-
ras from Gtl2-LOW iPSCs. iPSC line pBL4 contributed to the germline. (c) Methylation
analysis of IG-DMR in Collal 21ox OSKM-Jae iPSC lines. Genomic DNA was isolated from
V6.5 ESCs, parental targeted V6.5 Collal 21ox OSKM-Jae ESCs, and six Collal 21ox OSKM-
Jae lines. All DNAs were digested with StuI in combination with either methylation-
insensitive MspI, or methylation-sensitive HpalI or HhaL The digested DNAs were analyzed
by Southern hybridization with a probe to IG-DMR. Restriction enzymes: M, MspI; Hp,
HpaII; Hh, HhaI. (d) Quantification of chimeras generated from Collal 21ox OSKM-Jae
strain using agouti coat color. Open green diamonds, chimerism of adult mice from parental
V6.5 Collal 21ox OSKM-Jae ESCs; closed green diamonds iPSCs with ESC-like expression of
Gtl2 & Rian (Gtl2-ON); brown closed diamonds iPSCs with repressed expression of Gtl2 &
Rian (Gtl2-LOW). (e) Average chimerism for 44 mice analyzed from Collal 21ox OSKM-Jae
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iPSCs. Gtl2-ON (57%); Gtl2-LOW (50%). Error bars indicate standard deviations. P-value,
student's t-test = 0.4743. (f) Brightfield image of live born all-iPSC mouse from the Gtl2-
LOW iPSC line pBL4. (g) Methylation of IG-DMR (StuI+HhaJ) in 4n-mice and embryos using
Southern blot protocol described above. Only unmethylated bands were observed from
embryos and mice from iPSC line pBL4. As a control DNA of a live born pup generated from
the Livp2D3 iPSC line shows both methylated and unmethylated banding patterns. HD,
head; TL, tail & limbs.
FIGURE 4: Stoichiometry during reprogramming influences the epigenetic state of
the Dlkl-Dio3 locus (a) Quantitative RT-PCR in cells with DOX. 0.1, 2.0 is pIg/ml of doxy-
cycline, "_" is no DOX media. Error bars indicated standard deviation (S.D.) Values normal-
ized to GAPDH and all samples were relative to rtTA only, which was set as "1." (b) West-
ern blot analysis of reprogramming factor proteins upon induction with DOX in mouse em-
bryonic fibroblasts used in (a). * indicates high molecular unprocessed precursor proteins
for Oct4 and Klf4 (c) Quantification of protein levels detected by western blot. Images were
processed using ImageJ (NIH). Reprogramming factor protein levels are shown as relative
to actin for each sample (OSKM-Jae in green and OKSM-KH in blue). (d) Relative fraction of
iPSCs recovered with aberrant DNA methylation as tested by Southern at the IG-DMR re-
gion (StuI+HpaII digest). Secondary OSKM-Jae MEFs were reprogrammed with no addi-
tional factor (-), additional Oct4, Klf4, or both (+Oct4+Klf4). Total number of iPSCs recov-
ered and examined in each condition indicated below. P-value = fisher's exact T-test. (e)
Representative southern blot analysis of IG-DMR (StuI+HpaH digest) from OSKM-Jae+Klf4
iPSCs generated from MEFs. iPSC lines with aberrant methylation (bold #) are indicated by
loss of both lower molecular weight bands at ~ 250bp & 750bp. (f) Representative south-
ern blot analysis of IG-DMR (StuI+Hpal! digest) from iPSCs generated using OSKM-
Jae+Oct4+Klf4. Bold # samples indicated iPSC lines with aberrant methylation at the IG-
DMR locus. In some samples complete loss of bands was not observed due to higher pres-
ence of feeder MEFs.
FIGURE 5: iPSC mice do not show elevated mortality from tumors
(a) Tumorigenicity and mortality of iPSC-derived mice from tumors. Orange line indicates
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Collal OSKM-Jae strain containing reprogramming factor transgene. Blue line indicates
chimeric mice generated from factor-free OSKM-Jae iPSCs. (b) The cumulative mortality of
Collal OSKM-Jae iPSC-derived mice. Green line indicates F1 mice generated during main-
tenance of Collal OSKM-Jae mouse colony. All sacrificed mice irrespective of cohort were
dissected to evaluate the cause of death. Shown at the bottom of each figure are the num-
bers of mice analyzed at each time point.
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Supplementary Figure I
Mesoderm Ectoderm Endoderm
Supplementary Figure I: Hematoxylin and eosin (H&E) staining of teratomas
induced after subcutaneous injection of Col a I 21ox 4F2A iPSCs into SCID mice
indicates contribution to all three germ layers.
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Supplementary Figure 2: (a) Quantitative RT-PCR of Col a I 4F2A iPSCs using
transgene-specific primers (E2A-cMyc see Materials and Methods) to detect residual
transgene expression of 4F2A. Relative expression levels are normalized to DOX-
induced expression in Coll a I 4F2A fibroblasts carrying single copy of rtTA and
4F2A. (b) Sequencing of Coil a I - Ilox PCR band. Following isolation and gel
purification DNA was cloned into TOPO2.1 vector (Invitrogen) following
manufacturer's protocol.After transformation colonies were picked and plasmid DNA
isolated. Sequencing was performed at Koch Center for Integrative Cancer Research.
A single loxP site was found to be present In this band Indicating the origin of the
IPSCs from Col la I 2lox 4F2A mouse strain.
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Supplementary Figure 3
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Supplementary Figure 3: (a) Results summarizing the tetraploid (4n)
complementation assay using 9 factor-containing Coil a I 2lox 4F2A iPSC lines.All data
was generated 19.5 d.p.c. Grey indicates visible reabsorbtions (negative values), green
indicates stillborn embryos with estimated development from E8-20, blue indicates
liveborn pups that began breathing. Names of each cell line, total number of
blastocysts transferred, and % found breathing (relative to blastocysts transferred) at
birth are indicated below the graph. (b) Brighfield images of adult mice generated with
BB2 iPSC and two additional lines.The liveborn pBF I pup in the right panel shows
enlargement not unexpected with tetraploid embryos.
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Supplementary Figure 4
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(4n) BB2 (+/-; +/+) x C57BU6 (-/-: -/-): F Igeneration 100% transmission of 21ox 4F2A (57/57 pups)
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Supplementary Figure 4: (a) PCR assay for tetraploid cells and iPSC
contribution to all iPSC mice. Band size indicates all mice were generated from
Col Ia I 2lox 4F2A iPSCs by only the upper (Col Ia I targeted) PCR band is visible.
Tetraploid host cells (BDF I lane) and DNA from TTF F3 iPSC. DNA was isolated
from liveborn pups HD (head),TL (tail & limbs) and internal organs LV (liver). (b)
Representative fenotyping of F I pups from BB2 iPSC mice mated to BDF I females.
100% germline transmission of one Col I a I 4F2A allele has been found in 57/57
offspring tested.
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Supplementary Figure 5: (a) Hierachical clustering of microarray gene
expression data using Cluster3 module with tissue-specific iPSCs from non-excisable
Col laI 4F2A iPSCs of liver and proB cell origins. Seven transcripts from within the
Dlk I -Dio3 locus are indicated. Red, postive; Green, negative. Expression values are
gene normalized for the whole array. Heatmaps were visualized in javaTreeView. (b)
Table indicating genotype and sex of iPSCs used in for microarrays. (c) Quantitative
RT-PCR of uninduced transgenice MEFs from two reprogrammable mouse strains
carrying single copies of rtTA and respective Coll a I reprogramming vector (Carey et
al., 2010 and Stadtfeld et al., 2010). Relative expression is normalized to GAPDH.
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Supplementary Figure 6: Methylation analysis of IG-DMR in Col I a I 4F2A iPSC
lines (non-excisable) from Keratinocytes and MEFs.AIl DNA was digested with Stul in
combination with either methylation-insensitive Mspl, or methylation-sensitive Hpall
or Hhal. Images show data from Southern hybridization with a probe to IG-DMR.
Restriction enzymes: M, Mspl; Hp, Hpall; HH, Hhal.
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Supplementary Figure 7: (a) Brightfield images of 4n-embryos from Col I a I -
factor-free iPSC line pBL4 indicating late state development (-E16-18). (b)
Methylation analysis of IG-DMR in 4n-embryos and liveborn pup.AlI DNA was
digested with Stul in combination with either methylation-insensitive Mspl, or
methylation-sensitive Hpall or Hhal.The digested DNAs were analyzed by Southern
hybridization with a probe to IG-DMR. Restriction enzymes: M, Mspl; Hp, Hpall; HH,
Hhal.
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Table I: Summary of blastocyst Injections
4n injections (w/ OSKM) 4n injections (w/o OSKM)
Cell line Blastocysts inj. (4n) Embr arred at Live pups (% ini.) Blastocysts lnj. (4n) Embr arrested at Live pups (% inj.)
BB2 60 1 4(6.7) 60 I 1(1.7)
BC2 60 0 3(5.0) 120 1 9(7.5)
BEI 60 3 0 80 1 0
Liv p2D3 60 1 2(3.3) 60 5 1(1.7)
Liv p3D 1 60 2 1 (1.7) 60 2 1(1.7)
Liv p2E2 60 2 0 60 2 0
pBL4 60 1 0 60 5 1(1.7)
pBFI 60 3 1 (1.7) 60 0 2(3.3)
TTF F3 80 2 0 160 I 1 (0.5)
Total 560 11 (2.0) 720 16(2.2)
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Chapter 5
CONCLUSIONS
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In vitro reprogramming to pluripotency established an uncontroversial, technically un-
challenging, practical system to generate patient-specific stem cells. Chapter 2 focused
on addressing a more technical barrier that related to the use of multiple, independent
viruses to deliver reprogramming factors to somatic cells. By designing novel vectors
and adapting "2A" self-cleaving peptides we constructed a single virus capable of de-
livering up to four reprogramming factors (Oct3/ 4, Sox2, Klf4, and c-Myc) and success-
fully generating iPS cells in both mouse and human. Interestingly we found a reduced
reprogramming efficiency, as indicated by reactivation of the endogenous Nanog locus,
compared to delivery of reprogramming factors with single viruses. This suggests the
reprogramming factor stochiometry using 2A peptides are distinct from that created by
single viruses of all four reprogramming factors. Indeed, excess Sox2 during repro-
gramming inhibits generation of iPSCs (Eminli et al., 2008) from neural precursor cells.
Other polycistronic cassettes that utilize a combination of "2A" peptides and internal
ribosomal entry sites (IRES) have reported higher efficiencies of iPSC generation (Som-
mer et al., 2009) than that observed using "2A" peptides only. Next we found at least
some iPS cell lines harbor only single integrations of the reprogramming provirus, sug-
gesting reprogramming to pluripotency may be possible with minimal genetic modifi-
cation to the genome. These results also established the possibility of excision of repro-
gramming factors upon isolation of iPS cells with one integration. To this end, two
groups utilized the 2A-technology to generate single reprogramming cassettes capable
of being excised upon establishment of iPS cells. Delivery by piggbac transposition es-
tablished iPS cells with one integration that upon excision returned the integration site
to a germline configuration (Woltjen et al., 2009), a similar report used simple mammal-
ian expression vectors (Kaji et al., 2009). More recent work has now established that iPS
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cells can be generated from human somatic cells by repeated delivery of reprogram-
ming factor protein or RNA over a period of 2-6 weeks (Kim et al., 2009; Warren et al.)
suggesting efficient generation of genetically unmodified hiPSCs will soon be a routine
procedure.
Chapter 3 built on the previous chapter's observation that a single integration of
our polycistronic cassette could generate iPSCs. Several technical barriers to studying
reprogramming were addressed by "single-gene" reprogrammable mouse transgenic
strains. The ability to maintain a mouse colony that contained drug-inducible repro-
gramming factors was not possible without concerns of tumors and laborious genotyp-
ing. Previous reprogrammable mouse strains, or secondary systems, utilized single vi-
ruses to establish clonal primary iPS cells lines that were injected into blastocyst em-
bryos to generate somatic cells that harbored genetically identical proviral integration
patterns. However these lines typically had >7 integrations, and to maintain a homozy-
gous mouse colony required careful and extensive genotyping work with each F1 gen-
eration. Moreover many mice developed tumors limiting the use of these strains for
long-term analysis (Markoulaki et al., 2009). Using a single vector carrying all four re-
programming factors we instead targeted ES cells that were then injected to create a
mouse colony whereby four reprogramming factors were expressed from a single ge-
nomic locus (collagen lal). This not only afforded us the ability to maintain homozy-
gous mouse colonies but also allowed easy transfer to different genetic backgrounds
without concerns for tumors, which we do not observe in these strains. In addition we
established that polycistronic vectors could potentially be used to screen for genetic or
chemical compounds that replace individual factors in reprogramming, such as Sox2.
Finally the ability to excise reprogramming factors upon establishment of iPSCs gener-
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ated pluripotent cells that, other than a single loxP site within the 3'UTR of the Collal
locus, harbored genetically unmodified genomes.
Chapter 4 describes an extensive set of experiments on transgene-free iPSCs from
distinct adult tissues, something not possible with any other reprogramming system
published to date. These experiments attempted to address a nagging question and ob-
servation in the reprogramming field, that most iPSC lines created to date do not fulfill
all developmental criteria associated with naive pluripotency in ESCs. First we extend
the findings of others that report the successful generation of tetraploid-competent iPS
cells (Boland et al., 2009; Kang et al., 2009; Stadtfeld et al.; Zhao et al., 2009). These
authors report iPS cells from embryonic and adult mouse fibroblasts at efficiencies simi-
lar to ES cell lines (0.5-13%). However, the isolation of an 4n-competent iPS cell line dur-
ing an individual reprogramming experiment was typically quite rare (3/37 (Zhao et
al., 2009) and 4/61 (Stadtfeld et al.)). Whether these observations are technical and not
biological differences between iPSCs and ESCs has yet to be addressed. Two studies
analyzing gene expression differences between 4n-competent and 4n-non-competent
iPSCs proposed silencing of a single imprinted gene locus at Chr 12qF1 was responsible
for the reduced potency of some iPSC lines (Liu et al.; Stadtfeld et al.). Stadtfeld et al.
(2009) report that the vast majority of lines have aberrantly silenced this locus (4 /61, or
~ 6%). In contrast, we observe that 4F2A-induced iPSC lines do not generally silence the
Dlkl-Dio3 locus with ~ 66% of derived lines showing normal expression of genes within
this imprinted locus. Whether transcriptional differences are underlying these dispa-
rate results upon generation of tissue-specific iPS cells were ruled out by analyzing
transgenic MEFs from each strain, suggesting post-transcriptional differences generate
qualitatively different iPSCs. Finally, we tested whether iPSCs from defined adult tis-
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sues could fulfill all developmental criteria associated with ES cells, such as tetraploid
complementation tests. We find the majority (- 80%) of our iPSCs independent of this
tissue-of-origin are tetraploid competent. Previous reports have identified differential
methylation or altered histone modification patterns in iPSCs, few studies have ad-
dressed whether these are functionally relevant in differentiation towards somatic line-
ages in vivo.
FUTURE APPLICATIONS OF iPSC TECHNOLOGY
Overcoming the major ethical and practical hurdles associated with embryonic
stem cell research was achieved following the discovery of iPS cells. This technology not
only affords a novel tool to dissect nuclear reprogramming in vitro, but will also help
establish new in vitro models of many human diseases (Saha and Jaenisch, 2009). The
vast majority of patients with neurological disorders such as Parkinson's or Alzheimer's
disease do not harbor single mutations causing the disease, with most cases manifesting
"sporadic," non-familial forms of onset and disease occurrence itself. While mouse
models of many diseases do exist, frequently the disease phenotype only partially re-
sembles the human pathophysiology. Issues arising from the inbred nature of mouse
strains can also generate unreliable phenotypes. Therefore use of human patient-
derived induced pluripotent stem cells may afford unique insights into disease pa-
thologies by controlling for genetic background in which the disease occurs and gener-
ating the diseased cell type in vitro. These efforts will require genetic manipulations to
hiPSCs, potentially using highly efficient gene targeting strategies such as zinc-finger
nucleases (Hockemeyer et al., 2009) to generate reporter lines for candidate genes of the
diseased cell type.
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Human ES or iPS cells are unique when compared to blastocyst derived ES cells
in mouse, and more likely reflect the post-implantation epiblast derived stem cells of
mouse, termed EpiSCs (Tesar et al., 2007). These two pluripotent in vitro established cell
types have been called "naive" for the ICM-derived mouse ES cells and "primed" for
the post-implantation derived mouse EpiSCs. EpiSCs have unique gene expression pro-
files, epigenetic marks, X-chromosome states, and growth requirements when com-
pared to ESCs and experiments using "2i" conditions in addition to other compounds
established that further reprogramming of hESCs or hiPSCs can generate naive pluripo-
tent cells with all the aforementioned molecular hallmarks of naive ES or iPS cells of
mouse (Hanna et al. 2010). Although the naive pluripotent state in humans was shown
to technically exist it was stabilized only transiently, suggesting further enhancements
to the current protocol should yield more stable cells that reflect the "ground state" of
pluripotency in mouse.
Induced pluripotency has also opened up new areas of exploration for nuclear
reprogramming generally. It remains unclear how induced pluripotency occurs after
expression of reprogramming factors and applications such as single cell analysis may
offer novel insights into why some iPS cells appear earlier in time (Hanna et al., 2009).
The role of each individual reprogramming factor also remains to be clarified, however
many experiments point to Oct3/4 being one of the most crucial factors. Whether indi-
vidual reprogramming factors can impart unique epigenetic or gene expression states
following establishment of iPSCs also remains to be thoroughly investigated. The use of
polycistronic cassettes may offer novel means to test whether additional expression of
some factors may induce some of the molecular phenotypes described to date in iPSCs,
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suggesting many observations so far can most likely be overcome with further optimi-
zation and study of the reprogramming process.
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APPENDIX I:
Genome-wide maps of chromatin modifications in tissue-
specific iPS cells
NOTE: This data was generated in close collaboration with Menno Creyghton and Albert
Cheng. The data and analysis presented herein on adult tissues was used in Creyghton et
al., 2009 PNAS 107(50):21931-6.
Reprogramming to pluripotency by defined factors is a robust protocol to generate
pluripotent cells from adult somatic cells, yet variability in developmental potential be-
tween iPS cell lines has been reported by several groups 1, 2. Termed "epigenetic memory,"
some iPSC lines were shown to prefer to differentiate back into their tissue-of-origin when
compared to iPSCs derived from other unrelated somatic cell lineages. Whether these ob-
servations are inherent to the induced pluripotent state or due to technical limitations of
the current reprogramming technologies remains under investigation. We sought to ad-
dress these questions using a reprogrammable mouse strain in which we isolated iPSCs
from three separate lineages (e.g. CD19+ proB-cells and adult liver) and compared their
molecular and developmental potential to ES cells. We focused on cell-type-specific cis-
regulatory noncoding elements such as enhancers, which have been previously demon-
strated to harbor unique chromatin signatures in addition to being highly-conserved ele-
ments 3,4.
We tested global gene expression by microarray analysis and also performed ChIP-
Seq on various histone H3 tail modifications such as H3K4me3, H3K4mel, H3K27me3, and
H3K27ac in tissue-specific iPSCs as well as the adult tissues from which they were derived.
In adult tissues 94,437 different putative enhancer regions were identified on the basis of
distal H3K4mel. Similar to previous reports, Creyghton et al. (2010) show H3K4me1 assci-
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ated with a single cell type is also associated with gene activity in that specific cell type 5.
Motif search analysis on conserved DNA sequence identified DNA binding motifs for known
tissue-specific enhancer regulators (e.g. FoxA2) 3- with integration of ChIP-Seq datasets for
each transcription factor showing enrichment at the identified H3K4me1 region. Similar
results were found using 40,274 enriched promoters distal regions for H3K27ac s. Interest-
ingly, Creyghton et al. show enhancers that are H3K4mel+ but H3K27ac- are void of gene
activity and suggest that H3K4mel+ enhancers lacking H3K27ac mark "poised" enhancer
elements associated with potential future gene activity.
We employed similar analysis on tissue-specific iPSCs to determine the extent of re-
programming of histone marks associated with cell-type-specific enhancer elements. We
find that the majority of tissue-specific iPSCs, independent of their tissue-of-origin, success-
fully reprogram global histone modification profiles to that of an ESC-like state. However
some iPSC lines show regions of unchanged histone modifications (e.g. H3K4me1) associ-
ated with "inactive" cell-type-specific cis-regulatory elements. Interestingly, these lines ex-
hibit developmental potential similar, but not identical to ESCs, in they can generate tera-
tomas and liverborn chimeras. In agreement with the transcriptional analysis demonstrat-
ing these iPSCs are highly similar to ESCs, histone marks associated with "active" enhancers
regulating gene activity (e.g. H3K27ac), show complete reprogramming to an ESC-like
state. These data argue gene expression states do not necessarily reflect a fully repro-
grammed epigenome. Successful reprogramming of certain histone modifications but not
others, such as those associated with inactive or "poised" enhancers (e.g. H3K4mel), need
not necessarily reprogram to an ESC-like state. Finally, these lines show incomplete repro-
gramming of H3K4me1 and H3K4me3 at key pluripotency genes such as Oct4 and Klf2,
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suggesting that conclusions of "epigenetic memory" may not necessarily reflect an ESC-like
state given "incomplete reprogramming" of pluripotency genes cannot be excluded as the
cause of limited developmental potential of certain iPSC lines. These results are similar to
previous reports in which incomplete reprogramming of the endogenous Nanog locus was
observed in some iPSC lines that exhibited "epigenetic memory" phenotypes in vitro 1.
MATERIALS AND METHODS (from Creyghton et al., PNAS 2010):
Cell Growth and Culture Conditions. Blastocysts were isolated from the oviducts of hor-
mone-primed [pregnant mare serum at 5 IU/ mouse (catalog no. 367222; Calbiochem),
human chorionic gonadotrophin at 50 IU/mL (catalog no. 230734; Calbiochem)] B6D2F1
mice (Taconic) either 3 d after fertilization or 1 d after fertilization followed by 3 d of cul-
ture in potassium simplex optimized media (Specialty Media). C57/BL6-129JAE (v6.5)
murine ES cells and J21 (C57/BL6) ES cells were grown in DMEM supplemented with 15%
FBS (HyClone), 1,000 U/mL leukemia inhibitory factor 0.001% P--mercapto-ethanol
(M7522; Sigma), 100 iM nonessential amino acids (11140-050; Invitrogen), 2 mM L-
glutamine (25030- 081; Invitrogen), 100 U/mL penicillin, and 100 pg/mL streptomycin
(15140-122; Invitrogen). Adult tissues were isolated from 4- to 6-wk-old 4f2a mice 6.
CD19+ proBcells were isolated by magnetic affinity cell sorting cell separation (Miltenyi
Biotech) according to the manufacturer's protocol. Purified B cell subsets were resus-
pended in Iscove's Modified Dulbecco's Medium with 15%FCS as well as IL-4, IL-7, and
stem cell factor (10 ng ml-1 each; Peprotech) and plated on OP9 bone marrow stromal
cells (ATCC). Cells were fixed in formaldehyde or TRIzol reagent for ChIP and RNA isola-
tion. For isolation of liver cells, mice were first perfused with 50 mL HBSS buffer (without
Ca2+ and Mg2+), then with 50 mL HBSS (without Ca2+ and Mg2+) containing collagenase
(type IV) (Sigma) (100 U mL-1). Liver was dissected away from surrounding tissues and
dissociated in 10mLDAGmedia [phenol-red freeDMEM(Gibco) and BSA 1 g per 0.5 L] and
filtered two times through a sterile 100-pm cell strainer. Liver cell preparations were cen-
trifuged at 30 *- g for 3 min at 4 *C, and the cells were washed two times in PBS. RNA Iso-
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lation and Microarray Analysis. RNA was isolated using TRIzol reagent (Invitrogen) accord-
ing to the manufacturer's protocol and DNase treated using the DNA-Free RNA kit (R1028;
Zymo Research). Cy3 dye-labeled cRNA samples wereprepared using Agilent's QuickAmp
sample labeling kit. Input was 0.5 pg total RNA. Briefly, first- and second-strand cDNA are
generated using Moloney Murine Leukemia Virus-reverse transcriptase enzyme and an
oligo-dT based primer. In vitro transcription
is performed using T7 RNA polymerase and either cyanine 3-CTP or cyanine 5-CTP, creat-
ing a direct incorporation of dye into the cRNA. Agilent (mouse 4x44k) expression arrays
were hybridized according to our laboratories method, which differs slightly from the Ag-
ilent standard hybridization protocol. The hybridization mixture consisted of 1.65 pg cy3
dye-labeled cRNA for each sample, Agilent hybridization blocking components, and frag-
mentation buffer. The hybridization mixtures were fragmented at 60 *C for 30 min, fol-
lowed by addition of Agilent 2X hybridization. The arrays were then hybridized for 16 h at
60 *C in an Agilent rotor incubator set at maximum speed. Arrays were washed (6*-
SSPE/0.005% N-laurylsarcosine) on a rotating platform at room temperature for 2 min,
and then washed again (0.06*- SSPE) for 2 min at room temperature. The arrays were
then dipped briefly in acetonitrile, followed by 30 s in Agilent Stabilization and Drying So-
lution. Arrays were scanned with an Agilent scanner using the Agilent feature extraction
software.
Chromatin Immune Precipitation. Cells were chemically cross-linked eitheronplate or in
suspension by the addition of one-tenth volume of fresh 11% formaldehyde solution con-
taining [1mMEDTA, 0.5 mMEGTA, 100mMNaCl, and 50mMHepes-KOH (pH 7.5)] for 15 min
at room temperature. Cells were rinsed twice with 1*- PBS, harvested using a silicon
scraper or centrifuge, flash-frozen in
liquid nitrogen, and stored at -80 *C before use. Typically 1-3 *- 108 cells were resus-
pended in 10 mL lysis buffer [50 mM Hepes- KOH (pH 7.5), 140 mM NaCl, 1 mM EDTA, 10%
glycerol, 0.5% Nonidet P-40, and 0.25% Triton X-100] and rocked at 4 *C for 10 min. Cells
were pelleted at 2880 *- g on a tabletop centrifuge at 4 *C
and resuspended in wash buffer [200mMNaCl, 1mMEDTA, 0.5 mM EGTA, and 10 mM Tris
(pH 8.0)] and rocked at room temperature for 10 min. Cells were pelleted by spinning at
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2880 0- g/ 4 *C for 5 min and resuspended in 3 mLof sonication buffer [1mM EDTA,
0.5mMEGTA, 10mMTris (pH 8.0), 100mMNaCl, 0.1%
Na-deoxycholate, and 0.5% N-lauroylsarcosine]. We used a Misonix Sonicator 3000 and
sonicated at ~20 W for 8 *- 30-s pulses (60-s pause between pulses) at 4 *C for ES cells
while samples were immersed in an ice bath. For adult tissues we sonicated six to seven
rounds of 30-s pulses. Triton X-100 was added to the resulting whole-cell extract (1% end
concentration), which was then cleared by centrifugation (20,800 *- g at 4 *C), and super-
natant was incubated overnight at 4 'C with 100 iL of Dynal ProteinGmagnetic beads that
had been preincubated with 10 jig of the appropriate antibody for at least 3 h. Beads were
washed five times with RIPA
buffer [50mMHepes (pH 7.6), 1mMEDTA, 0.7% deoxycholate, 1% Nonidet P-40, and 0.5 M
LiCl] and once with Tris/EDTA buffer (TE) containing 50 mM NaCl. Bound complexes were
eluted from the beads by heating at 65 *C with occasional vortexing
in elution buffer [5OmMTris (pH 8), 10mMEDTA, andl%SDS], and cross-linking was re-
versed by overnight incubation at 65 *C. After removal of the beads, immunoprecipitat-
edDNAwas diluted 1:1 with TE and then treated with RNaseA(0.2 tg/ptL final) for 2 h at 37
*C, followed by proteinase K (0.2 ptg/ptL final) treatment for 2 h at 50 *C. DNA was purified
using two consecutive phenol:chloroform extractions using Phase Lock Gel tubes (5') and
once using Qiagen PCR purification columns. The resulting DNA was either used for gene-
specific PCR or further treated for analysis on the Solexa sequencer (GA2X genome se-
quencer) using the ChIP seq
sample prep kit (1003473; Illumina) according to the manufacturer's protocol (11257047;
Illumina), selecting library fragments between 200 and 350 bp. Samples were run by the
Massachusetts Institute of Technology biopolymers facility
(http://web.mit.edu/ki/facilities/biopolymers/index.html) using the GA2X genome
sequencer (SCS v2.6, pipeline 1.5).
Data Analysis. Images that were acquired from the Illumina/Solexa sequencer were proc-
essed using the bundled Solexa image extraction pipeline [version 1.5 or 1.6 (Cassava)]. Se-
quences (36 bp) were aligned using MAQ software (http://maq.sourceforge.net) using murine
genome National Center for Biotechnology Information Build 36 and 37 [University of Cali-
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fornia, Santa Cruz
(UCSC) mm8] as the reference genome. Sequences were map- ped using iterative mapping
from 36 to 26 bp, excluding reads with more than one mismatch and reads that have a se-
quence mapping quality Phred score of <50. Reads that had more than
two exact matches were also excluded to correct for sequence bias. As a minimal require-
ment between 5 and 10 million reads per IP had to be successfully mapped. Analysis of our
sequence data were done on the basis of previous models 73. Sequences were extended
-400/+600 bp for histone marks representing histone-bound DNA length plus fragment
length, or +200 bp for transcription factors, and allocated in 25-bp bins (1.05 *- 108 bins
total). Statistically significant enriched bins were identified using a Poissonian background
model, generally with
a P value threshold of 10-8 to minimize false-positive results. For enhancer identification, a
P value of 10-6 was used for K4me3 to minimize false-negative promoters in our enhancer
pool. We used an empirical background model (H3 for histone marks, whole-cell extracts
for other factors) that require genomic bins to
be enriched at least threefold above background and extended regions to be enriched at
least fivefold above background to correct for nonrandom enrichment observed previously
7. Enhancer locations were defined by the peak of the enriched regions, and these regions
were required to be located at least 1,000 bp away (edge to edge) from a k4me3-enriched
region or a known transcriptional start site (TSS) (downloaded from the UCSC table
browser; http://genome.ucsc.edu/cgi-bin/hgTables?command=start Refseq), including
TSS for miRNAs 7 using
Galaxy (http://main.g2.bx.psu.edu). Enhancer peaks that were within 500 bp of each other
were merged into one enhancer. Identification of DNA binding motifs on enhancers. Repeat
masked conserved sequences from 200-bp regions under the top enhancer peaks (75
counts or more) were analyzed using Bioprospector 9
to identify motifs having a width from 6 to 20 nt. Motifs were matched against known tran-
scription factor motifs in TRANSFAC, UNIPROBE (mouse), and JASPAR (core) databases us-
ing TOMTOM 10.
ChIP-Seq cluster and meta-gene analysis. Enhancers were aligned around the peak loca-
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tion, and genes were aligned according to the position of the transcription start site.
Around these sites a region of -4 to +4 kbp was selected and subdivided in 200-bp bins.
Read density profiles were normalized to the read density per
million total reads per bin around the center of the region. These regions were either left
unsorted or clustered using k-means clustering (Euclidean distance) using Cluster 3.0
software (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/software.htm)
.Heatmaps were generated using Java treeview (http://jtreeview.sourceforge.net/). Meta-
gene plots were generated by collapsing all bins and calculating the average read density
per bin corrected for the total number of reads
Correlation of ChIP-seq data. Correlations were performed on 100-bp bins spanning -4k
to +4k bp of each enhancer or TSS site. The maximum value of the region in each sample is
defined as the peak. The peaks for all regions from all samples were quantile normalized.
The bin values of each region were then rescaled
according to the normalized peak value. Then bin values across all regions from each sam-
ple are then concatenated to form a binding vector. Binding vectors from all samples were
clustered by hierarchical clustering using Pearson correlation and average linkage (see Hi-
erarchical clustering for more details).
Preprocessing of gene expression data. In addition to our our microarray data, a set of
531 microarray data generated using the same platform (GPL4134) was downloaded from
the Gene Expression Omnibus database, which will serve as basis for the rowwise z-score
transformation described below. Microarray data
were processed and normalized within the array by LOESS and across arrays by quantile
normalization using the limma package. To get the standardized expression of each probe
values across samples, row-wise z-scores were calculated using all array data per probe
across all samples.
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FIGURE 1: Genetic background, not tissue-of-origin, correlates with gene expression states
between ESCs and iPSCs. Gene expression of microarray data generated in nine pluripotent
(3 ESC, 8 iPSC lines) clustered using Cluster3 program. Cell type analysis (#1) shows that
liver- or proB-derived iPSCs do not cluseter together. Genetic background, or genotype,
analysis shows a better correlation with iPSCs from the same mouse showing higher simi-
larity. Note that ESCs are present within both iPSC-containing groups suggesting iPSCs do
not harbor as distinct gene expression state. The far left and right groups respectively, are
adult tissues (liver and CD19+ proB cells).
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FIGURE 2: Global enhancer networks are reset during nuclear reprogramming. Heatmap of
118,935 (only subset shown below) distal enhancers based on H3K4mel enrichemnt
(green) and H3K4me3 depletion in the four indicated cell/tissue types showing tissue-
specific enhancer distribution. Four-kilobase pairs around the center of the enhancer re-
gion are displayed.
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FIGURE 3: Majority of iPSC lines reprogram histone modifications associated with cis-
regulatory elements. Shown is correlation analysis for the H3K4mel-enriched regions
shown in A across the whole set of enhancer regions. Color intensities are a measure of cor-
relation (Peason). Note the closer similarity of Liv 1d1 to Liv p4 and Liv p2. In addition Liv
1d1 is an outlier, not similar to ESCs, by global H3K4me1 pattern and is as different as adult
liver compared to ESCs.
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FIGURE 4: Correlation analysis for the H3K27ac-enriched regions shown in A across the
whole set of enhancer regions. Color intensities are a measure of correlation (Peason),
which is also indicated by numbers (data not shown). Note the similarity of Liv 1d1 to
proB6 and V6.5 ESCs, which is in contrast to similar analysis using H3K4mel. NOTE: prior
to this analysis H3K27ac data was not divided into two groups i) promoter-associated or ii)
distal enhancer-associated therefore the extent of successful reprogramming at enhancer,
promoter, or both DNA elements, is unknown.
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proB
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FIGURE 5: ChIP-Seq tracks utilizing IGV genome browser to examine enriched regions for
specified histone modifications in adult and pluripotent cell types. Liv id1 iPSC shows
H3K4mel patterns that reflect the H3K4me3 profile in adult liver, suggesting incomplete
reprogramming of this region.
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FIGURE 6: Incomplete reprogramming of "poised" enhancers from adult somatic cells.
H3K4me1 regions show incomplete reprogramming in Liv 1d1 iPSC line and reflect the
state of adult liver. Note: Sox4 is not expressed in adult liver.
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FIGURE 7: Incomplete reprogramming of pluripotency genes in Liv 1d1 iPSC line. ChIP-Seq
tracks show lack of ESC-like enrichment of H3K4me1 and H3K4me3 in Liv 1d1 iPSC, al-
though these cells express Oct4, and Klf2 RNA as shown by microarray and H3K36me3 sig-
nal (below, green).
U WYmaV U man K3X.m. AIWO
proa PSC L ' A
V6.S ESC
LPv Id9 A
Lt
A. - L .L AA .& I
* AL_
183
REFERENCES CITED:
1. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-
290.
2. Polo, J.M. et al. Cell type of origin influences the molecular and functional properties
of mouse induced pluripotent stem cells. Nat Biotechnol 28, 848-855.
3. Heintzman, N.D. et al. Histone modifications at human enhancers reflect global cell-
type-specific gene expression. Nature 459, 108-112 (2009).
4. Heintzman, N.D. et al. Distinct and predictive chromatin signatures of
transcriptional promoters and enhancers in the human genome. Nat Genet 39, 311-
318 (2007).
5. Creyghton, M.P. et al. Histone H3K27ac separates active from poised enhancers and
predicts developmental state. Proc NatlAcad Sci USA. 107(50):21931-6 (2010).
6. Carey, B.W., Markoulaki, S., Beard, C., Hanna, J. & Jaenisch, R. Single-gene transgenic
mouse strains for reprogramming adult somatic cells. Nat Methods 7, 56-59.
7. Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory
circuitry of embryonic stem cells. Cell 134, 521-533 (2008).
8. Guenther, M.G. et al. Aberrant chromatin at genes encoding stem cell regulators in
human mixed-lineage leukemia. Genes Dev 22, 3403-3408 (2008).
9. Liu, X., Brutlag, D.L. & Liu, J.S. BioProspector: discovering conserved DNA motifs in
upstream regulatory regions of co-expressed genes. Pac Symp Biocomput, 127-138
(2001).
10. Gupta, S., Stamatoyannopoulos, J.A., Bailey, T.L. & Noble, W.S. Quantifying similarity
between motifs. Genome Biol 8, R24 (2007).
184
